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X I
SUM M ARY
1. The physiology o f m am m alian resp ira tion  and the pharm acology o f the 
po ten t; syn the tic  opioids, the fen tany ls , are reviewed. The cu rre n t 
knowledge of the opioid recep to r sub-type invo lvem ents in opio id- 
induced resp ira to ry  depression is summarised, toge the r w ith  the 
experim enta l methods which have previously been employed in studies 
o f recep to r invo lvem ent.
2. The com parative  binding ch a rac te ris tics  o f the p opioid recep to r 
se lec tive  ligand [^ H  ]-  [D -A la ^ -M e P h e ^-G lyo l^ ] enkephalin ([ ^ H ] -  
DAGO) and the 5 recepto r ligand C ^ H ]-[D -P e n ^ ,D -P e n ^  3 enkephalin 
( [^ H  3-DPDPE) were studied in homogenates o f both whole bra in  and o f 
pons/m edulla regions from  the ra t. The recep to r a ff in it ie s  and s ite - 
se le c tiv it ie s  o f f iv e  drugs o f the fen tany l series (a lfe n ta n il, c a rfe n ta n il, 
fen tany l, lo fe n ta n il and su fen tan il) were determ ined by in h ib itio n  
studies, using [  3-DAGO and [^H3 -DPDPE as m arkers o f the p and 6 
opioid binding sites, respec tive ly . The concentra tion  o f 6 opioid sites in 
pons/m edulia was found to be approx im ate ly  one th ird  th a t o f p sites. 
The concentrations o f both p and ^ sites in whole b ra in  were s im ila r to  
th a t o f p sites in  pons/m edulla . The rank order o f a ff in it ie s  o f the 
unlabelled drugs was d iss im ila r at the p and <S sites. The most potent 
fen tany l deriva tives  exh ib ited  neg lig ib le  preference fo r  the p or 6 sites, 
in  con trast to  the least po tent compound, a lfe n ta n il, which showed an 
ex trem e ly  high p -s ite  s e le c tiv ity .
3. The resp ira to ry  depressant p roperties o f the  fen tany ls  were 
investiga ted in urethane-anaesthetised ra ts . V e n tila to ry  param eters 
were measured using a vo lu m e tric  pressure transducer connected via a 
Fle isch tube to a trachea l cannula. Intravenous adm in is tra tion  o f the 
fen tany ls  produced an apnea o f im m edia te  onset and dose-related 
duration , in add ition  to depressing both tid a l volume and resp ira to ry  
frequency, and thus m inute volum e, in  a dose-related manner. The 
potency ra tios  of the fen tany ls  to produce apnea and to depress m inute 
volume were d iss im ila r. Studies o f the e ffe c ts  o f a lfe n ta n il on a rte r ia l 
blood gases confirm ed the reduction  in m inute volum e to  be a 
resp ira to ry  depression.
X l l
4. A method was developed fo r  the q u a n tifica tio n  of antagonism o f the
resp ira to ry  e ffe c ts  o f opioids by means o f infusion o f the  opioid 
antagonist, naloxone, to  p red ic ted  steady-sta te  blood concentra tions, 
which provided accurate measures o f p A 2 * The basis o f the technique 
rests upon de te rm ina tion  o f the plasma clearance o f the antagonist 
whence appropria te  loading doses and zero order infusion ra te  constants 
were ca lcu la ted. The p red ic ted  concentrations o f naloxone were 
ve rifie d  by d ire c t serum measurements using HPLC.
5. Naloxone pA^ values fo r antagonism o f the apnea produced by the
fen tany ls  were id e n tica l and ind ica ted  sole m ediation by the p opioid 
recepto r, which was con firm ed  by intravenous adm in is tra tion  o f 
recep to r-se lec tive  opioids. Apnea was produced by DAGO but not by 
DPDPE or U69,593. This com ponent o f the response was shown to be 
periphera lly -m ed ia ted  and vaga lly dependent, being abolished by 
b ila te ra l vagotom y and the quaternary opioid antagonist, N -m ethy l 
leva llorphan.
6. Naloxone pA^ values fo r antagonism of the m inute volum e depressant
e ffe c ts  o f the fen tany ls  showed s ig n ifican t d iffe rences through the
series, im p ly ing  both a p and non-p recep to r invo lvem ent in th is
cen tra lly -m ed ia ted  response, which could s t i l l  be e lic ite d  a fte r 
vagotom y. A k recep to r co n tribu tio n  to resp ira to ry  depression was 
e lim ina ted  by investiga tion  o f the resp ira to ry  e ffe c ts  o f U69,593 and 
U50,488H. The invo lvem ent o f the ô recep to r was suggested by the 
find ing th a t in tra ce reb ro ven tricu la r adm in is tra tion  of DPDPE produced 
resp ira to ry  depression which was blocked by high doses of naloxone.
7. A study o f the card iovascular e ffe c ts  o f the fen tany ls  confirm ed tha t 
the d iffe re n t naloxone pA^ values fo r depression o f resp ira tion  could 
not be a ttr ib u te d  to th is in fluence,
8. In conclusion, the binding s ite  se le c tiv itie s  o f the drugs o f the fen tany l 
series varied inversely w ith  th e ir  a ff in it ie s  at the p and 6 sites. In vivo 
studies have dem onstrated tha t p receptors alone in the periphery 
m ediate the  apneic responses to Intravenously adm inistered opioids. 
W hilst p receptors in the bra in  are the  most im p o rta n t in  the m ediation 
o f the m inute volume depressant e ffe c ts  o f the fen tany ls  another 
recep to r, possibly <5 , con tribu tes  to  th is response. This non-p 
con tribu tion  is d iffe re n t fo r  each o f the fen tany l drugs, broadly in 
accord w ith  th e ir binding s ite  s e le c tiv ity  exh ib ited  in  v it ro .
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CHAPTER 1 
IN TR O D U C TIO N
1.0 INTTRODUCTION
1.1 G EN ER AL IN TR O D U C TIO N
P ow erfu l m orph ine-like  analgesics, p a rtic u la r ly  when used in high doses, 
e xh ib it a long-las ting  depressant e ffe c t on the resp ira to ry  system  o f man and 
many o the r animals. In acute to x ic ity  studies w ith  such compounds in ra ts  
le th a lity  appears to  be due to th is  p rope rty  and fu rth e rm o re , the re  is evidence 
th a t p rim ates are more sensitive to  th is  e ffe c t than are rodents (Huang et al., 
1984). This has m eant th a t the use o f these compounds in man as anaesthetics 
o r as analgesic adjuncts to anaesthesia has always been lim ite d  by the 
poss ib ility  o f resp ira to ry  depression persisting a fte r the opera tion  is com plete  
and v e n tila to ry  assistance w ithd raw n. This problem  is underlined by the 
re s tr ic te d  recovery fa c il it ie s  in  many hospita ls and the  re la tiv e ly  short 
dura tion  o f most surg ica l procedures (Cookson et a i., 1983).
Since the discoveries in  the 1970’s th a t the re  existed in the nervous 
system o f many animals endogenous o p io id -like  compounds and m u ltip le  
recep to r types fo r  these and o the r opioid ligands, pharm acologists and 
tox ico log is ts  have hoped tha t each o f the diverse e ffe c ts  o f m orph ine-re la ted  
compounds could even tua lly  be assigned to  one or m ore o f these receptors. 
However, much o f the work reported  in  the lite ra tu re  which suggests the 
invo lvem ent o f one or more than one recep to r type  in the m ed ia tion  o f op io id - 
induced re sp ira to ry  depression has presented some d if f ic u lt ie s  in 
in te rp re ta tio n  because the ligands used were inadequately characterised w ith  
regard to  th e ir  a ff in it ie s  and se le c tiv it ie s  fo r  the d iffe re n t receptors, and thus 
i t  is s t i l l  unclear as to  the re la tiv e  con tribu tions  o f various recep to r 
populations in  th is  e ffe c t.
The studies described in th is  thesis have sought to add to the cu rre n t 
knowledge o f the opioid recep to r sub-type involvem ent in resp ira to ry  
depression in ra ts , w ith  special re ference to the 4 -an ilinop iperid ine  series o f 
opioids, the fen tany ls , w h ich  are both potent analgesics and resp ira to ry  
depressants. In add ition , the studies have provided an im proved model fo r the 
q u a n tific a tio n  o f antagonism  jn  vivo, enhancing the investiga tion  o f the opioid 
recep to r types w h ich  m ediate  changes in  au to m a tica lly  con tro lled  variables 
such as resp ira tion .
1.2 P R IM A R Y  AIMS OF THE STUDY
The in it ia l aims o f th is  research were tw o -fo ld . F irs tly , to  q ua n tify  the 
binding o f h igh ly re ce p to r-se le c tive  opioid radioligands both in  whole ra t b ra in  
and in bra in  regions invo lved in  resp ira tion , and then to characte rise  the opioid 
binding site  a f f in ity  and pre ference o f an homologous series o f fen ta ny l class 
drugs in ra t b ra in , w ith  sp ec ific  re ference to resp ira to ry  regions. Secondly, on 
the  basis o f the  binding data, to pursue the opioid recep to r mechanisms 
invo lved in resp ira to ry  depression in the whole anim al model, using a lte ra tions  
in resp ira to ry  frequency, t id a l volume and m inute volume, and production  o f 
apnea as indices o f re sp ira to ry  change.
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1.3 HISTORICAL PERSPECTIVES
1,3.1 Opiates and Opioids
Opium (from  the Greek word fo r  ju ice ) is the dried exudate from  unripe 
seed capsules o f the opium  poppy, Papaver som nife rum , w hich is indigenous to  
Asia M ino r. The a rt o f preparing opium and its  uses have been known to 
inhab itan ts  o f th is  region fo r a t least 5000 years. Opium re lieves pain and 
anx ie ty , prom otes sleep and induces a general fee ling  o f peace and w e ll-be ing , 
and its  use was described in  Chinese m edica l tex ts  in about ADIOOO as a 
tre a tm e n t fo r d iarrhoea.
The alkaloids o f opium co n s titu te  about 25% by w e igh t, and though 
the re  are in excess o f 20 o f them , only fou r: m orphine, codeine, papaverine 
and noscapine, have been used m e d ic in a lly .
Nowadays, a d is tin c tio n  is made between the term s opiate and opioid as
applied to  ce n tra lly  ac ting  analgesics. The fo rm e r te rm  is reserved fo r  agents
derived from  opium or one o f its  constituen ts  w h ils t the la t te r  is the more
general te rm  fo r  agents w ith  m o rph inom im e tic  properties. I t  must be stressed
th a t th is  d e fin it io n  is o f necessity vague, since the closely re la ted  syn the tic
compound, naloxone, is c lassified  as an opioid even though i t  does not m im ic ,
but opposes the actions o f m orphine. In sp ite  o f the fa c t tha t opioid analgesics
in th e ir  main action  in h ib it  ra th e r than prom ote  a pharm acological response,
they are term ed agonists, since the re  e x is t substances like  naloxone which a
block the actions o f m orphine in a co m p e titive  manner, and these are 
c lass ified  as antagonists.
Ever since the in tro d u c tio n  o f m orphine in to  c lin ic a l p ra c tice , i t  has 
been recognised th a t m orphine has a num ber o f s ide -e ffec ts  such as add ic tion ,
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p o te n tia l to lerance and re sp ira to ry  depression, which prom pted the quest fo r 
new opiates, and la te r , opioids lack ing  these s ide -e ffec ts . The search 
continues to  th is day.
1.3.2 Endogenous Opioids and Opioid Receptors
The high potency o f m orphine as an analgesic and the  s t r ic t  dependency 
o f its  ac tion  on its  chem ica l s tru c tu re  led to  the hypothesis tha t i t  must have a 
very re s tr ic te d  s ite  o f ac tion , ie : the re  may ex is t a sp e c ific  recep to r fo r  
opiates and re la ted  drugs. A lthough the existence o f recepto rs fo r  substances 
endogenous to the body, fo r  exam ple, the neu ro tra nsm itte r ace ty lcho line , had 
long been recognised, the existence o f receptors fo r  substances tha t were not 
known to  be endogenous, such as m orphine, was a novel concept. In th is  
co n te x t, i t  is in trig u ing  to  note tha t W eitz e t ^ . ,  (1981) have iso lated 
m orphine and codeine fro m  m am m alian b ra in , which they believe is not o f 
exogenous o rig in . In the m id 1970*s research in  the f ie ld  o f opioid
pharm acology was driven fo rw a rd  by several im p o rta n t discoveries. 
Independently, Simon e t ^ . ,  (1973) P ert and Snyder (1973) and Terenius (1973) 
dem onstrated th a t opiates bound w ith  high a f f in ity  to  homogenates o f bra in in 
a saturable and s te reospec ific  manner. These studies using b iochem ica l 
techniques dem onstrated the existence o f the  'op ia te  recep to r' previously 
hypothesised on the basis o f pharm acological evidence. Using op ia te  recep to r 
b inding techniques, Pasternak e t ^ . ,  (1975) and Terenius and W ahlstrom  (1975) 
dem onstrated tha t a substance in  bra in e x trac ts  displaced the binding to  bra in 
homogenates o f rad io labe lled  opiates. I t  was fu r th e r shown th a t such e x tra c ts  
had the a b ility  to  in h ib it contractions o f guinea-pig ileum  and mouse vas 
deferens preparations in a naloxone-reversib le  manner (Hughes, 1975), These 
find ings toge the r provided an em p irica lly -supported  exp lanation  o f the e a rlie r 
d iscovery by Reynolds (1969) and M ayer e t ^ . ,  (1971) th a t e le c tr ic a l
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s tim u la tio n  o f the periaqueducta l grey region o f ra t bra in  produced naloxone- 
revers ib le  analgesia. Such an exp lana tion  invoked both the opiate  recep to r and 
an endogenous m orph ine -like  ligand fo r  the recep to r, and as a resu lt, the  as 
yet uncharacterised m orph ine -like  substance was term ed enkephalin from  the 
Greek 'en kephalos' - in the head (Terenius and W ahlstrom , 1974; Hughes, 
1975). In 1975 Hughes e t a l., succeeded in id e n tify in g  and assigning s truc tu res  
to  tw o re la ted  pentapeptides which had potent opioid agonist a c t iv ity ,  and 
which d iffe re d  only in the amino acid a t th e ir  carboxyl te rm in i. This iso la tion  
heralded the s ta rt o f a m ajor th ru s t in pep tide-re la ted  research tha t has 
continued to th is  day and has resu lted  in the id e n tif ic a tio n  o f various classes 
o f opioid peptides, and a b r ie f overv iew  o f these is g iven in  Table 1. I t  is 
beyond the scope o f th is  in tro du c tio n  to  enlarge upon these aspects and the 
reader is re fe rre d  to  K itche n  (1985) and Lenz e t ^ . ,  (1986) fo r  a fu l l  rev iew .
A t approx im ate ly  the  same tim e  th a t the  basic s tru c tu re  o f the 
enkephalins was determ ined, the  existence o f various sub-types o f the opiate 
recep to r was postu lated by M a rtin  and colleagues (1976) on the basis o f th e ir  
extensive research in the chron ic spinal dog. On pharm acological grounds, 
M a rtin  described three  d if fe re n t syndromes produced by congeners o f 
m orphine in  th is  model th a t were a ttr ib u te d  to  the in te ra c tio n  o f agonists w ith  
th ree  d istinguishable recepto rs, nam ely, mu (m orphine as ty p ic a l antagonist), 
kappa (p ro to typ ica l agonist ke tocyc lazoc ine) and sigma (ac tiva te d  by SKF 
10047, N -a lly l norm etazocine). Subsequently a fo u rth  sub-type, de lta , was 
proposed, w hich had a re la tiv e ly  high a f f in ity  fo r  the enkephalins in v it ro  (Lord  
e t a l., 1977). Substantia tion fo r  the existence o f a heterogeneous population 
o f opioid receptors has come fro m  a va rie ty  o f b iochem ica l and 
pharm acological approaches, both in v ivo  and in  v it ro . K o s te r litz  e t (1980) 
showed tha t the rank order o f potency o f several opiates and endogenous
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opioid peptides fo r inh ib ition  o f e le c tr ic a lly  s tim u la ted  con tra c tio n  o f the 
guinea-pig ileum  (proposed to  conta in  m a in ly mu receptors) d iffe re d  fro m  th a t 
fo r in h ib itio n  o f con tra c tio n  o f the mouse vas deferens p repara tion  (proposed 
to  conta in  predom inantly  de lta  receptors). Radioligand binding studies have 
revealed sub-populations of receptors in both bra in and periphera l tissues by 
cu rv ilin e a r Scatchard p lo ts (Leslie , e t a l., 1980) and by biphasic in h ib itio n  p lo ts  
(Chang ^  a l., 1979). A no ther line  of evidence in support o f m u ltip le  opioid 
receptors is th e ir d if fe re n tia l d is tr ib u tio n  in the nervous system . This has 
been dem onstrated both w ith  membrane homogenates from  dissected regions 
o f bra in and spinal cord o f several an im al species (Robson e t ^ . ,  1985) and 
w ith  in  v it ro  autoradiographic techniques in  mouse (M oskow itz and Goodman,
1984) and in ra t brain (Mansour e t 1986). P u r if ica tio n  o f m u-, d e lta - and 
kappa-ligand binding polypeptides from  ra t bra in (Ueda e t W., 1987) showed 
them  to have m arked d iss im ila r itie s  in th e ir  m o lecu lar w e ights, suggesting 
th a t m u ltip le  opioid receptors ex is t w hich d if fe r  both fu n c tio n a lly  and 
phys ica lly  from  one another. Spain e t a l., (1985) and M cD ow ell and K itche n  
(1986) have c le a rly  dem onstrated tha t the postnata l ontogeny o f mu opioid 
receptors d iffe rs  from  th a t o f the de lta  recep to r. The irreve rs ib le  blockade o f 
a popula tion o f receptors responsible fo r  the  binding o f a se lec tive  ligand 
would be expected to decrease the binding o f th a t ligand subsequently to  a 
b ra in  homogenate thus trea ted , w ith o u t s ig n ifica n tly  a ffe c tin g  the binding o f a 
ligand which had pre fe rence  fo r a d if fe re n t s ite . James and G oldste in (1984) 
have provided experim enta l evidence fo r  such an e ffe c t by use o f se lective  
opio id  recep to r a lky la ting  agents. Analogously, the fa ilu re  o f the  mu re ce p to r
p ro ffe r in g  ligand su fen tan il to  induce cross-to lerance to  the de lta  p re fe rr ing
" 2 5ligand [D -A la  , D -Leu 3 enkephalin in vasa de fe ren tia  o f m ice ch ro n ica lly  
tre a te d  w ith  su fen tan il (Schulz e t a l,, 1980) supports the assertion th a t 
m u lt ip lic ity  o f opioid receptors can be defined in term s o f m u ltip le  recogn ition
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sites whose a c tiva tio n  by spec ific  opioids may produce independent responses. 
F u rthe r, much evidence exists aris ing fro m  q u a n tita tive  measures o f 
antagonism o f opioid responses by naloxone both in v itro  and in  v ivo  ( fo r a 
rev iew , see T a lla rid a  et ^ . ,  1979) w h ich  is in accord w ith  the hypothesis tha t 
opioids may ac t at d if fe re n t recepto rs  to  produce d iffe re n t e ffe c ts .
There have been suggestions tha t both kappa (C rucian i e t ^ . ,  1986) and 
mu receptors (Pasternak e t ^ . ,  1980) may be fu n c tio n a lly  sub-divided in to  tw o 
or more classes o f recep to r. I t  has been cla im ed tha t a common binding s ite  
(the so-ca lled m u-1 high a f f in ity  s ite ), m ediates the analgesic e ffe c ts  o f both 
enkephalins and exogenous opioids (Zhang and Pasternak, 1981). However, 
others have fa ile d  to  find  evidence fo r  the existence o f such sub-classes o f 
receptors (Rourke and Shaw, 1984). Indeed, Same and Kenner (1987) have 
drawn a lte rn a tive  conclusions fro m  the work o f Pasternak and colleagues 
which does not requ ire  the postu la tion  o f tw o  sub-classes o f the mu recep to r.
Despite these con trove rs ia l m a tte rs , the re  is much c lear and convincing 
evidence tha t there exists in the brains o f many animals m u ltip le  func tiona l 
opioid receptors, and these observations have led to the suggestion th a t 
d if fe re n t opioid receptors may m ed ia te  the d iffe re n t pharm acological e ffe c ts  
o f opioid compounds. I f  th is  was the case, i t  has been reasoned th a t the 
developm ent and use of drugs o f g rea te r s ite -s e le c tiv ity  m igh t be one rou te  
whereby the re la tiv e  co n trib u tio n  o f the unwanted s ide -e ffec ts  resu lting  fro m  
the a dm in is tra tion  o f opioids to the overa ll e ffe c t could be reduced. Thus, 
since 1976 inves tiga to rs  have a tte m p ted  w ith  varied degrees o f success, to 
assign pharm acological s ign ificance  to  each o f the opioid recep to r sub-types. 
The cu rren t position  w ith  regard to  opio id-induced resp ira to ry  depression is 
review ed in  Section 1.7.
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1.4 RESPIRATION AND RESPIRATORY CONTROL
1.4.1 Respiration and Respiratory Depression
The body requires many d if fe re n t substances fo r  the m aintenance o f 
l ife ,  but the m ost urgent need is fo r  a con tinua l supply o f oxygen. O f a lm ost 
equal im portance  is the e lim in a tio n  o f carbon d ioxide, a by-p roduct o f aerobic 
m etabolism . The exchange o f gases between the organism and its  environm ent 
is ca lled 'resp ira tion ', but in m am m als, the fo rm  encompasses th ree  in tim a te ly  
re la ted  processes:
(i) Pulm onary ve n tila tio n , m oving a ir  in  and out o f the lungs in order to  
m a in ta in  a r te r ia l Og, CO^ and pH w ith in  narrow  lim its .
( ii)  Gas exchange, o r rec ip roca l tra ns fe r o f gases between the blood and a ir 
in the  lungs.
( i i i)  C e llu la r resp ira tion , the process o f m e tabo lic  ox idation  requ iring  
oxygen and y ie ld ing  carbon d ioxide .
In the con tex t o f in ves tiga tion  in to  the adverse p roperties o f otherw ise 
th e ra p e u tica lly  valuable compounds such as those re la ted  to the opiate  drug, 
morphine, i t  is thus necessary to  define  what is meant by 'resp ira to ry  
depression', because drugs can a ffe c t resp ira tion  in many diverse ways. For 
exam ple, cyanide ions bind to  the p ros the tic  group o f cytochrom e c oxidase 
invo lved in e lec tron  transpo rt, in h ib itin g  e lec tron  tra ns fe r to  oxygen a t the 
leve l o f the m itochond ria l membrane. Substrates such as glucose are norm a lly
■4
oxidised progressively to  COg by the rem ova l o f e lectrons and th e ir tra n s fe r to  
oxygen via m od ified  adenine d inucleotides and the m itochondria l e le c tron - 
transport chain. I f  the reduction  o f oxygen to  w a te r is ha lted  by cyanide ions, 
the re -o x id a tio n  o f the adenine nucleotides, and w ith  i t ,  c e llu la r resp ira tion , 
ceases. The organism dies despite having adequate a rte r ia l oxygen tensions,
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because the compound has no d ire c t e ffe c ts  on gaseous exchange or pulm onary 
v e n tila tio n , in  as much as the e ffe c ts  on such systems are secondary to  the 
in h ib itio n  o f ce llu la r resp ira tion .
Chronic pulm onary in fe c tio n , ir r i ta t io n  by a irborne p a rtic les  or 
absorption o f the herb ic ide , paraquat, resu lt in a reduction  in the  surface area 
o f the lungs availab le  fo r gaseous exchange through the f i l l in g  o f a lveo li (the 
te rm in a l sacs o f the lungs) by in fla m m a to ry  exudate, a lthough the  p rox im a l 
causes o f th is  cond ition  are d iffe re n t fo r  each stim ulus.
In pharm acology, the te rm  're sp ira to ry  depression' is reserved fo r  a 
d rug-re la ted  increase in  a rte r ia l CO^ and decrease in  a rte r ia l Og and pH which 
rem ains uncompensated by the expected increase in pulm onary ve n tila tio n  and 
i t  is in th is  sense tha t the te rm  is used in  th is  thesis. I t  is im p o rta n t tha t a 
c lea r d is tin c tio n  is drawn between the e ffe c ts  of drugs which reduce 
pulm onary ve n tila tio n  w ith o u t pertu rb ing  blood gas concentra tions (fo r 
instance, by reducing the need fo r oxygen as a resu lt o f a decrease in the 
m etabo lic  ra te ) and those tha t a lte r a rte r ia l Og, CO 2  and pH as a d ire c t 
consequence o f th e ir  e ffe c ts  upon pulm onary ve n tila tio n . Thus, the a n ti-  
thy ro id  drugs, such as the th iocarbam ides, which in h ib it thy ro id  hormone 
synthesis and hence reduce basal m etabo lic  ra te , are not then tru e  resp ira to ry  
depressants in th is  sense, since a rte r ia l blood gas concentra tions rem ain w ith in  
norm al lim its  despite a decrease in the oxygen requ irem ent o f the organism 
and an adaptive fa l l in pulm onary ve n tila tio n . Many drugs o f the opioid class 
o f compounds, however, can produce a dose-related depression of resp ira tion  
as defined above and i t  is th is  m an ifes ta tion  o f to x ic ity  th a t lim its  the 
the rapeu tic  use o f many o f the most po ten t opioid compounds as analgesics, 
fo r  which purpose they are m ost com m only adm inistered.
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1.4.2 The R esp ira to ry  P a tte rn  G enera tor
The co n tro l o f re sp ira tion  is best described as a series o f feedback loops 
th a t s tr ive  to  m a in ta in  a r te r ia l COg and Og tensions w ith in  the lim its  required 
fo r the su rv iva l o f the organism . The au tom a tic  rh y th m ic  con trac tions o f the 
muscles o f b reath ing m igh t, a t f ir s t  glance, be compared w ith  the 
a u to m a tic ity  o f the heart. But, in  sharp con tras t to  the heart, the  resp ira to ry  
muscles possess no in tr in s ic  rh y th m ic ity  and i f  th e ir  m o to r nerves are severed 
they are com p le te ly  paralysed. Despite intensive neurophysio log ica l 
in ves tiga tion , the precise ana tom ica l lo ca tion  o f the re sp ira to ry  p a tte rn
genera tor or resp ira to ry  o s c illa to r is s t i l l  undefined (M e rr ill,  1981) as are the 
types o f b ra in  ce lls w hich m igh t underlie  cen tra l resp ira to ry  rh y th m ic ity  and 
c o n tro l. Because o f th is  d if f ic u l ty  and the com p lex ity  o f the synaptic
connections in the nervous systems o f even the  low est species, progress has
also been slow in the id e n tif ic a t io n  o f key neu ro tra nsm itte r substances in such 
neural loops. D uring the  past 30 years, m icroe lec trode  techniques have 
dem onstrated tha t neurons w ith  re sp ira to ry  re la ted  discharge patte rns are 
concentra ted in tw o  m edu lla ry  regions, the dorsal (DRG) and v e n tra l
re sp ira to ry  groups (VRG) (Speck and Feldm an, 1982). I t  has o ften  been 
assumed th a t resp ira to ry  rhythm ogenesis occurs in these regions (M itch e ll and 
Berger, 1981) but extensive b ila te ra l lesions o f the DRG and VRG resu lt only 
in a d ras tic  reduction  o f the phren ic m o to r nerve discharge w ith  l i t t le  change 
in resp ira to ry  p e rio d ic ity  (Feldm an, 1983). However, the  generation o f the 
basic breath ing p a tte rn  takes place in  the m edulla  (Onim aru and Homma, 1987) 
in tha t rem oval o f the fo reb ra in  and pons does not abolish the  generation o f 
th is  p a tte rn  (M e rr ill,  1981) and i t  does not appear to  depend upon any phasic 
sensory inputs such as s tre tch  a ffe re n t input from  the lungs (Cohen, 1979), 
a lthough m o to r output is c e rta in ly  a ffe c te d  by them . Fu rthe rm ore , the 
m edulla  its e lf  is not the only reg ion  in  w hich re sp ira to ry -re la te d  neurones are
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found, in th a t St John and Bledsoe (1985) have shown th a t rh y th m ic , 
re sp ira to ry -re la te d  a c t iv ity  could be recorded in the tr ig e m in a l nerve of cat 
even a fte r  transection  o f the bra in  stem  at the pontom edulla ry ju n c tion . O f 
the VRG o f neurones, those com prising the nucleus ambiguus have been 
e lim ina ted  as the s ite  o f the re sp ira to ry  pa tte rn  generator because they are 
a lm ost com p le te ly  inac tive  in deep anaesthesia when breath ing  continues 
reasonably w e ll, and because they d ire c tly  innervate  the accessory re sp ira to ry  
muscles (M ue lle r et al., 1982). The m a jo r candidates fo r  such a genera tor ro le  
are the groups o f neurones co ns titu ting  the nucleus o f the tra c tus  so lita rus  
(NTS) and the nucleus parabrach ia lis  m edialis (NPBM) in  the DRG o f the 
m edulla and pons respec tive ly  (M e rr ill,  1981). The NTS neurones provide 
rh y th m ic  output to  the c o n tra la te ra l phrenic m otor neurones and, in add ition , 
p ro jec t to the VRG, sp e c ifica lly  to  the nucleus ambiguus (N A) and to  the  
nucleus re troam biguus (NR A). The N A neurones innervate  the ip s ila te ra l 
accessory muscles o f re sp ira tion , p rin c ip a lly  via  the vagus nerves, w h ils t those 
from  the NRA provide both in sp ira to ry  and exp ira to ry  drive  to  the m otor 
neurones supplying the in te rcos ta l muscles. The NRA neurones, like  those o f 
the N A  f ire  rh y th m ica lly  and in  synchrony w ith  the resp ira to ry  cyc le , bu t may 
f ire  during insp ira tion  and/or e xp ira tio n , and are thought to be invo lved in 
shaping m o to r output (Cohen, 1979).
The insp ira to ry  e f fo r t  is te rm ina ted  by the H ering-B reuer re fle x ; 
s tre tch  recepto rs in the lung provide vaga lly-m edia ted  impulses in h ib ito ry  to
■it
neurones in the NTS. Since b ila te ra lly  vagotom ised anim als do not make 
continuous insp ira to ry  e ffo rts , but breathe sm oothly and very deeply w ith  low  
frequency, the te rm in a tion  o f in sp ira tion  must be possible even w ith o u t vagal 
in h ib itio n . The neurones responsible fo r  th is  continued resp ira to ry  cycle  in the 
absence o f vagal input to  the NTS are loca ted  in  the pons and are ca lled  the 
NPBM or pneum otaxic centre  (Ganong, 1981).
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Despite the absence o f f irm  e m p irica l evidence fo r  the neuroanatom ical 
lo ca tion  o f the resp ira to ry  p a tte rn  genera to r, there  have been no lack o f 
hypotheses fo r the mechanism o f re sp ira to ry  rh y th m ic ity . A lthough the tim e  
course o f resp ira to ry  a c tiv ity ,  such as the  abrupt trans itions  between the 
in sp ira to ry  (I) and e xp ira to ry  (E) phases, could p o te n tia lly  be explained by one 
or m ore o f several types o f in te ra c tio n  between bra instem  resp ira to ry  
neurones (Cohen, 1981) the re  is cu rre n tly  no evidence to  support any type of 
mechanism fo r the m am m alian re sp ira to ry  pa tte rn  genera tor. Pacemaker 
ce lls  analogous to  those in card iac s in o a tria l nodes may e x is t in m edulla  (Dekin 
and G e tting , 1987), but th e ir  presence has ye t to be con firm ed . Cohen (1981) 
suggests tha t such rh y th m ica lly  d ischarging ce lls  may provide the basic signal 
w hich is in teg ra ted  by the dorsal and ven tra l resp ira to ry  groups o f neurones 
and th a t the slope o f the p repo ten tia l vo ltage change o f these pu ta tive  
pacem aker ce lls governs a t least the  frequency o f ve n tila tio n .
Many proposals have been made concerning the  nature o f the neural 
loops responsible fo r  resp ira to ry  rh y th m ic ity . These include re cu rre n t 
in h ib itio n , re cu rre n t e xc ita tio n  and re c ip ro ca l in h ib itio n  (Feldman, 1983,* 
Berger, 1981; Cohen, 1981). R ecurren t in h ib itio n  theory envisages negative 
feedback by insp ira to ry  neurones on th e ir  own output, and a t im e -in te n s ity  
in te g ra l governing both dura tion  o f each insp ira tion  (ra te ) and its  depth. When 
resp ira tion  ceases, exp ira tio n  is triggered  by neurones which use both 
in sp ira to ry  neurone a c tiv ity  and the in sp ira to ry  in teg ra l as governing signals, 
and the procedure is repeated fo r  e xp ira to ry  neurones. Supporters o f the 
re cu rre n t e x c ita tio n  theory propose th a t the re  are e x c ita to ry  co lla te ra ls  
between neurons o f each type tha t produce continual increase o f discharge 
frequency during each phase; th is  could expla in  the augm enting pa tte rn  o f 
discharge observed w ith  m ost e xp ira to ry  and in sp ira to ry  neurones. The
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augm enting e x c ita tio n  w ith in  each resp ira to ry  phase presum ably occurs 
s im ultaneously w ith  augm enting a c t iv ity  in  recu rren t in h ib ito ry  loops which 
even tua lly  produces phase-sw itch ing.
The observation tha t a c t iv ity  o f insp ira to ry  neurones a lte rna tes  w ith  
a c tiv ity  o f e xp ira to ry  neurones has led to  the repeated suggestion th a t 
members o f each popu la tion  in h ib it  members o f the o the r. Such a mechanism 
appears to  operate in to rto ise  bra in  (Taheda e t 1984). However, such 
rec ip roca l in h ib itio n  is not s u ff ic ie n t to  explain the a lte rna tio n  o f resp ira to ry  
phases because such ac tion , i f  unopposed, would tend to keep the re sp ira to ry  
cyc le  fixe d  in  one or o the r phase. There fo re , in order to  explain the abrupt 
phase trans itions, i t  has been proposed th a t there are re cu rre n t Inh ib ito ry  
actions operative w ith in  each phase tha t reach c r it ic a l levels sho rtly  before 
the phase tra ns ition . A ll these recen t ideas are h ighly specu la tive  and a true  
explanation may invo lve  aspects o f a ll o r none o f these theories; fu rthe rm o re , 
the mechanisms o f phase-sw itch ing are themselves obscure. For a fu ll rev iew , 
see Cohen (1979, 1981).
1.4.3 Respiratory Gases and Transport
R esp ira to ry  gases gain access to  the c ircu la tio n  in mammals by sim ple 
d iffu s ion  through a lveo la r w a lls  in to  pulm onary cap illa ries . R ec ip roca lly , 
gases may be e lim ina ted  by d iffu s io n  in to  the alveolus. Such exchanges are 
passive and can only proceed down concen tra tion  gradients.
I t  is im p o rta n t tha t the concen tra tion  or p a rtia l pressure o f oxygen 
(PO2 ) in the blood be m ain ta ined w ith in  narrow lim its  fo r  tw o key reasons: 
C e llu la r resp ira tion  under anaerobic cond itions can proceed only fo r  a lim ite d  
tim e , because the  means by w hich energy fo r  a ll substrate b io transfo rm a tions
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is made availab le  is the co n tro lle d  ox ida tive  process its e lf ,  wherein oxygen 
becomes reduced to the leve l o f w a te r w ith  the co nco m itta n t fo rm a tio n  o f 
high energy phosphate bonds (M e tz le r, 1977). Nevertheless, many a ir-
b reath ing organisms inc lud ing  man, can to le ra te  reductions o f up to 50% in the 
PO2  o f inspired a ir  w ith o u t s ig n ifica n t changes in a rte r ia l PO2 . Conversely, 
ce rta in  ce llu la r components, especia lly  polyunsaturated lip ids , may be 
irre ve rs ib ly  and de le te rious ly  m od ified  in an excessively oxid ising
environm ent, w ith  adverse e ffe c ts  on the v ia b ility  o f the ce ll (K u lka rn i and
Hodgson, 1984).
The carbon atoms o f substrates such as glucose are s to ich io m e tr ica lly  
oxid ised to  carbon d ioxide and th is  m ust be e lim ina ted  because its
accum ula tion  produces changes in the pH o f blood and other body flu ids  
incom patib le  w ith  continued o p tim a l fu n c tio n  o f many aspects o f the 
organism , notab ly  o f e xc itab le  membranes (Rose, 1977) and enzymes (Green, 
1974). The presence of a ce rta in  concen tra tion  o f CO 2  in the blood is, 
however, requ ired because the  equ ilib rium  between blood CO 2 , b icarbonate 
and hydrogen ion is an im p o rta n t com ponent o f the to ta l acid-base bu ffe rin g  
capac ity  o f the body.
By means o f v e n tila to ry  and renal adjustm ents blood gas concentrations 
o f Og, CO 2  and N^ are m ain ta ined a t or near to  the values given in Table 2.
Between 80 and 90% o f the oxygen in the blood is transported  in the 
fo rm  o f oxyhem oglobin. Hem oglobin(Hb) is a p ro te in  o f a m ixed te tra m e ric  
s tru c tu re , each sub-un it having one iron  p ro toporphyrin  IX  m olecule (heme) 
bound cova len tly  to  i t .  Oxygen becomes reve rs ib ly  bound to  the  s ix th  
coord ina tion  position o f each ferrous ion, so th a t hem oglobin can ca rry  up to
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Table 2: P artie l Pressures of Gases in Resting
D ry
A ir
M oist 
Tracheal A ir
A lveo la r
Gas
A rte r ia l
Blood
M ixed 
Venous Blood
P0 2 159 149 104 100 40
pCÜ2 0.3 0.3 40 40 46
PH 2 O 0 47 47 47 47
PN 2 601 56 569 573 573
Pressures are given in mmHg a t standard tem pera ture . The p ropo rtion  o f any 
gas in each column can be ca lcu la ted  by d iv id ing  its  p a rtia l pressure by the 
to ta l pressure.
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fou r molecules o f O 2  per m olecule o f p ro te in . Because o f the pos itive ly  
coopera tive  nature o f the m u ltip le  Hb-Og in te rac tio ns  (H ill,  1910), the 
re la tionsh ip  between p a rtia l pressure o f O 2  and percentage sa tu ra tion  o f Hb is 
s igm oidal. Consequently, Hb is very e ff ic ie n t at tak ing  up O 2  a t the high 
p a rtia l pressure ex is ting  in  the a lveo la r cap illa ries , where Hb becomes a lm ost 
100% satura ted. A t gas tensions found in m ixed venous blood however, Hb is 
only about 75% sa tu ra ted, thus g iv ing  up about 5m l 0 2 /lOOm l blood. The 
oxyhem oglobin d issociation curve is a ffe c te d  by changes in pH, PCO 2 , 
tem pera tu re  and other c ircu la tin g  fac to rs  such as 2,3-d iphosphoglycerate, 
which enhance the binding and release o f O 2  in d if fe re n t loca tions in the body.
The CO 2  produced in the tissues read ily  d iffuses in to  the ca p illa ry  
blood, CO 2  is a la rger m olecule  than Og but its  so lu b ility  in body flu ids  is so 
much g rea te r tha t i t  d iffuses through tissues 20-30 tim es as rap id ly  as does 
0 2 » CO 2  is transported  fro m  the tissues to  the  lungs in blood in tw o  p rin c ip a l 
form s: chem ica lly  combined as e ithe r b icarbonate ion or bound to  prote ins as 
carbam ino groups (some o f w hich is carbam inohem oglobin) and physica lly  
dissolved.
The kidneys also play a m a jo r ro le  in  regu la tion  o f PCO 2  in d ire c tly  
because b icarbonate may re a d ily  be e lim ina ted  via the renal tubules (Bowman 
and Rand, 1980b). The ra t io  o f b icarbonate to  dissolved C O 2  w h ich is norm a lly  
20:1 contro ls  the pH o f the a r te r ia l blood, and w h ils t the co n tro l o f 
b icarbonate concen tra tion  is p r im a rily  ca rried  out by the kidney the  co n tro l o f 
PCO 2  is susceptib le to  the m ore rap id  and fin e r co n tro l a ffo rded  by v e n tila to ry  
adjustm ents.
Carbon dioxide re -b rea th ing  curves have been used both in anim als and 
man to  study the depressant e ffe c ts  o f opioids and the  s tim u la to ry  e ffe c ts  o f
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ana leptic  drugs on resp ira tion  (Jenne tt, 1981). Simple com parison o f m inute  
volum e before and a fte r a drug has the disadvantage tha t the m inu te  volum e 
obta ined may correspond to  tw o  d if fe re n t levels o f pCO^, representing  in 
its e lf  d iffe re n t degrees o f re sp ira to ry  s tim u la tio n . One approach to  th is  
problem  is to measure the re sp ira to ry  response before and a fte r  adm in is tra tio n  
o f the drug w h ils t m a in ta in ing  a known, e levated inspired pCG^. An exce llen t 
rev iew  o f the use o f such techniques in the study o f drugs w hich a ffe c t 
resp ira tion  can be found in Jenne tt (1981).
1.4.4 Sensory Inputs Influencing the Control of Breathing
The output o f cen tra l re sp ira to ry  neurones adjusts the  ra te  and depth o f 
the breath ing  movements in  response to  varying physio log ica l cond itions. 
A lthough there  are a t least 23 groups o f sensory recepto rs  th a t are concerned 
w ith  the nervous and chem ica l co n tro l o f ve n tila tio n  in mammals (P a in ta l, 
1977) the m ain systems invo lved in co n tro lling  ra te , depth and tim in g  o f 
re sp ira tion  com prise pulm onary s tre tch , ir r i ta n t  and type -J  recepto rs , 
periphera l chem oreceptors and chem oreceptors in the CNS its e lf .
1.4.4.1 S tre tch  Receptors
In fla tio n  o f the lungs s tim u la tes  s tre tch  recepto rs in  the a irw ays and 
■ th is  causes a discharge o f impulses in  a ffe re n t fib res  ca rried  in the vagus (X 
cran ia l) nerves which builds up during each insp ira tion  u n til,  a t a s u ff ic ie n t 
in te n s ity , i t  in h ib its  fu r th e r in sp ira to ry  e ffo r t .  These vagal a ffe re n ts  are 
believed to  te rm ina te  in the dorsal re sp ira to ry  group o f neurons where they 
in te ra c t to  in h ib it the ou tpu t in  the  phrenic m o to r nerves (K now lton  and 
Larrabee, 1946) and th is  is the basis o f the H ering-B reuer re fle x . There are at 
least two sub-types o f s tre tch  recepto rs, Type I and Type II (M iserocch i and 
Sant'Am brogio, 1974). A ffe re n t a c t iv ity  fro m  Type I receptors rises to  a 
p lateau as transpuim onary pressure increases, whereas th a t o f Type II s tre tch
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receptors increases lin e a r ly  w ith  increasing pressure. The fun c tio na l 
im p lica tio n s  o f the presence o f these sub-types o f s tre tch  receptors are s t i l l  
unclear (P ack,1981), but they may p e rm it b e tte r d isc rim ina tion  o f absolute 
lung volum e and dynam ic lung volum e changes. I f  the vagi are cu t, in sp ira tion  
is deeper and the ra te  o f re sp ira tion  is reduced; conversely, s tim u la tio n  o f the 
caudal end o f the cu t vagus in h ib its  in sp ira to ry  movements.
1.4.4.2 I r r i ta n t  Receptors
Both m echanical and chem ical ir r ita t io n  in fluence regu la r breath ing  
by evoking coughing or sneezing. Sensory receptors which respond to  
chem icals such as am m onia are present in the sm allest a ir passages and those 
responding to  ir r i ta t io n  by sm all pa rtic les  ex is t in the la rynx, the poste rio r 
w a ll o f the trachea and the upper branches o f the bronchi (W iddicom be, 1954). 
S tim u la tion  o f e ithe r recep to r type  produces vaga lly-m edia ted  impulses 
(P a in ta l, 1973) w h ich  in it ia te  a cough. This involves a p re lim ina ry  deep 
insp ira tion , then a strong e xp ira to ry  e ffo r t  against the closed g lo tt is , which 
resu lts  in a considerable rise  in  pressure in  the airways. When the g lo tt is  is 
suddenly re laxed, and the m outh opened, a ir is expelled a t high speed, w hich 
drives out the ir r i ta n t  m a te ria ls . C ig a re tte  smoke, fo r  exam ple, conta ins both 
chem ica l ir r ita n ts  such as aldehydes and acro le ins and m echanical ir r ita n ts  in 
the p a rtic u la te  m a teria ls . C hem ica l and m echanical ir r ita n t  receptors also 
ex is t in the nasal passages and upper pharynx (Boushey e t a l., 1972) but th e ir  
a ffe re n ts  are ca rried  p r im a rily  in  the tr ig e m in a l nerves (Sant'Am brogio e t al., 
1983).
1.4.4.3 Type-J Receptors
F irs t defined by P a in ta l (1970), type -J  receptors lie  in  the a lveo lar 
w a ll in the jux ta -pu lm onary  ca p illa ry  region and can be s tim u la ted  by 
phenyldiguanidine and by sys tem ica liy  adm inistered opioid drugs such as
27
m orphine (W ille tte  and Sapru, 1982a). W hils t the consequences o f J -recep to r 
s tim u la tion  by m orphine can be prevented by naloxone p re trea tm e n t, th is  has 
no e ffe c t on the response to  phenyld iguanidine. This im p lies th a t both opioid 
and non-opioid recepto rs ex is t on or near to the  structures described as type -J  
recepto rs. In e ithe r case, s tim u la tio n  o f type -J  receptors produces a tr ia d  of 
b radycard ia , apnea and trans ien t biphasic change in blood pressure. This 
response is very rapid in onset and has been described as a ca rd io resp ira to ry  
re fle x  (W ille tte  and Sapru, 1982b). Type-J receptors can also be s tim u la ted  by 
h istam ine, but apnea is usually absent and the overa ll e ffe c t is genera lly a 
trans ien t tachypnea (P a in ta l, 1977).
1.4.4.4 Blood Gas Homeostasis
The func tion  o f pulm onary ve n tila tio n  is to  p e rm it the uptake of 
oxygen (which is transported as oxyhem oglobin) and the e lim ina tio n  o f the 
m etabo lic  product, carbon d ioxide (which is transported as b icarbonate, 
dissolved CO 2  and carbam inohem oglobin). R esp ira to ry  chem oreceptors 
respond to  loca l chem ical changes and e lic it  appropria te  resp ira to ry  
adjustm ents in order to  m a in ta in  homeostasis. The chem oreceptors invo lved in 
the regu la tion  o f resp ira tion  have been classified  as 'periphera l' and 'ce n tra l' 
on the basis o f th e ir  respective  ana tom ica l locations.
1.4.4.5 Periphera l Chem oreceptors
Chem oreceptors which respond to hypoxia are s itua ted  in  the 
ca ro tid  and a o rtic  bodies. In add ition , pulm onary chem oreceptors have been 
described (C oleridge et a l., 1967) and anatom ica l tissue s im ila r to tha t o f 
chem oreceptors is also found along the course o f the abdom inal po rtion  o f the 
aorta  (Abbot and Howe, 1972). I t  is possible, however, th a t the so-called 
pulm onary chem oreceptors are in fa c t  the type -J  recepto rs described above, 
because the e ffe c ts  resu lting  fro m  th e ir  s tim u la tion  closely resembles the
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re fle x  tr ia d  (Ganong, 1981). The ca ro tid  bodies, located b ila te ra lly  at the 
b ifu rca tio n  o f the common ca ro tid  a rte ries , are composed o f specialised ce lls 
(glomus ce lls) w hich lie  in close con tac t w ith  blood cap illa ries  and nerve 
endings. They are s tim u la ted  by decreasing pO^ in a rte r ia l blood (Comroe and 
Schm idt, 1938) and to  a lesser ex ten t by e levated pC Ü 2  ( Hey mans e t a l., 1930) 
or decreased pH (Schm idt e t a l., 1939). The a ffe re n t fib res fro m  these bodies 
are ca rried  in the glossopharyngeal (III c ran ia l) nerve, w hich also carries the 
barorecep to r a ffe re n ts , and fib res  running from  the ca ro tid  chem oreceptor 
bodies have been shown to  te rm in a te  in the nucleus tra c tus  so lita riu s  in the 
m edulla  (L ipsk i e t a l., 1975). E ffe re n t fib res  have also been shown to  
te rm in a te  on the glomus ce lls , but th e ir  fun c tio n  is unknown.
The a o rtic  chem oreceptor bodies are s im ila r in  s tru c tu re  (below) to  
the ca ro tid  bodies and are found near the arch o f the aorta  beneath the roo ts 
o f the subclavian a rte ries . Because o f th e ir  anatom ica l lo ca tion , they have 
not been stud ied in as great de ta il as the ca ro tid  bodies and the convenient 
assumption has been made th a t th e ir  respective  ro les in  v e n tila to ry  
homeostasis are q u a lita tiv e ly  s im ila r, a lthough i t  is c lear th a t the ex ten t to 
which each con tribu tes  to th is  end d iffe rs . The a o rtic  bodies conta in  a ffe re n t 
nerve endings which run in the vagus (X cran ia l) nerve and p ro jec t to  the 
dorsal resp ira to ry  group o f neurons w hich include both those o f the nucleus 
tra c tu s  so lita rius  and the nucleus parabrach ia lis  m edialis (G illis  e t ^ . ,  1980).
The ca ro tid  and a o rtic  bodies conta in  islands o f tw o types o f glomus 
ce lls , Type 1 and II, p redom inantly  type  I (A bbot and Howe, 1972) w hich are 
surrounded by fenestra ted  sinusoidal cap illa ries  and provided w ith  the  la rgest 
sp ec ific  blood f lo w  o f any organ in the body (200Gml/min/10Dg compared w ith  
5 0m l/m in /lG 0g  fo r  the bra in). Nerve endings are found at in te rva ls  between 
the tw o types o f ce lls  and the nerve endings themselves are probably the
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chem oreceptors. In accordance w ith  th e ir  high spec ific  blood flo w  ra te , the 
ca ro tid  bodies are m e ta b o iica lly  in tense ly ac tive  - the consum ption o f oxygen 
is high at about lO m l/lO D g tissue /m in . The mechanism whereby hypoxia 
exc ites  the chem oreceptor bodies is unknown (Osborne and B u tle r, 1975) but 
s u ffic ie n t evidence exists concerning the nature o f the synaptic connections 
and the presence o f ce rta in  n eu ro tra n sm itte r substances to p e rm it postu la tion  
o f a p a rtia l hypothesis. Vesicles in the a ffe re n t nerve endings conta in 
ace ty lcho line , and dopam ine-conta in ing  granules are present in the glomus 
ce lls  (Bowman and Rand, 1980a). There appears to be a tw o-w ay synaptic 
connection between the nerve and the glomus ce ll, and i t  is suggested th a t 
during norm oxia, the  re lease o f dopamine hyperpolarises the nerve endings, 
thus in h ib itin g  s ig n ifica n t spontaneous discharge. I f  hypoxia reduces the 
synthesis or release o f dopamine fro m  the glomus ce ll, the a ffe re n t nerve, 
freed  fro m  in h ib itio n , discharges ac tion  potentia ls . In add ition , these 
s tim u la ted  nerve endings release ace ty lcho line  which, by in h ib itin g  dopamine 
release, fu r th e r enhance chem orecepto r a c t iv ity  in  response to hypoxia, which 
ceases only when a rte r ia l p02  is re turned  to normal lim its  (Osborne and 
B utle r, 1975; Bowman and Rand, 1980a). F rom  a b iochem ica l po in t o f view , 
the discovery o f apparently  inapp rop ria te ly  high leve ls o f m etabo lic  a c t iv ity  in 
a tissue such as the ca ro tid  bodies im m ed ia te ly  suggests the existence o f a 
' fu t i le  cyc le ' which p e rm its  a m p lif ic a tio n  o f a change (reduced PO2 ) in 
environm ent rap id ly  and w ith  high gain (S tryer, 1981). Despite the high usage 
o f oxygen, the  arteriovenous d iffe re n ce  in  oxygen tension is sm all across the 
ca ro tid  body, which im p lies th a t the tissues are s u ff ic ie n tly  supplied by 
dissolved oxygen alone. This also explains why carbon monoxide poisoning is so 
dangerous; because i t  does not reduce dissolved oxygen concentra tions (only 
the oxygen-carry ing  capac ity  o f hem oglobin), i t  does not read ily  s tim u la te  
h ype rven tila tion .
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Periphera l chem oreceptor discharge increases when e ithe r a rte r ia l 
pO^ fa lls  or pCO^ rises. The tw o  s tim u li in te ra c t in such a way th a t hypoxia 
enhances the discharge associated w ith  hypercapnia and vice  versa. These 
chem oreceptors can also respond to  a lesser degree both to  CO 2  d ire c tly  or to 
the loca l changes in pH w hich re su lt fro m  elevated a rte r ia l pCO^. Since 
carbonic anhydrase in h ib ito rs  such as acetazolam ide reduce the speed and 
in tens ity  o f the chem oreceptor response to  CO^, th is  suggests tha t a t least 
part o f the response involves conversion o f CO 2  in to  H^ and H C O j
Adenosine also s tim u la tes  resp ira tion  in man v ia  the ca ro tid  body 
chem oreceptors (W att e t 1987), but the physiological s ign ificance  o f th is  is 
unclear because the plasma h a lf- l ife  o f adenosine is less than 10 seconds 
(Klabunde, 1983).
Concerning the re la tiv e  con tribu tions o f components o f the blood 
gas hom eostatic mechanism, i t  has been estim ated th a t periphera l 
chem oreceptors are responsible fo r  about 15% o f the re sp ira to ry  drive  during 
eupneic ve n tila tio n , m ostly  fro m  the ca ro tid  chem oreceptors in man (McQueen 
and P a lle t, 1983). The concensus in the lite ra tu re  is tha t a c tiva tio n  o f ca ro tid  
chem oreceptors increases tid a l volume and to  a lesser degree, frequency, 
whereas a o rtic  chem oreceptor s tim u la tio n  has less e ffe c t on t id a l volume, but 
does e levate frequency; in add ition  i t  is held th a t the re la tiv e  in fluence  o f the 
ca ro tid  chem oreceptors on resp ira tion  is much more im p o rta n t than tha t of 
those in the aorta .
1.4.4.6 Endogenous Opioids and P eriphera l Chem oreception
There may be a physio log ica l ro le  fo r  c ircu la tin g  (C lem ent-Jones e t 
a l., 1980) or lo ca lly  released endogenous opioid peptides in m odulating the 
responsiveness o f ca ro tid  chem oreceptors to hypoxia or hypercapnia. The ca t
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ca ro tid  body contains both [M e t] and [L e u ] enkephalin (W harton e t a l., 1980) 
and opioid receptors, probably o f the 6 subtype (K irby  and McQueen, 1986) 
and in tra c a ro tid  in jec tions o f opioids depress chemosensory discharge in  a 
dose-dependent naloxone-reversib le  manner (McQueen and R ibe iro , 1980; 
Pokorski and L a h ir i, 1981). In tra c a ro tid  adm in is tra tion  o f the  6-antagonist IC I 
174,864 to  opio id-na ive cats fa iled  to  a lte r chemosensory discharge or resting  
v e n tila tio n , but the responsiveness to  hypoxia was enhanced, suggesting th a t 
endogenous opioids depress chem osens itiv ity  during hypoxia. In con tras t, the 
responsiveness to  hypercapnia was reduced a fte r  the antagonist, im p ly ing  the 
endogenous opioids may p o te n tia te  chem oreceptor se n s itiv ity  during 
hypercapnia (K irby  and McQueen, 1986). I t  is th e re fo re  possible th a t 
a c tiva tio n  o f opioid receptors in c a ro tid  chem oreceptors con tribu tes  to  the 
overa ll resp ira to ry  depression w h ich  occurs a fte r  a dm in is tra tion  o f opioid 
compounds. Since the most im p o rta n t ro le  o f the periphera l chem oreceptors is 
th e ir  de tec tion  o f and response to  changes in carbon d ioxide and oxygen 
tensions, the  above find ings are consistent w ith  such an hypothesis.
1.4.4.7 C en tra l Chem oreceptors
A lthough chem oreceptors in the ca ro tid  and a o rtic  bodies are
responsive p rim a rily  to hypoxia, and to  a sm a lle r degree, hypercapnia, the
ce n tra l nervous system has no known in tr in s ic  mechanism whereby changes in
oxygen tension may be detected. Indeed, hypoxia does not s tim u la te  ce n tra l
\chem oreceptors and resp ira tion  is depressed by the d ire c t e ffe c t o f hypoxia on 
the CNS. Conversely, w h ile  e levated pC 02  or decreased pH can s tim u la te  
resp ira tion  c e n tra lly  or pe riphe ra lly , a m arked hypercapnia can also resu lt in a 
ce n tra l depression o f resp ira tion  (Bowman and Rand, 1980a).
A na tom ica lly  described as a chem osensitive zone in  the supe rfic ia l 
ven tra l medulla o f ca t and ra t w hich when s tim u la ted  causes h ype rven tila tion
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(M itc h e ll £ t 1963) the cen tra l chem oreceptors are located near to, but are 
d is tin c tly  separate fro m  the main re sp ira to ry  centres. This zone, loca ted 
b ila te ra lly  along the po in t o f e n try  o f c ran ia l nerves 8-10 is sensitive to  low 
pH and e levated pC 02 but not to  hypoxia. O ther fac to rs  th a t depress neural 
a c t iv ity ,  such as cold or loca l anaesthetics, depress resp ira tion  when applied in 
th is  area (M itc h e ll e t a l., 1963). A lthough th is  area has been w e ll described 
phys io log ica lly , the precise ana tom ica l fea tures are as ye t unknown.
I t  is now c lea r th a t hydrogen ions are the sole stim u lus o f cen tra l 
chem oreceptors (Loeschcke et a l., 1979), despite the find ings tha t e levated 
inhaled CO 2  has a d ram atic  e ffe c t  on ve n tila tio n  compared to  the sm all e ffe c t 
o f a system ic acid in je c tion . I t  has been shown in pen tobarb itone- 
anaesthetised cats th a t tid a l volume (a fte r denervation o f periphera l 
chem oreceptors) is d ire c tly  re la ted  to  the pH on the surface of the ven tra l 
m edulla  but not, fo r  instance, on the  surface o f the  co rtex  (Ahmad and 
Loeschcke, 1983). This chem osensitive zone is thought to  be supe rfic ia l, and 
the com position o f the e x tra c e llu la r flu id  (ECF) is in fluenced by chem ica l 
changes in the cerebrospinal f lu id  (CSF). CSF is separated from  blood by a 
membrane known as the  b lood-bra in  b a rrie r. This b a rrie r a llows gases and 
o the r lip id  soluble substances to  move fre e ly  ye t re s tr ic ts  the passage o f ions. 
Thus, changes in blood pH cannot d ire c tly  be tra nsm itte d  to  CSF because the 
m a jo r ity  o f CO 2  in the blood exists in the fo rm  o f ionised b icarbonate. 
However, CO 2  and w a ter can combine to fo rm  carbon ic acid which rap id ly  
dissociates to  produce b icarbonate and hydrogen ions, reactions which are 
revers ib le  and whose products ex is t in  e qu ilib rium . A lthough e levations in 
pC Ü 2  do give rise to  decreased pH, th is  process is g re a tly  acce lera ted by the 
enzyme carbonic anhydrase, a m e ta llop ro te in  abundant in e ry th rocy tes  and, 
in c id en ta lly , in gas tric  acid secre ting  ce lls  and in ce lls  o f the renal tubules 
(th is  mechanism in the kidney plays a m ajor, though secondary, ro le  to the
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lungs in regu la tion  of blood pH (Bowman and Rand, 1980b), by co n tro lling  
b icarbonate  e lim ina tion ). The foregoing perm its  changes in  blood pH and 
pCO^ to  be qu ick ly  re fle c te d  by changes in CSF, which is less w e ll bu ffe red  
than blood and in which the pH para lle ls  th a t o f the blood.
Thus, although CO^ is the in te rm ed ia te  messenger in such a 
com m unication  system, COg its e lf  is not the e ffe c to r  (Loeschcke e t a![., 1979). 
E xpe rim en ta lly  produced changes in pCO^ o f CSF have m inor, va riab le  e ffe c ts  
on resp ira tion  so long as the pH is held constant, but any decrease in the pH o f 
CSF s tim u la tes  resp ira tion  in a d ire c tly  p roportionate  manner (Ahmad and 
Loeschcke, 1983). Thus, the e ffe c ts  o f CO 2  on resp ira tion  are apparently 
m a in ly due to  its  movement in to  CSF where i t  increases hydrogen ion 
concen tra tion  and s tim u la tes recepto rs sensitive  to  H^. I t  is unclear to  w ha t 
ex ten t forces other than those d riv ing  the  chem ical e q u ilib r ia  between CO 2 , 
b icarbonate and H^ con tribu te  to pH changes in CSF resu lting  fro m  e leva tion  
o f CSF pC02* C ircum sta n tia l evidence suggests th a t these in te r con versions 
are passive processes in CSF because in con tras t to the rap id  responses to 
changes in blood pCO^ m ediated by the periphera l chem osensitive systems, the 
ce n tra l chem oreceptors require  many seconds or m inutes to  a ffe c t ve n tila tio n .
There appear to  be two d is tin c t areas on the ve n tra l m edullary 
surface which are sensitive to changes in pH (Cherniak e t a l., 1979). The tw o 
areas are m edial to  the vagal roo ts  and m edial to the hypoglossal roo ts, 
notably the input areas from  the periphera l chem oreceptor a ffe re n ts . 
A pp lica tions o f acid to the in te rm ed ia te  area between the caudal and vesta l 
sites does not produce a s im ila r response; indeed, a s ligh t depression o f 
ve n tila tio n  occurs. This area has been ca lled  the in te g ra tio n  zone because 
although i t  is not d ire c tly  responsive to  changes in pH, i t  is essentia l to the 
e levations in ve n tila tio n  produced by decreases in pH at the o ther two sites.
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Cooling or procaine block at th is  in te rm ed ia te  area abolishes v e n tila to ry  
adjustm ents in response to inhaled COg or to p ica lly  applied acids (Cherniak e t 
1979).
W hils t i t  is abundantly c lear tha t many, though not a ll, c e n tra lly -  
m ediated card iovascu la r e ffe c ts  o f drugs involve m edullary neurones (B e lle t e t 
a l., 1980; McQueen, 1983; Hassen et af .^, 1984a; H urle  e t a l., 1982; fo r  a 
rev iew , see Feuerste in , 1985) i t  must be doubted th a t these card iovascu la r 
responses are re layed by the same neurones as those re la ting  to  resp ira to ry  
chemosensory responses. This has been dem onstrated by Loeschcke, e t a l., 
(1979) who dem onstra ted tha t pH changes on the ven tra l m edullary surface are 
w ith o u t c lear and reproducib le  e ffe c ts  on a rte r ia l blood pressure and hea rt 
ra te .
The neurochem ical mechanisms underlying ce n tra l chem oreception  
are even less w e ll understood than those involved in the periphery, a lthough i t  
may e n ta il a cho line rg ic  lin k  w h ich  can be blocked by a trop ine . A ce ty lch o lin e  
applied to p ic a lly  to  e ithe r the ro s tra l or caudal chem osensitive zones produces 
e levations in v e n tila tio n , and a trop ine  not only blocks th is  e ffe c t but also the 
response to  to p ica l acid (Fukada and Loeschcke, 1979).
1.4.4.8 M iscellaneous Inputs
A ffe re n t fib res  from  the baroreceptors in  the ca ro tid  sinuses, a o r tic  
arch, a tr ia  and ve n tric les  re lay to  the resp ira to ry  centres as w e ll as the 
vasom otor and ca rd io in h ib ito ry  centres. Impulses in them  do in h ib it 
resp ira tion , but the in h ib ito ry  e ffe c t is s ligh t and o f l i t t le  physio log ica l 
im portance; they may assume a more s ign ifican t ro le  i f  drugs adm in istered 
which depress resp ira tion  also a lte r blood pressure or heart ra te  (Feuerste in ,
1985). The h yp e rve n tila tio n  in shock is due to chem oreceptor s tim u la tio n
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caused by acidosis and hypoxia secondary to  loca l stagnation o f blood flo w  and 
is not barorecep to r m ediated (Landgren and N e il, 1951). In add ition , the 
a c tiv ity  o f the insp ira to ry  neurones a ffe c ts  blood pressure and heart ra te  in  a 
cyc lic a l and d is tin c t manner, whereas a c tiv ity  in the card iac and vasom otor 
centres in the m edulla  has only m ino r e ffe c ts  on resp ira tion , fu r th e r 
underscoring the re la tive  neural autonom y of the m edulla igfrespiratory centres.
The resp ira to ry  cen tre  is in fluenced by higher centres o f bra in ; the 
cerebra l co rtex  contains centres th a t both fa c il ita te  and in h ib it b reath ing. 
These are probably concerned w ith  the degree o f vo lun ta ry  con tro l which can 
be exerted , fo r  exam ple, over the holding o f the breath, and the in te n s ity  o f 
such inputs co n tribu te  to  the 'break po in t' in such an exercise due to s tead ily  
ris ing  pCO^.
A lthough the re la tiv e  Influence o f card iac and vasom otor sites in 
the bra in stem upon re sp ira tion  appears to be s ligh t, inputs o f m ore 
im portance ex is t which arise in more ros tra l areas, c e rta in ly  in  the a n te rio r 
hypothalamus (Faden and Feuerste in , 1983). These authors and P fe if fe r  and 
coworkers (1983) have dem onstra ted th a t in jections o f opioid in to  the  nucleus 
preopticus m edialis (POM), w h ich  comprises a m ajor pa rt o f the a n te rio ve n tra l 
hypothalamus o f ra t, and is known to  have an im portan t ro le  in card iovascular 
co n tro l, can produce both pertu rba tions o f card iovascular param eters and 
resp ira to ry  depression which is not secondary to  the fo rm e r e ffe c ts . This 
provides ye t another mechanism whereby exogenous opioid compounds may 
in fluence resp ira tion  and f in a lly  serves to  underscore the com plex natu re  o f 
the responses to  these substances, w hich probably are due to  a num ber o f 
in te ra c tin g  sub-responses produced by the drugs. A schem atic represen ta tion  
o f the m ajor inputs to  re sp ira tion  is shown in F igure 1.
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Figure 1 Factors A ffecting Respiration
A schem atic represen ta tion  o f the m ajor in fluenc ing  fac to rs  on resp ira tion . 
The arrows stress neural connections which can produce a lte ra tions  in  the 
p a tte rn  o f breath ing. The asterisks ind ica te  systems suspected o r known to be 
a ffe c te d  by opioids.
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1.5 F E N T A N Y L DRUGS
1.5.1 Introduction
Fentanyls are a class o f po ten t, syn th e tic  opioid analgesics based on a 
4 -an ilinop ipe rid ine  nucleus (F igure 2). The p ro to type  drug fen ta ny l was f ir s t  
synthesised by Janssen P harm aceutica ls in 1960 and since then many others 
(ca rfe n ta n il and su fen tan il, 1974; ca rfe n ta n il, 1975; a lfe n ta n il, 1976) have been 
produced. To date, m ore than tw o dozen deriva tives have been synthesised 
(Van Sever e t ^ . ,  1976; To ilenaere  e t ^ . ,  1986) but o f these only a lfe n ta n il, 
fen ta ny l and su fen tan il have seen extensive c lin ic a l use.
1.5.2 Applications
In te res t in the fen ta ny l series o f drugs o r ig in a lly  focussed on th e ir  
ex trem e ly  high potency as conventional opioid analgesics. For exam ple, 
fen ta ny l is 50-100 fo ld  m ore potent than morphine in  man when adm inistered 
in travenously (Cookson and Towse, 1981). However, much o f the cu rren t 
in te re s t in  a lfe n ta n il, fen ta ny l and su fen tan il re la tes to  th e ir  use in  surgery as 
sole anaesthetic agents w ith o u t supplem entary hypnotics (Janssen, 1982). 
Stanley and W ebster (1978) described anaesthesia w ith  fen ta ny l 50-lOOpg/kg as 
a com plete  anaesthetic, w ith  no p rem edica tion  or supplements fo r  m itra l valve 
surgery. P atien ts  were ve n tila te d  w ith  100% Og and sa tis fa c to ry  anaesthesia 
was accompanied by m in im a l card iovascu lar depression. F u rthe rm ore , 
fen tany l appeared to  abolish the hyperg lycaem ic, co rtiso l and g row th  hormone 
responses to  surgery (Lunn e t a l., 1979). The card iovascu lar s ta b il ity  is 
a ttr ib u te d  to  low er release o f h istam ine by the opioid w hich is a problem  w ith  
high doses o f m orphine (Stanley e t a l., 1973).
In humans, th e ir  m in im al e ffe c ts  on the card iovascu lar system 
compared w ith  m orphine a t anaesthetic doses (F reye, 1974) makes them  
p a rtic u la r ly  advantageous in pa tien ts  w ith  low  card iovascu lar reserve, such as
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CH2 -CH2 -N ^ _______  ^ CIS (-) oxalate.
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N-CO-CH2 -CH3
CHo-O-CHCH, Sufentanilc itra te .
(578)
R33800
Figure 2
Chemical Structures of Five Drugs of the A-Anilinoplperidine Series
The drugs were supplied as the sa lts ind ica ted , w ith  th e ir  m o lecu lar weights in  
parentheses. The codes given below are those by which they are sometimes 
known, and o rig ina te  fro m  the m anufacturers, Janssen.
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those undergoing card iac surgery. In addition, the doses (re la tive  to the 
e ffe c tiv e  analgesic doses) required to  induce convulsions are much la rger 
compared w ith  peth id ine  or morphine (Cookson and Towse, 1981), thus these 
compounds have a w ider m argin o f sa fe ty .
A lthough the fen tany ls  have been used as com plete anaesthetics, i t  is 
more usual to  employ them  as anaesthetic adjuvants. However, the main 
advantage o f a lfe n ta n il, nam ely, short duration  o f ac tion  p e rm ittin g  rapid 
recovery, is lost i f  o ther adjuvants are used whose durations o f ac tion  are long.
O f the many fen tany l deriva tives  synthesised, re la tiv e ly  few  have 
found widespread c lin ic a l app lica tion . The ir actions appear to  be q u a lita tiv e ly  
s im ila r and th e ir d if fe re n tia l u t i l i t y  rests upon large d iffe rences in h a lf- l ife  
and potency. However, ca rfe n ta n il has proved an e ffe c tiv e  rep lacem ent fo r  
the long-acting  opioid e torph ine in the im m ob ilisa tion  and capture o f large 
w ild  animals (de Vos, 1978). This compound is h ighly po ten t, thus only sm all 
volumes o f so lu tion  are required , gives rapid induction  and its  e ffe c ts  can 
rap id ly  be reversed by opioid antagonists. L o fe n ta n il possesses an 
e x tra o rd in a rily  high potency as an analgesic, but its  very long duration  o f 
action  (Leysen and Laduron, 1978) and equ iva lent resp ira to ry  depressant 
e ffe c ts  preclude its  use as a the rapeu tic  agent.
1.5.3 Respiratory Toxicity
Despite the c lin ic a l advantages displayed by many o f the drugs o f th is  
series, fen tany ls  are ty p ic a l m orph inom im etics and possess o therw ise s im ila r 
pharm acological properties to  m orphine, nam ely, they produce a t s u ff ic ie n tly  
high doses resp ira to ry  depression, constipa tion , emesis and nausea and have 
the associated problems o f to lerance and dependence lia b il i ty .  The p rim ary  
tox ic  e ffe c t, the re fo re , o f the drugs o f th is  series is resp ira to ry  depression and
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in acute to x ic ity  studies th is is the cause o f death. Because o f the high 
potency o f some o f the fen tany l de riva tives  there has been in te res t in the 
mechanism of to x ic ity  o f these compounds (Fone and Wilson, 1986; Freye and 
Hartung, 1981; Hewson and B radley, 1982). As an in d ica tion  o f the ex trem e  
to x ic ity  o f one o f the fen tany ls , the  in ra ts fo r lo fe n ta n il is 10-fo ld
low er a t G.066mg/kg than the fo r  the  nerve agent, the
anticho linesterase d iisopropylfluorophosphate  (DFP) a t 0.5m g/kg.
O f p a rticu la r concern in the c lin ic a l con tex t is resp ira to ry  depression 
o f la te  onset (Freye e t ^ . ,  1983) in which pa tien ts  appear to have recovered 
fu l ly  fro m  the e ffe c ts  o f the fen ta ny l drug but subsequently are subject to  
re sp ira to ry  depression many hours la te r ;  This c h a ra c te ris tic  a lm ost ce rta in l) ' 
re la tes  to the accum ula tion  o f the fen tany ls  in many tissues, especia lly in 
blood, fa t and muscle. In man, fo r  exam ple, 65% o f a 7yg/kg  dose o f fen tany l 
was estim ated to reside in such sites a fte r  60 m inutes (Heykants, 1977). I t  
has been suggested th a t from  these depots, loca l pH changes induce a release 
o f the drug which produces la te  onset re sp ira to ry  depression, a process te rm ed  
'rem orph in isa tion ' (Freye et 1983). Post recovery re sp ira to ry  depression 
may also occur i f  an opioid antagon ist such as naloxone is used to  reverse the 
anaesthesia, because its  h a lf- l i fe  is re la tiv e ly  short (Janssen, 1982). This 
la t te r  problem  has been essen tia lly  e lim ina ted  by the m ore extensive use o f 
the much shorter acting  drug, a lfe n ta n il.  However, even w ith  th is  de riva tive , 
unexpected sudden re sp ira to ry  arrests have been reported  a fte r  apparent 
recovery from  a lfe n ta n il anaesthesia (Sebel e t al .^, 1984) so the phenomenon 
can not ye t be considered to  be fu lly  understood.
1.5.4 Pharmacokinetics and Metabolism
The drugs o f th is  series are fa r less polar than m orphine and are thus 
more able to penetra te  the CNS, This is supported by the find ing  th a t in ra t.
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the ra tio  o f equianalgesic doses by intravenous and In trace re b rove n tricu la r 
ra tes fo r fen tany l is 100-fo ld  less than fo r  m orphine (K u tte r  e t 1970). 
N o rm a lly , low p o la rity  in  a pharm aceutica l is considered p o te n tia lly  
disadvantageous, because non-polar substances are not read ily  e lim ina ted  fro m  
the body. In accord w ith  th is , the  te rm in a l h a lf- l ife  o f e lim in a tio n  fo r 
a lfe n ta n il in man, determ ined a t tim es g rea te r than 60 m inutes a fte r  dosing 
was 87-88 m inutes (Shafer et a l., 1986) whereas M ich ie ls  and cow orkers (1983) 
found the equiva lent value fo r  su fen tan il to be 140 m inutes. Fentanyl is even 
less read ily  e lim ina ted , w ith  te rm in a l h a lf- l i fe  o f 217 m inutes in man (Janssen, 
1981). However, these values re la te  only to the h a lf- l ife  o f e lim in a tio n  o f the 
drug during the fin a l, th ird  phase o f a three com partm ent model to which 
fen tany l-se ries  pharm acokinetic  data best apply.
When bolus doses o f these drugs are given, th e ir  durations o f action  
are much shorte r than would be expected fro m  the te rm in a l h a lf- l ife  values 
and i t  has been concluded th a t the dura tion  o f ac tion  o f a ll o f the com m only- 
used drugs o f th is  series a fte r  sm all bolus doses re la tes m ore to  th e ir  rap id  
re d is tr ib u tio n  from  the bra in  to o ther tissues ra the r than to  high ra tes o f 
m etabo lism . In ra ts , the durations o f analgesic action  o f a lfe n ta n il, su fen tan il 
and fen ta ny l are approx im ate ly  5, 10 and 20 m inutes respec tive ly  (Niemegeers 
and Janssen, 1981).
The drugs o f the fen tany l series are a ll h igh ly bound to  plasma 
pro te ins, w ith  values fo r a lfe n ta n il, su fen tan il and fen tany l o f 92%, 90% and 
85% (Meuldemans et a l., 1982). In the c lin ic a l s itu a tio n  such extensive binding 
presents a p o te n tia l fo r drug-drug in te rac tio n s  o f serious consequence.
Fentanyl drugs are extensive ly m etabolised, both in  liv e r  and blood, 
and m ore than 25 m etabo lites  o f a lfe n ta n il in ra t have been
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detected . Sufentanil and fen tany l also produce many m etabo lites , but i t  has 
been concluded th a t in ra t, ra b b it and man the analgesic e ffe c t is probably due 
to  the unchanged drug, since the m etabo lites  a ll have m arkedly low er opioid 
potency than the parent compounds (Schneider and Brune, 1986). For 
a lfe n ta n il the main m etabo lic  pathway involves ox ida tive  dém éthy la tion  and 
ox ida tive  N -dea lky la tion ; su fen tan il has a s im ila r m e tabo lic  fa te  and in both 
cases in  ra t, the m a jo r ity  o f the dose is e lim ina ted  in the u rine. There was no 
evidence fo r ente rohepatic  re c ircu la tio n . Schneider and Brune (1986) showed 
tha t the most potent fen tany l m e tabo lite  in ra t (th a t which is s im ply the 
parent compound p-hydroxy la ted  on the phenethyl m o ie ty) is nearly 100-fo ld  
less potent in  the guinea pig ileum  assay than the unchanged drug,
1.5.5 Tolerance
Although to le rance  to  the e ffe c ts  o f the fen tany ls  can be induced 
a fte r  ch ron ic dosing (Schulz e t ^ . ,  1980) there  is no evidence fo r  the 
developm ent of ve ry rap id  to le rance  (tachyphylaxis) in v ivo  or in  v it ro  to  these 
compounds in the lite ra tu re . Indeed, Brown and P leuvry (1981) showed th a t 
reproducib le  dose-response re la tionships could be obtained in rabb its  w ith  
a lfe n ta n il and fen tany l w ith  no decrease in  apparent resp ira to ry  depressant 
potency a fte r  the fo u rth  such dose-response curve, as long as fu l l recovery was 
p e rm itte d  between them .
1.5.6 Receptor Selectivity
I t  has been assumed on the basis o f re la tive  potency o f the fen tany ls  
to  in h ib it the e le c tr ic a lly  induced co n trac tion  o f the guinea pig ileum  and 
mouse vas deferens preparations (Magnan et ^ . ,  1982) th a t they are a ll drugs 
h igh ly  se lec tive  fo r the mu opioid recep to r. F u rthe rm ore , su fen tan il has been 
proposed as a p ro to typ ica l mu recep to r binding ligand on the basis o f such 
studies (Leysen e t a l., 1983). However, there  is evidence th a t a lfe n ta n il and
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fen tany l in te ra c t w ith  d iss im ila r sites in production o f re sp ira to ry  depression 
in rabb its  (Brown and P leuvry, 1981) since naloxone was a m ore e ffe c t iv e  
antagonist o f the e ffe c ts  o f the fo rm e r drug than of the la t te r .  M oreover, the 
recep to r binding se le c tiv it ie s  o f the im p o rta n t members o f the 4 - 
an ilinop ipe rid ine  series have not been defined in  a consistent assay system , 
using rad ioligands h igh ly se lec tive  fo r  each opioid recepto r sub-type, although 
ind iv idua l values obtained in  a va rie ty  o f systems have appeared (Leysen et al., 
1977; Stahl e t ^ . ,  1977; Leysen and Laduron, 1978).
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1.6 R A D IO LIG A N D  B IN D IN G  STUDIES
1.6.1 In troduc tion
Radioligand binding techniques have been successfully applied to the 
study o f a wide range o f hormone (R oth, 1975) and n eu ro tra nsm itte r receptors 
(Yam am ura et a l., 1978). B inding studies have been concerned not only w ith  
the p roperties and d is trib u tio n s  o f such receptors, but also w ith  the 
charac te risa tion  o f drugs, the generation o f new in fo rm a tion  on the 
pathogenesis o f disease states and the  d iscovery o f the ro le  o f endogenous 
ligand -recep to r systems in the developm ent and m aintenance o f the organism.
N e u ro tran sm itte r receptors are assumed to  be d iv is ib le  in to  tw o  
fun c tio na l components; a tra n s m itte r binding s ite  which se le c tive ly  recognises 
the  tra n s m itte r and a transducer system  w hich is ac tiva ted  by agonist binding 
and which converts such binding in to  a b iochem ica l signal such as an a lte ra tio n  
o f membrane ion p e rm e ab ility  or o f synthesis o f c y c lic  nucleotides. 
Radioligand binding studies are concerned only w ith  the recogn ition  s ite  o f 
recepto rs. However, a binding s ite , even one th a t s te reose lec tive ly  recognises 
a ligand, does not co ns titu te  a fun c tio na l recep to r. In order to  im prove the 
like lihood  th a t the binding assay is se le c tive ly  measuring the recogn ition  s ite  
po rtion  o f a recep to r, a number o f experim en ta l p rinc ip les should be m et, and 
a series o f necessary, but not s u ff ic ie n t, c r ite r ia  should be established to  be 
va lid  under the conditions o f the assay. The most im p o rta n t o f those is 
considered to  be the dem onstra tion  th a t the  s p e c ific ity  o f b inding para lle ls  
pharm acologica l a c t iv ity ,  i f  th is  is known.
H is to r ic a lly , ligand binding studies began w ith  periphera l hormone 
receptors such as those fo r  oestrad lo l (Jensen and Jacobsen, 1962) and insulin  
(Cuatrecasas, 1971) and the n ico tin ic  cho line rg ic  recep to r o f the e lec trop lax  
o f the  e le c tr ic  eel. Torpedo (Changeaux £ t  ^ . ,  1970). The in tro du c tio n  o f high
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s p e c if ic -a c tiv ity  tr it iu m -la b e lle d  ligands, combined w ith  the developm ent o f 
rap id  phase-separation ( f i lt ra t io n )  techniques, has led to  an explosion o f 
studies, especia lly in the opioid fie ld . A lthough ligand binding assays are 
ve rsa tile  and techn ica lly  sim ple, i t  is necessary to  understand the basic 
th e o re tica l and m ethodolog ica l p rinc ip les  invo lved and to  in te rp re t w ith  care 
the la rge amount o f data which can rap id ly  be generated. These princ ip les 
have been e xce lle n tly  reviewed by Yam am ura e t a l., (1978).
1.6.2 M ethodolog ica l Considerations
1.6.2.1 Choice o f L igand
The approach adopted by m ost groups is to  study the binding o f ligands 
fo r  the receptors o f in te res t to  homogenised preparations o f tissues conta in ing 
the recep to r, then rem oving the unbound ligand by a physical phase-separation 
step (K o s te rlitz  and Paterson, 1980; Simon e t 1975). A co ro lla ry  o f the 
fun c tio n  o f membrane-bound receptors fo r neu ro transm itte rs  and 
neurom odulators is th a t they are re la t iv e ly  few  in number on the ce ll surface. 
Because the membrane p repara tion  in  which the ligand binding studies are 
perfo rm ed is incapable o f any response to the binding o f ligand to the recep to r 
(con trasting  w ith  the  in ta c t anim al or iso la ted tissues) a sensitive  m ethod fo r  
the  measurem ent o f such ligand -recep to r in te rac tions  is required. This 
requirem ent is m et by the use o f rad io labe lled  ligands fo r the receptors o f 
in te re s t. and ^H -labe lled  compounds are most com m only used because
such labe lling  has l i t t le  e ffe c t on the chem ica l nature o f the compound, unlike
125 ^I-in co rpo ra tion  (Chang e t al.., 1979) and th e ir  presence is easily, qu ick ly  and
safe ly measured by liq u id  s c in t illa t io n  counting.
U n til re ce n tly , i t  has not proved feasib le to  produce the sm all, 
rad io labe lled  peptides o f po te n tia l value in the study o f opioid receptors w ith  a 
s u ff ic ie n tly  high spec ific  ra d io a c tiv ity  to p e rm it de tec tion  o f the compounds
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a fte r binding, o fte n  in as l i t t le  as fem ptom olar concentra tions. This 
requ irem ent arises out o f the low  num ber o f binding sites and the high a f f in ity  
o f ligands fo r  the sites o f in te res t.
The rad ioac tive  ligands used in binding studies are o fte n  lip o p h ilic  
(To ilenaere  e t a l., 1986) or possess o ther p roperties which give a high leve l o f 
non-spec ific  b inding, th a t is, to  non-recep to r acceptor sites (K o s te r litz  and 
Paterson, 1985). F u rthe rm ore , due to the presence o f m u ltip le  recep to r 
binding sites in bra in and the lack o f re c e p to r-s e le c tiv ity  o f many ligands, 
binding is fre qu e n tly  to  m ore than one recep to r s ite  (Rosenbaum e t ^ . ,  1984). 
Thus in defin ing  sp ec ific  binding care must be taken in excluding both non­
spec ific  binding and in te rac tio n s  w ith  o the r binding sites. The f ir s t  d if f ic u l ty  
is overcom e by the  use o f p a ra lle l incubations which conta in  both the labe lled  
ligand and a large excess o f an unlabelled compound w hich also binds to  the 
spec ific  sites under study. This displaces the spec ifica lly -bound  rad io ligand so 
th a t the rem ain ing binding is deemed to be non-specific  and is sub tracted  fro m
the to ta l binding in  order to ca lcu la te  the spec ific  binding. Because the
compound chosen to  define  non-specific  binding is genera lly  chem ica lly  
d iss im ila r from  the labe lled  ligand (K o s te rlitz  and Paterson, 1980) i t  is
assumed th a t the  unlabelled compound w il l  not d isplace a s ig n ific a n t 
p roportion  o f the non -sp e c ifica lly  bound rad io ligand.
In order to  m in im ise  in te rac tio n s  o f the rad io ligand  w ith  m u ltip le
-4
recep to r sites, the ligands o f choice are those which e xh ib it high re ce p to r- 
s e le c tiv ity , where ava ilab le .
Many o f the endogenous opioid peptides have been shown to  have poor 
recep to r s e le c tiv ity  (A k il e t a l., 1984) and to  be unstable (James and
Goldstein, 1984) to  the peptidase enzymes ubiquitous in bra in tissue
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homogenates (Snyder, 1986) but advances in peptide chem is try  have made 
possible the developm ent o f m od ified  enkephalins w ith  the desired 
cha rac te ris tics . The s truc tu res  o f the enkephalin de riva tives  w h ich  best 
exem p lify  th is  p rinc ip le , -C b -A la ^-M eP h e^-G lyo l^  3 enkephalin (DAGO)
(K o s te r litz  and Paterson, 1981) and 3-  [D -Pen^,D -Pen^ 3 enkephalin
(DPDPE) (Mosberg et 1983) toge the r w ith  the s tru c tu re  o f the k -se lec tive  
ligand, 069,593 (L a h ti e t ^ . ,  1985), are given in Table 4. DAGO is h ighly 
se lective  fo r the p opioid binding s ite  (100 over 6 ) and DPDPE possesses high 
s e le c tiv ity  fo r  the ô s ite  (300 over p); at the concentra tions ty p ic a lly  used in 
rad io ligand binding studies, these peptides each appear to label only one s ite , 
and are the re fo re  valuable too ls in the  study o f the p and 6 binding 
ch a rac te ris tics  o f unlabelled drugs and also p e rm it accurate de te rm ina tion  o f 
the number o f binding sites in a tissue homogenate.
1.6.2.2 Membrane P repara tion
The choice o f hom ogenisation procedure can only be determ ined 
e m p irica lly  and i t  is c lear th a t the  m ethod employed can in fluence the 
apparent m axim al number o f b inding sites. The most com m only used methods 
invo lve  m echanical d isruption , w ith  o r w ith o u t sonication, and the m ajor 
advantage o f such a procedure is the reproducib le  nature o f the resu lting  
homogenates w hich perm its  comparison o f resu lts w ith  those o f o ther groups. 
Hom ogenisation is fo llow ed by ce n trifu g a tio n  to  p re c ip ita te  membranous 
m a te ria l, and most groups wash the p e lle t one or m ore tim es in order to 
prom ote d issociation from  receptors o f endogenous ligands and to  remove 
substances which may in te r fe re  w ith  the assay. Inh ib ito rs  o f the m etabolism  
o f the radioligands used are som etim es added (C o rbe tt e t ^ . ,  1984), but th is  is 
becoming increasing ly unnecessary w ith  the developm ent o f chem ica lly  stable 
ligands.
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1.6.2.3 Incubation Conditions
In order to  obta in  re lia b le  and reproducib le  resu lts i t  is necessary to 
pe rfo rm  the incubation under op tim um  conditions o f pH, tem pera tu re , ion ic  
s treng th  and com position, and fo r  an appropria te  duration , these again only 
being determ inab le  e m p irica lly . However, w hatever conditions are se lected, i t  
must be dem onstrated tha t equ ilib rium  binding is achieved, th a t the ligand is 
pure before use and is m e ta b o lica ily  stable during the assay and fu r th e r th a t 
non-specific  binding is va lid ly  defined. T yp ica lly , the assay is ca rried  out in 
TRIS b u ffe r because binding is considered unsa tis fac to ry  in physiological 
bu ffe rs  (Bourhim  et ^ . ,  1985) and th is  may be explained by the observation 
th a t sodium ions d if fe re n t ia l ly  a ffe c t the  binding o f opioid agonists and 
antagonists (P ert and Snyder, 1974).
I t  is also advantageous fo r the purposes o f comparison to  show tha t the 
amount o f binding is lin e a rly  re la ted  to  the amount o f tissue represented in the 
homogenate, because d if fe re n t groups may use d iffe re n t amounts o f 
homogenate re la ting  to  the a v a ila b ility  o f tissue and the spec ific  a c t iv ity  o f 
the ligand.
1.6.2.4 Phase Separation
In the case o f membrane-bound receptors such as those fo r  opioid 
neu ro transm itte rs , the membranes conta in ing  bound ligand m ust be separated 
from  unbound, o r free , ligand at the end o f the incubation. The m ethod o f 
choice by v irtu e  o f its  ra p id ity  and v e rs a tility  is f i l t ra t io n  under reduced 
pressure through g lass-fib re  f i lte rs  (Bennett, 1978), although ce n trifu g a tio n  
(Young and Snyder, 1973) or equ ilib rium  dialysis (Farrow  and Van Vunakis, 
1972) have been used. In the case o f phase separation methods where 
equ ilib r ium  is disturbed, the key fa c to r  in accurate  de te rm ina tion  o f binding is 
speed. Some ligands dissociate so rap id ly  under conditions o f f i l t r a t io n  and
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washing th a t th is  m ethod is unsuitable (Bennett, 1978). W hether or not 
f i l t r a t io n  is appropria te  can be explored by investiga ting  the ease w ith  which 
sp ec ific  binding can be reduced by repeated washing.
1.6.3 T h eo re tica l and A n a ly tic a l Considerations
1.6.3.1 E qu ilib rium  Binding
The basic ligand binding model involves the revers ib le  in te ra c tio n  o f 
ligand (L) and a single class o f recep to r (R). I f  such a ligand is added to  a 
bra in  homogenate and allowed to equ ilib ra te , and i f  the s im p lify in g  
assumptions are made th a t a ll sites are equally available to the ligand and th a t 
a ll have the same a f f in ity  fo r it ,  then the law o f mass ac tion  provides a 
descrip tion  o f th a t dynam ic e qu ilib rium :
Cr]  + [  Ü  [R U
(where [R Ü  is the bound ligand concen tra tion )
Thus: [  -  [R  L ]
[ R L ]
(where is the equ ilib rium  d issociation constant of the ligand fo r recep to r).
Assuming th a t there  are a f in ite  number o f receptors, te rm ed B ^ ^ ^ ,
then:
and the amount o f binding B = RL , then:
B [  L ]  
B = ___
4. [  L  ]
52
I f  a series o f de te rm ina tions o f B are made w ith  constant amount o f 
homogenate and d iffe r in g  C L ] ,  then a p lo t o f [ L  ]  vs B has the ch a ra c te ris tic  
shape o f a sa tu ra tion  p lo t, a rec tangu la r hyperbola. B ^ ^ ^  can be estim ated as 
the plateau value o f B as [  L  ]  approaches in f in ity  and K q  as th a t value o f [  L  ]  
producing ha lf-m a x im a l b inding.
In cases where in s u ff ic ie n t points a t high values o f CL] have been used, 
perhaps because o f the cost o f the  ligand, a p lo t o f log C L ]  vs B may be 
useful. This is a sym m etrica l sigm oid curve (K lo tz , 1982) and only when a 
c lea r tu rn ing  po in t is ev iden t should the data be fu r th e r analysed by means o f 
the Scatchard p lo t (Scatchard, 1949). This la t te r  p lo t is based upon a sim ple 
m anipu la tion  o f the sa tu ra tion  equation:
[  L  ]  K p  K p
such th a t a p lo t o f B / [L ]  vs B gives a s tra ig h t line  i f  the ligand binds to  a 
single population o f recepto rs. The in te rc e p t on the ord ina te  is B ^ ^ ^  and the 
K q  value is the re c ip ro ca l o f the slope. Note tha t ex trapo la tion  o f the line  to 
the ord ina te  im p lies in f in ite  C L ] ,  although the distance required  appears 
sm all. I t  is c lear from  the lite ra tu re  th a t linear Scatchard p lo ts  are taken to 
ind ica te  a single binding s ite  paradigm , but i t  is possible fo r  such a p lo t to 
conceal tw o  sites fo r which the ligand has equal a f f in ity .  Conversely, a non-■i
linea r p lo t has many possible in te rp re ta tio n s , o f which the existence o f tw o or 
m ore d iss im ila r binding sites is only one, a lb e it tha t most com m only made.
1.6.3.2 Inh ib ition  Studies
The progressive and co m p e titive  d isplacem ent o f the spec ific  binding o f 
a rad io labe lled  ligand fro m  binding sites by an unlabelled ligand w hich also 
binds to the s ite  o f in te res t can be analysed by means o f the H il l  p lo t (H ill,
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1910). Its  p rim ary  value is in those s ituations where a ligand o f in te res t is 
unavailable in rad io labe lled  fo rm  or, by v irtu e  o f its  rapid d issociation from  
binding sites (upon d isruption  o f equ ilib rium  during phase-separation, is 
unsuitable fo r  use as the labelled ligand (Bennett, 1978).
The H il l  equation resembles the hyperbolic equation re la ting  to  the 
sa tu ra tion  o f binding sites on a p ro te in , but includes a te rm  which perm its  the 
m a them atica l descrip tion  o f binding o f ligand to m u ltip le  sites in a 
coopera tive  manner, th a t is, th a t the binding o f ligand to  one s ite  influences 
the binding o f ligand to fu r th e r sites.
The equation can be derived by assuming tha t a p ro te in , R, has n 
binding sites fo r  a ligand, L , and th a t the  binding o f L is ex trem e ly  
coopera tive. This means tha t as soon as one site  on R is occupied, the 
rem ain ing sites are im m ed ia te ly  occupied, so th a t i t  is only necessary to  
consider the equ ilib rium  between R and R L^, w ith  no s ig n ifican t co n tribu tio n  
fro m  in te rm ed ia te  species. Thus;
[R] + CnL]£5;[RL^]
and: K p  = [  R ] L ^
C R L J
where K p  = the dissociation constant fo r  binding o f L to  R.
The amount o f binding (B) o f L as a fra c tio n  o f to ta l possible binding 
(Bmgx^ the re fo re  is:
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B = RL n
[R ] + RL n
subs titu ting  from  1:
B = CL] "
K p  f  [L ] n
The value o f n is known as the H il l  c o e ffic ie n t and can be
derived fro m  measurement o f B a t various C L ] .  Equation 3 can be arranged to  
give:
B = C l ]
Bmax
and tak ing  logs to  produce a linea r trans fo rm a tion :
Log ^  -  n log Cl ]  -  log K p
B -B max
Thus a p lo t o f log (B /B ^ ^ ^  -B) vs log CL ]  should be a s tra ig h t line  w ith  
slope n. For in h ib itio n  studies, binding sites are labelled w ith  rad io ligand and 
displaced by increasing concentrations o f unlabelled co m p e tito r, L. I f  the 
rad io ligand concen tra tion  is such th a t the  in it ia l amount o f binding is equal to 
Bmax> the  H il l  p lo t w il l  give a value o f log Cl  ]  = K j w hich is tha t value of 
CL ] when B ^ ^ ^  is reduced by h a lf, to the IC^Q (Note th a t the IC ^^  is reached 
when log (B /B ^ ^ ^  -B) = 0, and tha t the in h ib itio n  constant K j is equiva lent to 
the K p  fo r  the unlabelled com p e tito r at the binding s ite  marked by the
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rad io ligand If  the H il l  number is one). However, i t  is evident tha t i t  is not 
p ra c tica l econom ica lly  to  label a ll the  binding sites in it ia lly  w ith  rad io ligand, 
which would requ ire  a rad io ligand  concen tra tion  o f 4-5 x K p .  T yp ica lly  a 
concen tra tion  value o f 1 x K ^, fo r  the  labe l is chosen (Stahl e t a l., 1977). I t  isU  —
clear tha t in th is  s itu a tio n  IC ^^  w il l  not be equal to  K j because IC^Q w il l  be 
re la ted  to  in it ia l rad io ligand concen tra tion . Cheng and P ruso ff (1973) have 
shown tha t the K j can be obta ined fro m  IC ^g provided th a t the binding o f the 
rad io ligand has f ir s t  been characte rised , thus:
IC 5 0
K j = 1 + [  M ]
K p M
(where [M  ]  and K p M  are the concen tra tion  and K p  values o f the rad io labe l, 
respective ly ).
The value o f n is com m only taken  as a measure o f the co o p e ra tiv ity  o f 
the binding, or o f the number o f b inding sites fo r  the  ligand. In th is  s lig h tly  
less com plex s itu a tio n , since i t  is known th a t the m arker ligand binds only to  
one site  w ith o u t apparent c o o p e ra tiv ity  (ie. H il l slopes fo r the m arker ligands 
alone are un ity), the  deviations o f H il l  slopes produced in these in h ib itio n  
studies ind ica te  the presence o f c o o p e ra tiv ity  in  the binding o f the unlabelled 
compound o f in te res t.
1.6.4 Distribution of Opioid Binding Sites in the CNS
The anatom ica l lo ca lisa tion  o f binding sites fo r  exogenous and 
endogenous op io id  compounds is o f considerable u t i l i t y  in  fo rm u la ting  
hypotheses concerning th e ir physio log ica l and pharm acological ro le . U n t il 
re ce n tly , however, the lack o f h igh ly  se lective  ligands fo r the d iffe re n t 
recep to r types has precluded a de ta iled  d e fin it io n  o f recep to r d is trib u tio n .
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although there is considerable in fo rm a tio n  in the lite ra tu re  concerning the use 
o f less se lective  ligands. A tw eh and Kuhar (1977) studied the d is tr ib u tio n  o f 
opioid binding sites using the unselective opioid ]  d iprenorphine as an 
autoradiographic m arker and showed high densities o f opio id binding in 
d iscre te  regions in pons and m edulla, p a r tic u la r ly  in the parabrach ial nucle i, 
w hich are believed to  be associated w ith  resp ira to ry  con tro l (Section 1.4.2). In
a less deta iled  study of binding in  homogenates o f e ight b ra in  regions, but
125 3using the s lig h tly  se lective  ligands [  I ]  D ADL and [  H ]  naloxone, Chang
and colleagues (1979) showed tha t the abundance o f binding sites fo r  [ ^ H ]
naloxone was 2 -fo ld  higher than fo r the s lig h tly  6 -se lec tive  iod inated ligand in
the bra instem  region. The synthesis o f the highly p -se lec tive  peptide DAGO
(K o s te rlitz  and Paterson, 1981) p e rm itte d  fo r  the f ir s t  tim e  an im proved
descrip tion  of the regional d is trib u tio n  o f m u ltip le  opioid binding sites w ith in
3the cen tra l nervous system. In 1985, Robson e t al .^, used [  H J DAGO to mark 
p s ites, C ^ H ]  D ADL and unlabelled DAGO to  define ô sites, and [ ^ h 3 
brem azocine w ith  unlabelled DAGO and D A D L (te rm ed suppression) to p e rm it 
measurement o f k binding sites in ra t b ra in  homogenates. They showed tha t 
the re  was a preponderance o f p over 6 sites in the m edulla, con firm ing  the 
in ference from  the work o f Chang e t a l., (1979). However, Robson et a l., 
(1985) determ ined the number o f binding sites by an inexact m ethod, th a t is, 
the binding exhib ited a t a single C^H 3 ligand concentra tion  in homogenates o f 
the brain regions. There is no way to  determ ine w hether regional d iffe rences 
in the a f f in ity  o f binding made a s ig n ifican t co n tribu tio n  to  the to ta l binding 
observed. The suppression technique fo r  im proving  the s ite -s e le c tiv ity  o f 
ligands in binding assays was employed by Mansour e t a l., (1986) in an 
extensive autoradiographic study o f the  d is trib u tio n  and density o f p, 6 and k 
binding sites in the ra t CNS. The resu lts  dem onstrated tha t although there 
were areas o f high density 5 binding in ce rta in  pontine nuc le i, the overa ll 
density o f 6 sites was much low er than tha t o f p sites in the pons and medulla
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regions. I t  was also dem onstrated tha t there were few  6 or p sites in the 
hypothalam us, an area whose in fluence  on resp ira to ry  and card iovascular 
co n tro l rem ains to be c le a rly  defined, although i t  has been suggested tha t th is 
s tru c tu re  may have an im p o rta n t m odu la to ry  ro le  (Feuerste in and Faden, 1982; 
Faden and Feuerste in , 1983). There was, in contrast, a high density o f k 
b inding sites in the hypothalam us.
A lthough the density o f 6 receptors has thus been shown cons is ten tly  to  
be low  ove ra ll in bra in stem regions, d is tin c t and concentra ted areas o f 6 
binding have been dem onstrated in m edullary and pontine nucle i. C e rta in  o f 
these nucle i are s trong ly believed to  have im p o rta n t ro les in the generation 
and regu la tion  o f re sp ira to ry  rhythm  (Cohen, 1979; M e rr ill,  1981; Section 
1.4.2), although there  is cu rre n tly  much controversy surrounding the 
invo lvem ent o f d iffe re n t recep to r types in the m ediation o f opioid-induced 
depression o f resp ira tion .
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1.7 OPIOIDS A N D  RESPIRATION
1.7.1 A  Role fo r  Endogenous O pio id  Peptides?
I t  is w e ll-estab lished  th a t the rapeu tic  doses o f m orphine and o ther 
opioid agonists produce a dose-related depression o f re sp ira tion  in most 
anim als which is reversed by opioid antagonists. Cushny (1913) showed th a t 
th is  e ffe c t was la rge ly  due to the suppression by m orphine o f the response o f 
the anim al to increases in a rte r ia l CO^ tension and i t  has fu r th e r been 
dem onstrated tha t th is  genera lly undesirable e ffe c t can be a ttr ib u te d  more 
sp e c ifica lly  to  a reduction  in the se n s itiv ity  o f neurons in the bra in  stem to 
COg (F lorez e t 1968).
Fo llow ing  the d iscovery by Hughes and colleagues (1975) th a t 
m am m alian bra in  conta ined endogenous o p io id -like  peptides, the question 
arose o f possible roles fo r  the enkephalins and la te r, fo r  o the r opioid peptides 
(Lenz e t a l., 1986) in regu la tion  o f numerous aspects o f physiology inc lud ing  
resp ira tion . A  reasonable postu la te  was tha t i f  endogenous opioids exerted  a 
to n ic  in fluence  on resp ira tion  then adm in is tra tion  o f the opioid recep to r 
antagonist naloxone to  an anim al should produce re sp ira to ry  a lte ra tions . 
Several studies have shown th a t th is  does indeed occur (Moss and Friedm an, 
1978; Lawson et ^ . ,  1979) a lthough in  con trast, others re p o rt th a t naloxone 
has no e ffe c t on resp ira tion  (C hern ick, 1981; F leetham  e t ^ . ,  1980). The 
p ic tu re  is thus unclear, but discrepancies may be explained by d iffe rences in 
the species o f anim al and doses o f naloxone employed. However, the 
conditions under which such experim ents are perfo rm ed may be p ivo ta l w ith  
regard to the e ffe c ts  o f naloxone on v e n tila tio n . In rabb its , fo r  exam ple, the  
re sp ira to ry -s tim u la tin g  a c tiv ity  o f naloxone is only observed in neonatal 
animals up to post-na ta l day 5 (H azinski e t ^ . ,  1981), The decreasing p u ta tive  
ro le  o f endogenous opioids w ith  m a tu ra tion  in inh ib iting  neonatal resp ira tion  is 
s im ila r ly  supported by the work o f G runstein and coworkers
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(G runste in ^  1981; G runste in and G runste in , 1982) and fu rthe rm o re , Long
and Lawson (1983) showed th a t the  e ffe c ts  o f both 3-endorphin and naloxone in 
newborn p ig le ts  were reduced then abolished, during m a tu ra tion . In newborn 
humans, the plasma 3-endorphin concen tra tions are 3 -fo ld  g rea te r than in the 
adu lt and fu r th e r, W ardlaw et (1979) dem onstrated a strong negative 
co rre la tion  between such concentra tions and u m b ilica l a r te r ia l p02  ^nd pH. I t  
has been suggested fro m  the fo rego ing th a t endogenous opioids may have a 
ro le  in in h ib itin g  v e n tila to ry  m ovem ents o f the  foetus in  u te ro  and m oreover, 
may make a co n tribu tio n  to  the fa ta l sleep apnea in  sudden in fa n t death 
syndrome (McQueen, 1983). S a tis fa c to ry  reso lu tion  o f such hypotheses aw a it 
fu r th e r in ves tiga tion . F rom  the mass o f negative data in  the lite ra tu re  on the 
e ffe c ts  o f naloxone on v e n tila tio n  i t  is tem p ting  to  conclude th a t endogenous 
opioids are not o f ce n tra l im portance w ith  respect to  resp ira tion  in  fre e - 
b reath ing, hea lthy adu lt anim als. In con tras t, there is evidence th a t these 
peptides are c ruc ia l to  re sp ira to ry  adapta tion  and homeostasis and th is  is 
illu s tra te d  by the work o f Olsen (1987) who showed th a t naloxone accelera tes 
the ra te  o f v e n tila to ry  a cc lim a tisa tio n  to  hypoxia in  conscious ra ts . I t  is not 
possible fro m  th is  study to  deduce the sites o f ac tion  o f naloxone in th is  
regard, bu t both K irb y  and McQueen (1986) and Pokorski and L a h ir i (1981) 
suggest th a t endogenous opioids released in response to  hypoxia and 
hypercapnia m odulate the a c t iv ity  o f both ce n tra l and periphera l 
chem oreceptors in  such a manner as to  fa c i l i ta te  a re tu rn  to  norm al blood gas 
values by appropria te  v e n tila to ry  adjustm ents.
Receptors fo r opioid compounds have been dem onstrated in lung 
homogenates (Tang et a l., 1983) and on vagal fib res p ro jec ting  to  the lungs 
(Sapru e t al .^, 1981; Lundberg ^  ^ . ,  1979). The fun c tion  o f opioid receptors in 
lung parenchyma is s t i l l  unclear, but many repo rts  have appeared concerning 
the e ffe c ts  o f s tim u la tio n  o f those recepto rs associated w ith  the  pulm onary
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vagal te rm ina ls . Such s tim u la tio n  produces a re fle x  tr ia d  o f bradycard ia , 
hypotension and resp ira to ry  apnea (Sapru e t W., 1981; Dashwood et _W., 1983; 
W ille tte  e t 1987). A  study o f the receptors involved in th is  re fle x  form s a 
p a rt o f the work reported  in th is thesis.
1.7.2 Rationale and Methods for the Study of the E ffects of Opioids on Respiration
W hils t the question o f the  invo lvem ent o f endogenous opioids in 
re sp ira to ry  homeostasis is an uncerta in  issue, exogenously adm in istered opioids 
ce rta in ly  produce many pharm acological e ffe c ts , includ ing  analgesia and 
re sp ira to ry  depression. I t  has become c lea r tha t not only may opioids act via 
m u ltip le  recep to r sites but also at m ore than one anatom ica l lo ca tion  in the 
ove ra ll p roduction  o f a response. P o ten tia l d iffe rences in the recep to r 
invo lvem ent and regions of ac tion  o f opioids have been o f g rea t in te re s t 
because o f the poss ib ility  o f developing drugs which are potent analgesics but 
possess a reduced resp ira to ry  depressant l ia b il i ty .  Were d iffe rences  in the 
mode o f ac tion  of opioids to ex is t in regard to  these tw o  pharm aco logical 
responses, th is  c lin ic a l separation m igh t be achieved by use o f h igh ly recep to r 
se lec tive  analgesics whose s tructu res confe r d is tr ib u tio n a l p roperties 
favouring  the d isc rim ina tion  o f analgesia and depression o f resp ira tion . The 
p rinc ip les, methods and models previously employed in  the study o f opio id - 
induced resp ira to ry  depression are b r ie f ly  reviewed below, toge the r w ith  
conclusions which may be drawn fro m  these studies.
'i
These studies fa l l  in to  one or m ore o f a number o f categories. A lthough 
they d if fe r  in p ra c tic a l term s, the  a im  in each case is to  a tte m p t to  a c tiva te  a 
single recep to r popula tion in  order to  determ ine the pharm acological response 
associated w ith  each recep to r type.
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A lm ost every physio log ica l param eter which varies c y c lic a lly  w ith  
re sp ira tion  has at some poin t been u tilise d  as a measure o f the e ffe c ts  of 
opioids upon resp ira tion . Those include dete rm ina tions o f frequency (Ward and 
Holaday, 1982), t id a l volum e, instantaneous m inute  ve n tila tio n  (Pazos and 
F lo rez , 1984), peak a ir flo w  ra te , phrenic nerve output (M orin-Surun e t a l., 
1984b), diaphragm e lectrom yogram  and end -tida l e xp ira to ry  gas 
concentra tions (H urle  e t 1985), A r te r ia l blood gases have also been used 
as a measure o f re sp ira to ry  sta tus (Olson, 1987; Mauser and Chapman, 1987). 
A lthough i t  is possible to m o n ito r some o f these param eters in the conscious 
anim al using whole body plethysm ography (G runstein and G runste in, 1982; 
W einstock e t a l., 1980) m ost w orkers have employed anaesthetised 
preparations (Pazos and F lo rez , 1983; M artynova and Medvedev, 1986; W ille tte  
e t a l., 1987) w ith  a trachea l cannula connected to a F le isch tube. No single 
measure can be considered to  be superior to  a ll others, fo r  w h ils t changes in 
a r te r ia l blood pCO^ fo r  exam ple, close ly fo llo w  re sp ira to ry  a lte ra tions , i t  is 
not possible to  m on ito r th is  param eter con tinua lly . However, i t  is probably 
unwise to  re ly  on any single measure, c e rta in ly  i f  th a t measure was resp ira to ry  
frequency (Ward and Holaday, 1982) o r t id a l volum e, because i t  is the product 
o f these th a t defines pulm onary v e n tila tio n , and e ith e r can change w ith o u t 
s ignalling  resp ira to ry  depresson, g iven appropria te  a lte ra tio n  in the other.
1.7.2.1 R ecepto r-S e lective  Agonists
The te rm  'recep to r se lec tive ' is used here in  its  fo rm a l sense, tha t is, 
a compound w hich exh ib its  a g rea te r pre fe rence  fo r one opioid recep to r than 
another has s e le c tiv ity . This concept is only o f g reat value fo r compounds 
whose recep to r s e le c tiv ity  exceeds tw o orders o f m agnitude although some 
in fo rm a tion  as to  recep to r invo lvem ent in  the production  o f a response may be 
deduced fro m  a comparison o f the a c t iv ity  o f a num ber o f poorly se lective  
agonists (see Table 5). Dashwood e t a l., (1983) used e to rph ine as an agonist in
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order to investiga te  the vagal re fle x  tr ia d  (Section 1.4.4.3), but the very poor 
s e le c tiv ity  o f the compound (K o s te r litz  and Paterson, 1980) did not p e rm it 
assignment o f the receptors involved in th is e ffe c t.  No such caution  in 
draw ing conclusions fro m  the e ffe c ts  o f poorly se lec tive  compounds was 
displayed by M artynova and Medvedev (1986) who concluded tha t the find ing  
th a t th is  re fle x  e ffe c t could be e lic ite d  by both the poorly 6 -se lective  peptide 
D A D L and by DAGO im p lied  tha t both p and 5 receptors were invo lved. In 
con tras t, Hassen e t ^ . ,  (1982) deduced fro m  the 10-fo ld  g rea te r re sp ira to ry  
depressant potency o f the h igh ly  p -re ce p to r se lective  peptide, DAGO, than the 
m a rg ina lly  se lec tive  peptide, D A D L upon m ic ro in jec tio n  in to  the nucleus 
tra c tus  so lita rius  o f pentobarb itone anaesthetised ra ts  tha t the re sp ira to ry  
e ffe c ts  o f both peptides were m ediated via p receptors. When in jec ted  via the 
in tra ce re b ro ve n tricu ia r rou te , Pazos and F lo rez  (1983) showed tha t the 6 - 
se lec tive  peptide CD-5er^,Thr^ ]  enkephalin was more po ten t than m orphine in 
reducing resp ira to ry  frequency in  urethane anaesthetised ra ts  but th a t the p - 
se lec tive  peptide [  D -A la^-M eP he^M et-(Q )-o l ]  enkephalin (FK-33824) was 
m ore potent than D A D L, and they proposed accord ing ly th a t in th is  model a t 
least, d if fe re n t types o f recepto rs  co n tribu te  to  opioid-induced re sp ira to ry  
depression. This conclusion was also reached by Haddad ^  ^ . ,  (1984) using 
m orphine and D AD L to depress resp ira tion  a fte r  in tra c is te rn a l a dm in is tra tion  
in conscious dogs. Such a conclusion is rendered more plausible by the  find ings 
o f Egan and N orth  (1981) th a t both p and opioid receptors ex is t on some 
e n te ric  neurons and o f M orin-Surun e t ^ . ,  (1984a) th a t both p and 6 receptors 
are present, m ore s p e c ific ia ily , on ce n tra l re sp ira to ry -re la te d  neurons. W hilst 
no t co n trad ic ting  the proposal o f a dual com plem entary e ffe c t invo lv ing  p and 
6 recepto rs , M orin-Surun e t ^ . ,  (1984b) showed th a t TR IM U -4, a p -re ce p to r 
se lective  peptide reduced t id a l volume but not frequency when adm inistered 
in tra p e rito n e a lly  and th a t [  D -S e r^ ,D -T hr^  ]  enkephalin was m ore potent upon 
frequency than t id a l volum e, suggesting th a t the d if fe re n t recep to r types
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m igh t subserve separate functions in co n tro llin g  re sp ira tion . The poss ib ility  
th a t the s tru c tu ra l d iffe rences between the compounds could resu lt in 
d if fe re n t ia l access to  d iscre te  ana tom ica l sites invo lved in the separate 
regu la tion  o f the  two re sp ira to ry  param eters was not explored.
Drawbacks o f th is  kind reduce the value o f studies undertaken w ith  
agonists alone, w hether or not the recep to r s e le c tiv ity  is h igh. In studies 
invo lv ing  system ic adm in is tra tio n , access to  a ll ana tom ica l regions by tw o  
d iss im ila r compounds cannot be assumed to be equ iva len t, ye t i t  is c lear th a t 
s tim u la tio n  o f receptors in d iscre te  bra in  nuclei may produce pro found ly 
d if fe re n t e ffe c ts  upon the same re sp ira to ry  param eter (Hassen e t 1984a, 
1984b; P fe if fe r  e t 1983). When adm in is te ring  compounds in to  such nuclei 
by m ic ro in je c tio n  techniques, the recep to r s e le c tiv ity  o f the compound alone 
may not be the m a jo r de te rm inan t o f the b io log ica l response. F o r exam ple, a 
compound w ith  appreciable p -s e le c t iv ity  may s t i l l  produce its  e ffe c ts  v ia  the 
6 -re ce p to r i f  the re  are re la tiv e ly  few  p -recep to rs  present. This is illu s tra te d  
by the find ing  th a t in ca t re sp ira to ry  areas in the hind b ra in , the nucleus 
parabrach ia lis  m edialis conta ins a high density o f 6 recepto rs w h ils t the 
nucleus tra c tu s  so lita rius  (Section 1.4.2) is re la tiv e ly  r ich  in  p recepto rs (Sales 
e t ^ . ,  1985). Even more p rob lem a tica l is the like lihood  th a t recep to r 
s e le c tiv ity  may e ffe c t iv e ly  be lo s t when drugs are adm in istered in to  sm all 
b ra in  regions, because pharm aco log ica l s e le c tiv ity  is p a rtly  a fun c tio n  o f 
concen tra tion . A t  the high loca l concentra tions which may be reached a fte r  
ce n tra l m ic ro in je c tio n , a drug may in te ra c t s ig n ific a n tly  w ith  its  non­
p re fe rred  s ite  and produce a response via  th is  recep to r. This phenomenon may 
expla in  the co n tra d ic to ry  find ings o f Hassen et a l., (1984a) who found tha t the 
k -re ce p to r agonist, MR2034, had no e ffe c t on resp ira tion  and P fe if fe r  e t a l., 
(1983) who dem onstrated tha t the k-agon is t brem azocine at h igher doses, did 
depress resp ira tion , when both compounds were m ic ro in jec te d  in to  h indbrain
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regions o f spontaneously breath ing  ra ts . W hilst studies w ith  agonists alone, 
p a rtic u la r ly  those possessing high recep to r s e le c tiv ity , have a ro le  to  p lay in 
e luc ida ting  m u ltip le  recep to r invo lvem ents in  pharm acological e ffe c ts , th e ir  
use cannot be considered to  p rovide  pow erfu l evidence unless the potencies o f 
an homologous series o f agonists whose recep to r se le c tiv it ie s  are d if fe re n t and 
known are compared.
1.7.2.2 C o m p e titive  A ntagonism ; P rinc ip les
The p rinc ip les o f co m p e tit ive  antagonism  have been much employed in 
a ttem p ts  to assign drug re ce p to r s e le c tiv it ie s  and recep to r invo lvem ents in 
pharm acological responses, both in  v it ro  and ]n  v ivo . For a rev iew , see 
T a lla rid a  e t ^ . ,  (1979).
The tes ting  o f substances w h ich  are passive antagonists can only 
proceed when the  agonist is also given. By passive is m eant th a t the 
antagonist alone has no e ffe c t on the  te s t system, in con tras t to  a 
physio log ica l antagonist.
The e ffe c ts  o f an antagon ist could be estim ated  by the  percentage 
reduction  in  the response to  a standard dose o f agonist, but th is  is lik e ly  to  
vary fro m  prepara tion  to  p repa ra tion , depending on va ria tions  in  the position  
and slope o f the  log dose-response curve. However, the basis o f co m p e titive  
antagonism theory is tha t a given response to  a dose o f agonist A is reduced by 
a dose o f antagonist 8, but can be restored by an increased dose o f agonist A '. 
The ra t io  A '/A  is ca lled  the dose-ra tio  and i t  is a measure o f antagonism . I t  
should increase w ith  increasing concen tra tions o f B and can be used to  
ca lcu la te  an equ ilib rium  constant (o r K g ) w hich is a fundam enta l measure 
o f antagonist a c t iv ity .
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Although the re la tionsh ip  between the binding o f agonists to receptors 
and the pharm acological response is com plex, tha t between the change in 
response caused by the binding o f antagonists is much sim pler:
A + R ^  A R — Response 
4-
B ^  BR— ^  No response 
When A = agonist, B = antagonist and R = recep to r.
Since th is can be regarded as a sim ple chem ical equ ilib rium , the 
equ ilib rium  constant = [  A ] [  R ] / [ A R ]
I f  the quan tity  [ A ] / [ A R ]  can be regarded as being equiva lent to  the 
'fra c tio n a l recep to r occupancy' as a func tion  o f [  A ]  then the equation
can be rearranged to  give:
[ A ] /  [ A R ]  = = [  A ]/I .  [A  ] + K ^ ;  1
In the presence o f a second drug, B, a com p e titive  antagonist reacting  
reve rs ib ly  w ith  the recepto r fo r A , the  'fra c tio n a l recep to r occupancy' by A 
becomes
[ A ]
Y ^ , = [A  ]  + K ^ /1  + CB]t i
( - ^ 1
Note tha t since becomes (1 + B /K g ) in the presence o f antagonist, and 
determ ines where the dose-response fun c tio n  lies on the log [A  ]  axis, the 
e ffe c t o f B is sim ply to trans la te  the func tion  along the log [A ] axis w ithou t
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a ffe c tin g  the slope o f the function . Thus, the dose-response curves should be 
pa ra lle l because the degree o f antagonism is independent o f the m agnitude o f 
the response.
The method o f estim a ting  K g , th a t o f Arunlakshana and Schild (1959), 
amounts sim ply to comparing doses A and A ' which produce m atching 
responses before and in the presence o f some dose B o f antagonist. The dose- 
response curves are para lle l, so th a t the size o f the response chosen fo r the 
comparison does not in fluence the resu lt.
The 'fra c tio n a l recep to r occupancy' in  the presence and absence of 
antagonist is assumed to  be iden tica l to  produce id e n tica l responses, thus Y ^ ,
^ A '
From  1 and 2 above:
[A ] [ A ' ]
[ A ]  + K ^  [A  ']+  K ^ U  + B /K g )
rearranging:
KB = [B ] C B ]
^EA' ] /  [A ]  1 (DR-1)
where DR is the dose ra tio . C le a rly , the estim ate  o f K g  is independent both 
o f the dose o f B and o f the ac tua l concentra tions [A ] and [ A ' ]  as long as the 
dose o f A is considered p roportiona l to  [ A  ].
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1.7.2.3 The Schild P lo t and p A p
In order to  render dete rm ina tions o f K g  re la tiv e ly  easy, the  common 
tra ns fo rm a tio n  o f equation 3 is used:
log (DR -  1) = -log K g  + log C B ]
since the  -log  l[ B ]  w hich reduces the response to  C A ' ]  to th a t o f [  A ]  is 
defined as the pA^, then when DR = 2, -log  B = -log K g  = pA 2 « I f  log (DR - 1) 
is p lo tte d  against log [  B ] , th is  is a Schild p lo t (Schild, 1947) w h ich  has un it 
slope i f  the antagonism is tru ly  co m p e titive . This is equiva lent to  the 
s ta tem ent th a t K g  is independent o f [  B ]. p A 2  is found by ex trap o la ting  the 
line  to  zero on the log (DR -  1) axis (ie , when DR = 2) although i t  could also be 
found by d iv id ing  CB] by (D R -1) to  g ive the  K ^ (or K g) value, the  -log  o f 
which is p A 2 * I f  the Schild p lo t has slope un ity , i t  does not m a tte r which 
method is used.
In v ivo , one does not usually know the equ ilib rium  concen tra tion  o f B, 
un like  the cond ition  in  v it ro , where [  B ]  can be read ily  ca lcu la ted  and ’true ' 
estim ates o f pAg made. Thus in the fo rm e r case, an equ iva lent to  a pA 2  may 
be ca lcu la ted  by p lo tt in g  log (m ola r dose o f B) against log (DR -  1) as explored 
by Smits and Takem ori (1970). The apparent pA 2  in vivo and th a t determ ined 
in  v itro  w il l d if fe r ,  and i t  is only when [  B ]  a t equ ilib rium  is known in  v ivo  th a t 
i t  is reasonable to  equate pA 2  de te rm ina tions in such a s itua tion  w ith  in v it ro  
de te rm ina tions.
In p ra c tice , when a Schild p lo t is drawn using dose-ratios measured at 
varying doses or concentra tions o f antagon ist B, the slope o f the  line  is no t 
e xa c tly  un ity . Thus, de te rm ina tio n  o f p A 2  by simple ex trap o la tion  to  the 
ord ina te  is sub ject to  a dev ia tion  fro m  the value of the p A 2  found v ia  K ^ , the 
size o f which is p ropo rtiona l to  the d iffe rence  between the actua l slope and
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u n ity . Both methods are considered va lid , and fu rthe rm o re , even in  the 
absence o f a s ig n ifican t dev ia tion  o f the  Schild p lo t slope from  un ity , qu ite  
large discrepancies between 'In te rce p t' and 'K ^ ' pA 2 's can occur. Some 
w orkers have taken the v iew  th a t co m p e titive  antagonism theory requires 
slopes o f p recise ly un ity , thus i t  is best to  f i t  to  the data a line  o f un it slope. 
An exam ple o f th is  approach can be found (T a lla rida  and Jacob, 1979). The use 
o f to  ca lcu la te  pA 2  is e xac tly  analogous to  th is, bu t i t  is c le a rly  necessary 
in th is  case to  show th a t the  Schild p lo t has a slope which is not s ig n ifica n tly  
d iffe re n t from  un ity . F u rch go tt (1978) argues tha t th is  la t te r  is the most 
consistent approach although i t  is acknowledged tha t there  may be fac to rs  
o the r than pure chance w hich produce Schild p lo t slopes not equal to  u n ity , fo r  
exam ple, inadequate experim en ta l design, or use o f antagonists which have an 
agonist component in th e ir  pharm acological p ro file . Nevertheless, since pA 2  
is a measure o f antagonist a f f in ity ,  i t  is ch a ra c te ris tic  o f a p a rtic u la r 
antagonist and recep to r type and is independent o f the agonist used o r the 
system  in which the response is measured. Thus, the p A 2  o f a co m p e titive  
antagonist is a pow erfu l to o l fo r  recep to r c la ss ifica tion  and d iscrim ina tion .
1.7.2.4 p A p and R esp ira to ry  Depression
The f ir s t  reported  q u a n tita tive  use o f an opioid antagonist to  ca lcu la te  
an apparent pA 2  in  vivo was the work o f Cox and W einstock (1964). A lthough 
they did not investiga te  the re sp ira to ry  depressant e ffe c ts  o f the opioid 
agonists employed they did show th a t the nalorphine pA 2  values against the 
analgesic e ffe c ts  o f m orphine and methadone were id e n tica l, dem onstrating 
th a t the recep to r slte(s) m ed ia ting  analgesia were the same fo r  the two drugs. 
Even at th is  early  stage, lim ita tio n s  inheren t in  de te rm ina tion  o f apparent pA 2  
values by single in jec tions o f antagonist were ev iden t. The agonists had peak 
e ffe c t a t d iffe re n t tim es a fte r  a dm in is tra tion , but the antagonist was given
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concu rren tly . In th is  case, the degree o f antagonism re la ted  both to  the 
a f f in ity  o f nalorphine fo r  the site(s) through which the agonists acted and to 
the tim e  o f m easurem ent.
This problem  was la te r addressed by Smits and Takem ori (1970) who 
adm inistered d if fe re n t agonists and the antagon ist naloxone in  such a way th a t 
both drugs had peak e f f ec t  sim ultaneously, a t which tim e  the degree of 
antagonism was measured. In te re s tin g ly , they showed th a t the naloxone 
apparent pA^ values fo r m orphine and levorphanoi were s ig n if ic a n tly  g rea te r 
than those fo r  pentazocine and cyclazocine  in producing analgesia, and may 
have been the f ir s t  to  id e n tify  w hat was la te r fo rm a lly  shown to  be tw o 
recep to r mechanisms fo r  opioid analgesia, nam ely the \i and k recep to r types.
Using an a lm ost id e n tica l dosing p ro toco l in m ice, M cG illia rd  and 
Takem ori (1978) rep lica te d  these find ings th a t apparent pA ^ fo r  blockade o f 
analgesia fo r  the pairs naloxone/m orphine and naloxone/pentazocine were 
d if fe re n t w h ils t those fo r blockade o f re sp ira to ry  depression produced by both 
agonists were c le a rly  id e n tica l, bu t d if fe re n t fro m  the apparent pA^ values fo r  
blockade o f analgesia. A possible in te rp re ta tio n  o f these resu lts  is th a t the 
recepto rs  invo lved in  analgesia d if fe r  fro m  those m ed ia ting  the depression of 
resp ira tion , a lthough i t  is not possible to  d e fin ite ly  assign recep to r types to  
e ithe r e ffe c t on the basis o f th e ir  data alone.
An a lte rn a tive  hypothesis is th a t naloxone d is tribu tes  unevenly between 
areas o f the bra in at which the analgesic and resp ira to ry  depressant e ffe c ts  o f 
the  agonists ac t, thus producing d if fe re n t apparent p A 2  values. However, 
M cG illia rd  and Takem ori (1978) investiga ted  th is poss ib ility  and showed th a t 
the antagonist d is tribu tes  fa ir ly  evenly th roughout the bra in.
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Using a d if fe re n t s tra in  o f mouse, Sm ith (1977) determ ined an apparent 
pA^ fo r naloxone/levorphanol fo r  antagonism  o f resp ira to ry  depression o f 6.99, 
which d iffe re d  m arkedly fro m  the analogous value determ ined by M cG illia rd  
and Takem ori (1978) o f 7.49. This d iscrepancy h igh ligh ts the d if f ic u lt ie s  
encountered in comparisons o f single antagonist dose apparent pAg values 
between labora to ries, and a lm ost ce rta in ly  arises out o f d iffe rences in 
pharm acokinetic  param eters o f the same antagonist In anim als fro m  d iffe re n t 
sources, ra th e r than being a true  re fle c tio n  o f d iss im ila r itie s  in the recep to r 
mechanisms invo lved in p roduction  o f analgesia in the d if fe re n t m ice by the  
same agonist. This is considered m ore fu lly  in Chapter 4.
In a m ore comprehensive a tte m p t to  assign recep to r types to op io id - 
induced analgesia and re sp ira to ry  depression in ra ts, Pazos and F lo rez  (1983) 
measured the apparent naloxone pAg values fo r both e ffe c ts  using m orphine 
and FK38824 as p agonists and D A D L and DSLET as 6  agonists. They showed 
th a t w h ils t those fo r blockade o f analgesia were s im ila r, the apparent pA^ 
values fo r antagonism o f the re sp ira to ry  e ffe c ts  produced by D A D L and 
DSLET were s ig n ific a n tly  d iffe re n t and they concluded w ith  the  in ference th a t 
D A D L and DSLET depressed re sp ira tion  v ia  the 5 recep to r. However, the 
only resp ira to ry  param eter m on ito red  was frequency, and Ward and Holaday 
(1982) have shown tha t re sp ira to ry  ra te  alone is not a good in d ica to r o f 
m orphine-induced depression o f re sp ira tion  in ra ts . In 1984, Pazos and F lo rez 
in a s im ila r study re in fo rced  th e ir  v iew  tha t w h ils t a p recep to r in te rac tio n  
resu lts in an tinoc icep tion , a p rom inen t, but not exclusive in te ra c tio n  w ith  ô 
receptors were required to  depress re sp ira to ry  ra te .
Because o f the d iffe rences  in  m ethodology employed by workers in 
various labora tories, the lim ita tio n s  inherent in the single antagonist dose 
p ro toco l h ith e rto  used in a ll in v ivo  apparent pA^ studies, and discrepant
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resu lts  obtained by d iffe re n t groups using the same agon ist/an tagonist pairs, i t  
is not possible w ith  any degree o f assurance to  assign a recep to r type to  
opioid-induced depression o f resp ira tion  a t th is  tim e . Nevertheless, i t  appears 
possible th a t p, <5 and k recepto rs may each play a g rea te r or lesser ro le  in  th is 
e ffe c t, depending upon the species and agonists used and measures o f 
resp ira tion  employed. On the o ther hand, the status o f the anim al w ith  
respect to being anaesthetised or unanaesthetised Is probably un im portan t in 
th is  regard, since F lo rez  and Pazos (1982) obtained iden tica l apparent naloxone 
pA ^ values fo r  antagonism of re sp ira to ry  depression in awake and urethane- 
anaesthetised ra ts , regardless o f the agonist used.
A m ajor concern w ith  the experim en ta l use of naloxone has been the 
poss ib ility  o f non-opioid e ffe c ts  and these issues have been reviewed by 
Sawynok e t (1979). Forem ost among these concerns was th a t naloxone 
may act as an antagonist o f the resp ira to ry  depressant n eu ro transm itte r, 
GABA, but i t  is now genera lly accepted th a t a t the doses of naloxone ro u tin e ly  
used (<5m g/kg) th is  is un like ly  to  be o f any im portance and naloxone can be 
considered to  be essentia lly  a pure antagonist a t opioid receptors.
1.7.2.5 Irreve rs ib le  Antagonists
A nother useful method fo r  recep to r and drug c la ss ifica tion  is to 
exam ine responses to  agonists before and a fte r  se lective  in a c tiva tio n  o f a 
given recep to r type, and th is  is most easily achieved by the use o f a se lective  
irreve rs ib le  antagonist. An exam ple o f th is  is 0 -funa ltrexam ine  ( 6 -FN A ), a 
d e riva tive  o f naltrexone which is reported  to be a se lective  irreve rs ib le  
antagonist fo r  the p opioid recep to r (Ward e t ^ . ,  1982). Using th is  too l, Ward 
and Takem ori (1983) showed th a t the depression o f resp ira to ry  ra te  caused by 
m orphine, e thy lke tazoc ine  or D ADL was not a lte red  by 6 -FN A  a t doses w hich 
produced m arked antagonism o f morphine an tinoc icep tion . Since i t  is believed
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th a t the analgesia produced by m orphine is p recep to r m ediated (Tyers, 1980) 
th is  find ing  suggested tha t re sp ira to ry  depression was produced by in te ra c tio n  
w ith  o the r opioid recep to r sites. In d ire c t con tras t, Hayes e t a l., (1985) re p o rt 
tha t in ra ts , 6 -FN A  at the same dose used by Ward and Takem ori (1983) 
produced dose-related antagonism  o f both m orphine an tinoc icep tion  and 
depression o f resp ira to ry  ra te , a lthough the la t te r  group em ployed m ice as the 
tes t species. However, doubt has re ce n tly  been cast upon the recep to r 
s e le c tiv ity  o f 6 -FN A , w hich has been shown to  increase the ID ^g  values of 
both DAGO on the e le c tr ic a lly -s tim u la te d  iso la ted guinea-pig ileum  and 
DPDPE on the iso lated mouse vas deferens (C o rb e tt e t 1985).
Pasternak and colleagues have provided p re lim ina ry  evidence th a t the  
opioid receptors though which the analgesic e ffe c ts  o f m orphine are m ediated 
can be d ivided in to  tw o sub-types: (Pasternak dnd Snyder, 1975), fo r  w hich
the irreve rs ib le  antagonist, naloxonazine (L ing  ^  ^ . ,  1983) has high a f f in ity  
and a re la tiv e ly  naloxonazine-insensitive  low  a f f in ity  pg re ce p to r. Using the  
p rin c ip le  o f recep to r-se lec tive  in a c tiv a tio n . L ing  e t W., (1985) showed th a t 
naloxonazine se lec tive ly  antagonised m orphine analgesia w ith o u t s ig n ifica n t 
blockade o f resp ira to ry  depression, concluding th a t analgesia was m ediated 
but resp ira to ry  depression was produced as a resu lt o f a y^  recep to r 
in te ra c tio n . F u rthe r to  th is , they also suggested th a t because at equianalgesic 
doses o f m orphine and D A D L, the degree o f re sp ira to ry  depression produced by 
the tw o compounds was s im ila r, th a t depression o f resp ira tion  was not 
m ediated via the  opioid recep to r. W hils t Xu e t ^ . ,  (1985) co n firm  th a t 
naloxonazine can se lec tive ly  b lock op io id  analgesia produced by m etorpham ide 
but not resp ira to ry  depression, th is  group concluded fro m  the low  6  -rece p to r 
a c t iv ity  o f m etorpham ide tha t y^  or k-recep to rs  were responsible fo r  the 
adverse e ffe c t. As in the case o f 6 -F N A  however, considerable c r it ic is m  has 
been made o f the methods used by Pasternak and colleagues to  define  the y -
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isoreceptors both in  v itro  (R othm an, 1986; Same and Kenner, 1987) and in  v ivo 
(Rourke and Shaw, 1984) and there  is controversy as to  w he ther or not y 
re ce p to r sub-types exis t at a ll.
Ano ther opioid analgesic m eptaz ino l, has been shown to  have 
s ig n ific a n tly  less e ffe c t upon resp ira tion  than morphine a t equianalgesic doses 
(Goode e t a l., 1979) and is proposed to  be a y^^-selective agonist (Pasternak e t 
a l., 1983). However, W einstock e t al .^, (1980) have shown th a t the 
anticho linesterase physostigm ine antagonises m orphine-induced resp ira to ry  
depression but not analgesia in dogs and rabb its , and both B il l e t ^ . ,  (1983) and 
C o w lrick  and Shepperson (1985) propose tha t the resp ira to ry  e ffe c ts  o f 
m eptazino l are lim ite d  by its  cho lino m im e tic  properties. Thus i t  can be 
apprecia ted tha t the association o f re sp ira to ry  depression produced by opioids 
w ith  a p a rtic u la r recep to r type  is, a t th is  tim e , unclear (Table 5).
A lthough recep to r se lective  in a c tiv a tio n  techniques are in  p rin c ip le  a 
valuable too l in determ in ing  the re la tiv e  im portance o f d if fe re n t receptors 
invo lved, a pharm acological e ffe c t, the re  are tw o  m ajor drawbacks associated 
w ith  th e ir  use. F irs tly , they are very dependent on the s e le c tiv ity  o f the 
agents used to  in a c tiva te  the recep to r, and there  are very fe w  irreve rs ib le  
antagonists cu rre n tly  availab le  which have a high degree o f s e le c tiv ity  fo r a 
single type o f opioid recep to r, a de fic iency  p a rtic u la r ly  m arked in  the case of 
the  6  and k receptors. F u rthe r, as in the case o f agonists (see above) the 
recep to r s e le c tiv ity  o f the compound may be los t at th e J iig h  concentra tions 
used to desensitise the recep to r.
Secondly, and perhaps o f g rea te r concern, is the very p rinc ip le  
employed. The problem  w ith  the use o f se lec tive  in a c tiva tio n  techniques is 
th a t each approach reduces the size o f the active  recep to r pool and
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consequently the degree o f recep to r reserve (fo r a review , see Les lie , 1987). 
Agonists w ith  equal a f f in ity  and s e le c tiv ity  fo r a given type of recep to r may 
be d if fe re n t ia l ly  a ffe c te d  by th is  reduction  in recep to r number depending upon 
th e ir  in tr in s ic  a c tiv it ie s . Compounds w ith  low  in tr in s ic  a c t iv ity  and a sm all 
re ce p to r reserve w il l be m ore sensitive  to  p a rtia l rem oval o f the recep to r pool 
than w il l agonists w ith  high in tr in s ic  e ffic a c y  and a large recep to r reserve. 
Thus, a lthough the se lec tive  recep to r in a c tiv a tio n  may e lim in a te  the response 
o f one agonist but not another, th is  does not necessarily im p ly  th a t the tw o  
compounds a c tiva te  separate recepto rs.
1 .7 .2 . 6  To lerance and S ensitisation
C hronic s tim u la tio n  o f opioid receptors by agonists o r antagonists 
produces m arked decreases (Schulz and H erz, 1977) and increases (P fe if fe r  e t 
a l., 1984), re sp ec tive ly , in the number o f cen tra l and periphera l opioid 
recep to r binding sites w ith o u t apparently  changing th e ir  a ff in it ie s  fo r  op io id  
compounds (L a h ti and C o llins , 1978; Bar do e t a l., 1982). This can th e o re tic a lly  
be used as a basis fo r  se le c tive ly  increasing or decreasing the  p u ta tive  ro le  o f 
a p a rtic u la r recep to r type in  a pharm acological response. A lthough l i t t le  w ork 
has appeared in the  lite ra tu re  w ith  regard to  the  use o f se lec tive  to lerance to  
investiga te  the recep to r type invo lvem ent in opioid-induced resp ira tion  
depression, P fe if fe r  e t ^ . ,  (1984) employed naloxone as a too l to  increase the 
number o f opioid recepto rs  in ch ron ica lly  tre a te d  ra ts. Such ch ron ica lly  
na loxone-trea ted  ra ts  showed no a lte ra tio n  in  resp ira to ry  responses to  
m orphine, whereas the re  was a m arked supe r-sens itiv ity  to  the hypertensive 
and bradycard ic e ffe c ts . Because th is  study also showed th a t the  increase in  
the number o f p b inding  sites in b ra in  homogenates was g re a te r than the 
increase in  the num ber o f 6  and k sites (as m igh t be expected fro m  the 
d if fe re n tia l a f f in ity  o f naloxone fo r  the three sites) the authors concluded th a t 
a non-p recep to r played a considerable p a rt in m orphine-induced depression o f 
resp ira tion  in ra ts .
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2.0 METHODS
2.1 A N IM ALS
A ll animals used in the ligand binding studies and re sp ira to ry  and 
card iovascu lar experim ents were obta ined fro m  the U n ive rs ity  o f Surrey 
Breeding U n it.  These were adu lt, m ale W istar albino ra ts, w eighing 25G-35Gg 
(binding studies) or 350-500g (resp ira to ry  studies). The animals were housed 
five  per cage, under co n tro lled  conditions o f tem pera tu re  (20-22°C ) and 
hum id ity  (50-60%) and were a llow ed free  access to standard rodent chow and 
w a te r. L ig h tin g  was co n tro lle d  on a 12-hour cyc le , 0700-1900h lig h t and 1900- 
0700h dark.
2.2 DRUGS
T y ro s y l-3 ,5 - [^ H  ][D -A la ^ -M e P h e '^ -G lyo i^  ]  enkephalin ( C^H ]  
DAGO, 40-60C i/m m ol) and T y ro s y l-3 ,5 -[ ]  [ D -Pen^, D-Pen^ ]  enkephalin 
( C ^ H ]  DPDPE, 27-48C i/m m ol) were purchased from  Am ersham  In te rn a tion a l 
U K , and m orphine sulphate fro m  May and Baker, U K .
U nlabelled DAGO and DPDPE were purchased from  Cam bridge 
Research B iochem ica ls (UK) as was N ,N -d ia lly l-T y r-A ib -A ib -P h e -L e u  (IC I 
174864, A ib  = a -a m in o isob u ty ric  acid).
A lfe n ta n il hydroch lo ride  hydrate , ca rfe n ta n il c it ra te , fen tany l 
c it ra te  and su fen tan il c it ra te  were g if ts  fro m  Janssen P harm aceutica ls, 
Beerse, Belgium . The fo llo w in g  were g ifts : naloxone hydroch lo ride  (Dupont, 
UK); d iprenorphine hydroch lo ride  (R e c k itt &  Colm an, U K ); lo fe n ta n ii cis (-) 
oxalate  (Professor P B B radley, B irm ingham ); ( - ) -N -m e th y l-N -(7 -( l-  
p y rro lid in y l)- l-o xa sp iro (4 ,5 )d e c -8 -y l) benzeneacetam ide (U69593) and (^)-3 ,4- 
d ic h lo ro -N -m e th y l-N - 2 -( l-p y rro lid in y l)-c y c lo h e x y l -benzeneacetam ide 
m ethane sulphonate hydrate  (U50,488H) (Upjohn Co, UK); leva llo rphan ta r tra te  
(Roche Products L im ite d , U K); N -m e th y l leva llo rphan methane sulphonate (A 
B ia nch e tti, SANOFI, Ita ly ) .
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2.3 L IG A N D  B IN D IN G  ASSAYS
2.3.1 R adioligand P u r if ic a tio n
C ^ H ]  DAGO and [^ H ]D P D P E  were pu rified  by reverse phase high 
perform ance liqu id  chrom atography (H PLC ) according to  the methods o f 
Bailey and K itchen  (1984).
[  ]  DPDPE was dried under a flo w  of oxygen-free n itrogen and
[  ]  DAGO was freeze -d ried  under reduced pressure (V ir t is  Freeze m obile  6 ;
V ir t is  Co., New Y ork, USA). The H PLC  solvents were as fo llow s: Solvent A - 
6.25% v /v  g lac ia l ace tic  acid, 0.25% v /v  am monia in d is tille d  w a te r; Solvent B 
- 100% a c e to n itr ile . Both so lvents were prepared fresh on each occasion, 
f ilte re d  (M illip o re  HAWP aqueous 0.45pm and FH organic 0.5pm pore d iam ete r 
f ilte rs , respective ly ), then degassed by sonication  (K e rry  PUL55 son icator) 
w h ils t under reduced pressure (M illip o re  vacuum /pressure pump). The p~ 
Bondapak C18 octadecyls ilane colum n 3.9 x 150mm (W aters Associates, Mass.,
USA) was equ ilib ra ted  to  the s ta rtin g  cond itions (85:15, A :B) fo r  30 m inutes
before chrom atography was begun. U n labe lled  peptide standards o f DAGO and 
DPDPE (2.5, 5.0 and lO.Opg in lOOpl s ta rtin g  so lvent) were in jec ted  p rio r to  
the labe lled  samples to establish colum n perform ance and re te n tio n  tim es. A ll 
samples were e lu ted a t a flo w  ra te  o f 1ml min~^ using a linear g rad ient o f 15- 
30% B over 30 m inutes (W aters A u tom ated  G radient C o n tro lle r) and peptides 
were m onitored by th e ir  absorbance at 280nm (W aters LC  spectrophotom eter, 
Lambda Max, model 481).
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D ried  rad io labe lled  peptides were dissolved in 100 p i s ta rtin g  
so lvent. A f te r  in je c tion  onto the colum n, the en tire  e luate was co lle c ted  in to  
th ree  fra c tio n s : from  in je c tion  to  leading edge o f absorbance peak, the peak 
its e lf  and fro m  the tra ilin g  edge o f the peak to  30 m inutes. A liquo ts  (5p l) o f 
each fra c t io n  were added to  5m i s c in t illa t io n  via ls (K och -L igh t, S uffo lk) in 
tr ip lic a te  to  which were added 4m i liq u id  s c in t il la to r  (Unisolve E, Koch L ig h t 
L im ite d , S u ffo lk). [^H  3 hexadecane standards (Am ersham ) o f app rox im a te ly  
25,000dpm were added to  th ree  separate v ia ls  in order to  ca lcu la te  counting 
e ff ic ie n c y . The via ls were counted by liq u id  s c in tilla t io n  (LK B) Rackbeta, 
model 1215) fo r f ive  m inutes or u n til 100,000 counts were recorded.
C a lib ra tio n  curves were drawn up o f peak height against w e igh t o f 
unlabelled peptide standards on colum n: the w e ight and thus percentage 
recovery o f the labelled samples were ca lcu la ted  fro m  such ca lib ra tio n  graphs 
by in te rp o la tio n . The percentage recovery o f ra d io a c tiv ity  was ca lcu la ted  and 
the sp ec ific  a c t iv ity  o f the  labe l de term ined. The tr it ia te d  peptides were 
stored as frozen  solutions at -20°C  in 50pC i a liquots.
2.3.2 Preparation of Brain Homogenates
Rats were k ille d  by decap ita tion , the brains rap id ly  rem oved and 
qu ick ly  dissected according to the procedure o f G low inski and Iversen (1966) to  
give e ith e r whole bra in  or a reg ion com pris ing the pons and m edulla.
The procedure fo r p repara tion  o f membranes fo r  use in the binding 
studies was iden tica l to tha t o f G illan  and K o s te r litz  (1982). The tissue was 
weighed then placed in 50ml ice -co ld  T ris  MCI b u ffe r (50mM, pH7.4 at 4°C ) 
(BDH L im ite d ) and coarsely chopped w ith  scissors. Fo llow ing  a 45 second 
hom ogenisation using a P o ly tron  on position  6  (N o rthe rn  Media, N o rth
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Hum berside, U K) the suspension was trans fe rred  to  two cen trifu g e  tubes and 
spun at 49,000g and 4°C  fo r 15 m inutes (Beckman L5-65B u ltra c e n tr ifu g e ). 
The supernatant was discarded and the pe lle ts  resuspended in  T ris  MCI (50mM, 
pH7.4 a t 37°C) by a 10 second hom ogenisation. The suspension was d ilu ted  to  
a to ta l volum e of 160ml and d iv ided in to  fou r a liquots then incubated in a 
shaken w a te r bath (The M ick le  L abo ra to ry  Engineering Company, Gom shall, 
UK ) at 37°C  fo r 45 m inutes. The m a te ria l was then decanted in to  tw o  
ce n trifu g e  tubes and spun as before . The supernatant was again discarded and 
the pe lle ts  resuspended in T ris  MCI (50mM, pH7.4 at 25°C) by a f in a l 10 second 
hom ogenisation. The homogenate was made to  lOOml/g w et w e ight b ra in  
tissue and stored at 4°C  u n til requ ired, and in no case fo r  longer than tw o 
hours.
2.3.3 S atu ra tion  B inding Experim ents
The experim ents were ca rried  out in  disposable polypropylene tubes 
o f 5ml capac ity  (Sarstedt L im ite d , Le ices te r, UK). For assays w ith  [^H  ]  
DAGO, 12 f in a l concentra tions (0.03-9.0nM) o f labelled peptide were used. 
Fo r each concen tra tion  tw o sets o f tubes in tr ip lic a te  contained e ithe r 1.9m l 
bra in  homogenate and C^h I  DAGO alone or homogenate, C^H ]  DAGO and 
diprenorphine at Ip M  fin a l concen tra tion  in order to  define to ta l and non­
spec ific  binding o f the labe lled  peptide, respec tive ly . The f in a l volum e o f the 
incubates were 2.0m l and T ris  H C l (50mM, pH7.4 at 25°C ) was added 
accord ing ly.
For [ ^ H ]  DPDPE assays, 10 f in a l concentra tions (0 .20-0 .25nM) were 
used; in th is  case, naloxone at lO pM  fin a l concen tra tion  was added to  the sets 
o f tubes in  which non-spec ific  b inding was to  be determ ined.
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For each assay, a fu r th e r set o f t r ip lic a te  tubes conta in ing  2ml bra in  
homogenate only were prepared in which the e ffic ie n cy  o f counting the t r it iu m  
label would la te r be measured. An a liquo t o f the bra in homogenate (1m l) was 
re ta ined  fo r  la te r measurement o f p ro te in  concen tra tion  by the method of 
Low ry  e t ^ . ,  (1951) and stored at -20°C . The assays were s ta rted  by add ition  
o f the labe lled  peptides; the tubes were m ixed vigorously fo r  5 seconds then 
placed in a shaken w a ter bath at 37°C . Labe lled  peptides at the appropria te  
concentra tions were added to  the tubes in tr ip lic a te s  at in te rva ls  o f 90 seconds 
so th a t each set o f tubes could be incubated fo r the same tim e , since the 
te rm in a l phase separation required 90 seconds to com plete . The dura tion  of 
incubation  was 60 m inutes, and was te rm in a te d  by rapid f i l t r a t io n  through 
g iass-fib re  f ilte rs  (W hatman G F/B 21mm d iam eter) pre-soaked in  T ris  H C l 
(50mM, pH7.4 at 4°C ). The f i lte rs  were supported on a coarse s in tered  glass 
disc w ith in  a sm all f i l t e r  funnel, and f i l t r a t io n  was ca rried  out under reduced 
pressure (M illip o re  vacuum /pressure pump). The f ilte re d  incubates were 
rap id ly  washed three  tim es w ith  5m l a liquots o f ice -co ld  T ris  H C l (50mM, 
pH7.4 at 4°C), and the f i lte rs  were placed separate ly in s c in t il la t io n  v ia ls . 
[^ H  ]  hexadecane standards were added to  the f i lte rs  through which 
homogenate alone had been f i lte re d  and also to  em pty v ia ls  and 5p l a liquots o f 
the rad io labe lled  peptide stock so lu tions were placed in tr ip lic a te  in  separate 
via ls to  p e rm it de te rm ina tion  o f ac tua l f in a l peptide concentra tions. To each 
v ia l was added 0.5m l so lub ilis ing  so lu tion  (T rito n  X-100, 20% v /v  in  toluene) 
then 4m l liqu id  s c in t illa n t. The via ls were then capped, shaken and le f t  
overn igh t at room tem pera tu re  before dete rm ina tion  o f binding by liqu id  
s c in t illa t io n  counting.
Each v ia l was counted fo r  10 m inutes or u n til 10,000 counts were 
recorded, w hichever was the shorte r tim e . The mean value o f the number o f
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counts per m inute (cpm) was ca lcu la ted  fo r each set o f tr ip lic a te  via ls and the 
counting e ffic ie n c y  was determ ined by a comparison o f the cpm given by the 
[  H J hexadecane standards and the number o f d is in tegra tions per m inute 
(dpm) expected on the basis o f the supplier's spec ifica tions. The fin a l 
concentra tions o f the t r it ia te d  peptides in each set o f via ls was s im ila r ly  
ca lcu la ted  from  the counting e ff ic ie n c y , the cpm in the labelled peptide 
standards and the spec ific  a c t iv ity  o f the peptide. The to ta l and non-specific  
binding in fm o l pep tide/m g w et w e ight o rig ina l bra in tissue were ca lcu la ted 
fro m  the cpm, the counting e ff ic ie n c y , the f in a l labelled peptide concentra tion  
and the peptide spec ific  a c t iv ity ,  and spec ific  binding was defined as the 
d iffe rence  between the to ta l and non-spec ific  binding.
3Saturation p lo ts o f [  H ]  peptide concentra tion  against spec ific  
binding were rou tine ly  drawn to p e rm it sub jective  assessment o f the binding 
p ro file  p rio r to  fu r th e r analysis. O b jec tive  measures o f the maxim um  binding 
capacity  ( 8 ^ ^ ^ )  and the equ ilib rium  dissociation constant (K ^ )  (Section 
1 . 6 .3.1) were determ ined by linea r regression o f the points from  Scatchard 
p lo ts o f the data.
2.3.4 Determination of Homogenate Protein Concentration
The p ro te in  concen tra tion  o f a ll bra in homogenates in which 
sa tu ra tion  binding assays were perfo rm ed was determ ined by the method of 
Low ry e t ^ . ,  (1951). To dup lica te  0.5m l a liquots o f bovine serum album in 
standards (50-500pg/m l) or b ra in  homogenate samples was added 2.5ml o f 2% 
w /v  NagCo^ in O .IM  NaOH: 1% w /v  CuS 0 ^ . 5 H 2 0 : 2% w /v  N a /K  ta r tra te  
(98:1:1). The solutions were m ixed and allowed to  stand fo r  10 m inutes. To 
each tube was then added 0.25m l F o lin -C ioca lteau  reagent (d ilu ted  1:2 w ith  
d is tille d  w ater) and the tubes were m ixed im m ed ia te ly , sample by sample,
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before being l e f t  fo r 30 m inutes at room tem pera ture  to  a llow  fu ll
developm ent o f the co lour. Standards and samples were read at 690nm using a 
C ecil spectropho tom ete r and the mean blank co rrec ted  absorbance values used 
to  cons truc t a standard curve and to determ ine p ro te in  concen tra tion  in the 
b ra in  homogenate samples.
2.3.5 Validation of Binding Assay Protocol
2.3.5.1 T im e Course of T r it ia te d  Peptide Binding
In order to determ ine the incubation  tim e  required at 25°C  fo r  
equ ilib rium  binding to  be achieved, homogenates o f b ra in  regions were
incubated w ith  [^H  ]D A G 0  a t or w ith  C^H ]DPDPE at 0 .5 K ^  fo r various 
tim es (1, 5, 15, 30, 75 and 105min). T o ta l, non-specific  and spec ific  binding 
were determ ined as described in  Section 2.3.3.
2.3.5.2 R e la tionsh ip  o f S pec ific  B inding to  C oncen tra tion  o f Homogenate
F or an assay w hich measures the number o f binding sites per u n it
w e ight o f tissue to be o f value, and com parable w ith  the resu lts  of o ther
labora to ries , i t  was necessary to  show th a t the amount o f spec ific  binding o f 
the recep to r se lec tive  peptides [  ^ H ] DAGO and [ ^ H ]  DPDPE was 
independent of the amount o f tissue used per tube. A ccord ing ly , [^ H  ]  DAGO 
and C ^ H ]  DPDPE at 0 .5K |^ were incubated w ith  whole bra in  homogenates 
conta in ing  12.5, 25, 50, 100 and 200% o f the tissue ro u tine ly  to  be used. 
Incubations at 25^C were of 60 m inutes duration .
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2.3.5.3 Dependency o f N on-S pecific  B inding on the C oncen tra tion  of 
Naloxone or D iprenorph ine
The unlabelled ligands used to define non-specific  binding o f [ ^ H ]  
DAGO and C^H ]  DPDPE (diprenorphine and naloxone, respectve ly) should
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displace the s p e c ific a lly  bound label but not the n on -sp e c ifica lly  bound
fra c tio n . In order to  dete rm ine  w hether the chosen concentra tions o f 
d iprenorphine ( Ip M ) and naloxone (lO pM ) were approp ria te , whole bra in  
hom ogenate was incubated w ith  the peptides, each at th e ir  values, fo r  60 
m inutes at 25°C  in the  presence and absence o f concen tra tions o f
d iprenorphine and naloxone which were 25, 50, 100, 200 and 400% o f the above 
values respec tive ly .
2 .3.5.4 V e r if ic a tio n  o f the E ffec tiveness o f the Phase Separation 
E ffe c t iv e  phase separation im p lies th a t unbound rad io labe l is
rem oved fro m  bound label w ith o u t each contam ina ting  the o the r. To assess
the e ffec tiveness  o f the f i l t r a t io n  through g lass-fib re  f i l te rs  [ ^ H ]  DAGO at 
K q  was incubated w ith  whole bra in  homogenate at 25°C  fo r 60 m inutes in 
tr ip lic a te . A f te r  the incuba tion , the homogenates were f ilte re d  and washed 
w ith  0 , 1 , 2, 3, 4 o r 5 X 5m l a liquots o f cold T ris  b u ffe r. The mean number of 
counts per m inute only w ere recorded.
2.3.5.5 S ta b ility  o f R ad io labe lled  Peptides D uring Incubation
Experim ents were perfo rm ed  to  investiga te  the s ta b il ity  o f the
3 3t r i t ia te d  peptides used in the binding assays. [  H ]  DAGO and [  H ] DPDPE 
at K p  and 0 .5 K p  resp ec tive ly , were incubated fo r  60 m inutes or 17.5 hours a t 
25°C  w ith  whole b ra in  homogenates or w ith  T ris  H C l b u ffe r alone (50mM, 
pH7.4 a t 25°C). A f te r  the incubations six id e n tica l tubes o f incubate  in each 
case were f ilte re d  through a single glass fib re  disc. The f i l t ra te s  were 
re ta ined  and freeze -d ried  u n til the  pressure was < 1 0  m icrons as previously 
described. The samples were resuspended in 2ml s ta rting  H P LC  so lvent then 
ce n trifu g ed , and lOOpl in je c ted  onto the  H PLC column as described in  Section 
2.3.1. A u th e n tic  samples o f unlabelled DAGO and DPDPE preceded the 
labe lled  samples, and the flo w  ra te  was reduced to  0.5m l min~^ to im prove 
reso lu tion .
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A liquo ts  o f unincubated [  DAGO and [  DPDPE were also applied to 
the column to  p e rm it d ire c t com parison o f the e lu tion  p ro files  o f the
incubated and unincubated peptides. F ractions (0,5m l) were co llec ted
continuously at 1 m inute  in te rva ls  fo r  25 m inutes (DAGO) or 40 m inutes
(DPDPE). To each fra c tio n  was added 3.5m l Unisolve E s c in t illa t io n  f lu id  and 
the v ia ls  were counted fo r  600 seconds or u n til 1 0 , 0 0 0  counts were recorded.
The ease w ith  which the disulphide bridge lin k in g  the two 
pen ic illam ine  residues in DPDPE could be reduced to  su lphydryl groups was 
explored using d ith io th re ito l (5mM) or 2-m ercaptoethano l (10% v /v ) w ith
DPDPE (lOOpg/m l). The m ix tu res  were incubated fo r 15 m inutes at 20°C  
before in je c tion  o f lOOpi samples onto the H PLC  column.
2.3.6 In h ib itio n  Studies w ith  U n iabe lled  Drugs
In order to  de te rm ine  the  a ff in it ie s  o f f ive  drugs o f the fen tany l 
series (Section 1.5) fo r  the p and ô op io id binding sites the displacem ent o f the 
spec ific  binding o f C ^ H ]  DAGO and [  ^H  ]  DPDPE respective ly , by increasing 
concentrations of unlabelled drug was investiga ted (Section 1.6.3.2). 
C ^H IdA G O  and [^ H  ]  DPDPE were incubated at 25°C  w ith  bra in homogenates 
prepared as described in Section 2.3.2 at and 0.5K j^, respec tive ly , in  the 
absence and presence o f 6 - 8  concen tra tions of a lfe n ta n il (4-400nm and 1- 
64pM), fen tany l (l-40 n M  and 4-1280nM), su fen tan il (0.4-32nM and 4-128nM), 
ca rfe n ta n il (0.1-6nM and 0.4-4nM) and lo fe n ta n il (0 .06 -lnM  and 0.5-8nM). The
' '  3pairs o f concentra tion  ranges represent values used to  in h ib it [  H ]D A G G  and 
[ ^ H ]  DPDPE binding respec tive ly . N on -spec ific  binding o f the peptides was 
determ ined both in the absence and a t the highest concen tra tion  used o f the 
unlabelled com pe tito r. The incubation  tim es were increased by 30-40% since 
the presence of in h ib iting  drug increases the tim e  required  fo r  equ ilib rium
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binding to be reached according to  VVeiland and M o lin o ff (1981). Inh ib ition  
experim ents w ith  [^H  ]  DAGO were perfo rm ed in homogenates of pons and 
medulla but th is  proved impossible fo r  com pe tition  studies w ith  [^H ] DPDPE 
because of the high non-specific  binding o f the la t te r  peptide in homogenates 
o f th is  bra in  region. A ccord ing ly , d isplacem ents o f [^H  ]  DPDPE were ca rried  
out in homogenates o f whole b ra in . To ensure com parab ility  o f K . values 
obta ined in the two tissue homogenates a para lle l study using [^H  ]  DAGO and 
a lfe n ta n il was made using both tissue homogenates.
The a ff in ity  and opioid recep to r s ite  s e le c tiv ity  o f m orphine was 
also determ ined in whole bra in  homogenates using the concen tra tion  ranges 
0.2-12.8nM and 40-5120nM fo r  in h ib itio n  o f C^H ]  DAGO and [  ^ H ] DPDPE 
binding, respective ly .
Inh ib ition  studies w ith  lo fe n ta n il were perfo rm ed using tw o 
incubation  lengths (60 m inutes and 17.5 hours) to ensure th a t equ ilib rium  
binding o f th is long-acting  drug w ith  opioid binding sites was a tta ined  
(Gommeren and Leysen, 1982).
The data from  in h ib ition  studies were analysed by means of H il l 
p lo ts and in h ib itio n  constants (K j values) determ ined by the use o f the Cheng- 
P ruso ff re la tionsh ip  (Section 1.6.3.2) and each study was perfo rm ed at least 
fou r tim es using separate b ra in  homogenates.
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2.4 OPERATIVE PROCEDURES IN  VIVO
A il resp ira to ry  and card iovascu lar studies were perfo rm ed in 
urethane-anaesthetised ra ts . Most o f the procedures described were common 
to  both studies, but any d is tinc tions  where made are ind icated in the te x t.
2.4.1 Anaesthesia
Rats were anaesthetised by the in trape ritonea l in je c tion  of 25% w /v  
urethane (e thy l carbam ate: Sigma C hem ica l Company, St Louis, USA). Each 
ra t was weighed then su itab ly  held w h ils t 1.5m l o f the urethane so lu tion was 
in jec ted . A f te r  5 m inutes, when the anim al was im m obile, but s t i l l  responsive 
to  ta i l or paw pinch, the  balance o f the anaesthetic was adm inistered to  give a 
to ta l dose o f 6 .4m l/kg  equiva lent to  1.6g/kg, A fu r th e r 15 m inutes was 
allowed fo r  deep anaesthesia to  be achieved at which tim e  the animal was la id  
on its  dorsal side on a heated anim al operating tab le  (Pa lm er L im ite d , 
England). A re c ta l therm oprobe was inserted (Edale Instrum ents L im ite d , 
Cam bridge, England) and the re c ta l tem pera tu re  was m aintained w ith in  the 
lim its  37 - 1°C  by use o f the operating tab le  heater (15w) and by varying the 
position  o f two 60w overhead lamps. When fo o t w ithd raw a l and b link re flexes 
could not be e lic ite d , surgery was begun.
2.4.2 Tracheal C annu ia tion
A patch o f skin approx im ate ly  2.5 x 2.0cm was removed from  the 
neck region o f the ra t and the trachea exposed by re fle c tin g  the paro tid  glands 
tow ards the head and by tea ring  the muscle surrounding the trachea. The 
trachea was cleared o f surrounding tissue fo r  a length o f 1 cm so th a t a co tto n  
lig a tu re  could be passed underneath. An inc is ion  was made between tw o rings 
of ca rtila ge , cu ttin g  down through about th ree -quarte rs  o f the d iam eter o f the 
trachea. A polythene cannula was inserted fo r  about 5mm and tied  in p lace.
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The in te rna l and exte rna l d iam eters o f the cannula were 2.5 and 3.0mm 
respective ly . To the cannula was attached an adaptor which fa c ilita te d  
connection o f the ra t to the re sp ira to ry  m on ito ring  equipm ent. The trachea o f 
ra ts  used in  card iovascular studies were cannulated to prevent collapse but 
were not connected fo r resp ira to ry  m on ito ring .
2.4.3 Venous Cannuiation
The r ig h t jugu la r ve in was always cannulated fo r  drug 
adm in is tra tions, the le f t  only being cannulated in those experim ents during 
which infusions of naloxone were to be given. A pprox im ate ly  1cm of vein was 
separated from  the surrounding fa t  and connective tissue and two co tton  
liga tures were placed around the vessel. The vein was m anually pumped fu l l  o f 
blood and the vein tied at the ros tra l end. A sm all incision was made in to  the 
vein close to  the ros tra l t ie  and a 10cm length of fine  polythene tubing (17 
gauge blue Luer; Portex L im ite d , H ythe, England) fille d  w ith  0.9% w /v  s te rile  
saline (Travenol Labora to ries, N o rfo lk , England) was inserted in to  the vein fo r  
a distance o f approxim ate ly  1.5cm and tie d  in place. This cannula was 
attached to  a three-w ay tap through w hich drugs were adm inistered. 
Cannuiation o f the le f t  jugu la r vein was carried  ou t using an id e n tica l 
procedure fo r naloxone in fusion experim ents, but in those cases a 19 gauge 
(green Luer, Portex L im ite d ) cannula was used.
2.4.4 A rteria l Cannuiation
The ca ro tid  a rte ries  lie  e ithe r side of the trachea, deep under the 
muscles o f the neck, running closely w ith  both the vagus and ce rv ica l 
sym pathe tic  nerves. The nerves were separated from  the le f t  ca ro tid  a rte ry  
and two co tton  ties were placed around the vessel. The a rte ry  was tied  at a 
point closest to  the head and an a rte ry  c lip  used to  clamp the o ther end of the
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vessel. A 16 gauge polythene cannula (pink Luer, Portex L im ite d ) p rim ed w ith  
héparinised saline (lOOU/m l) was inserted in to  the a rte ry  via a sm all incis ion
and tied  in place. The cannula was connected to a pressure transducer fo r
experim ents invo lv ing  the measurement o f blood pressure and heart ra te  or to 
a th ree -w ay tap only fo r  those experim ents requiring e ithe r period ic  sampling 
o f a rte r ia l blood fo r the measurement o f blood gas tensions, or exsanguination 
fo r the purpose o f de te rm ina tion  o f plasma naloxone concentra tion .
2.4.5 B ila te ra l Vagotom y
The vagus nerves were separated from  the ca ro tid  a rte ry  and 
ce rv ica l sym pathe tic  nerve on both sides of the neck; the vagus is recognisable 
as being by fa r the la rgest nerve running para lle l to  the ca ro tid  a rte ry . 
L iga tu res  were passed around both vagi and prepara tive  surgery continued 
appropria te  to the experim ent in hand. The vagi were cu t a fte r a period of 
post-surg ica l equ ilib ra tio n  as described in Section 2 .4 . 7 .
2.4.6 In trace re b rove n tricu la r In jections
The anaesthetised anim al was placed prone on the operating tab le  
and a piece o f scalp approxim ate ly 1 cm in d iam eter was rem oved fro m  the 
centre  of the head exposing the bregm a, the  in te rsection  o f the sagg ita l and 
coronal sutures. Freehand in tra ce reb ro ven tricu la r (i.c .v .) in jec tions were 
made using 25 gauge needles w ith  Luer f it t in g s . A length o f guide tube whose 
in te rna l d iam eter approxim ated to  the ex te rna l d iam eter o f the needle was 
f i t te d  such tha t the p ro jecting  length o f needle was 5mm (400g ra ts), 5.5mm 
(450g ra ts ) or 6.0mm (500g rats). The needles were le f t  sharp o f necessity, 
since in jections were made w ith o u t p r io r d r ill in g  o f the sku ll and according ly, 
the p ro jec tin g  lengths were measured from  the guide tube to  the  centre  o f the 
lumen on the tapered needle po in t. Holding the head o f the anim al a hole was
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bored through the sku ll by means o f a ro ta ry  m otion  of the needle before the 
needle was pushed home u n til the guide tube impeded fu r th e r m ovem ent. The 
in je c tion  coordinates were 2.5mm la te ra l and 1mm caudal to  the bregm a. The 
anim al was then placed on its  dorsal side and surgery carried  out as described 
in Section 2.4.2, et seq.
Drug adm in is tra tions i.c .v . were made a fte r a period of equ ilib ra tio n  
or a fte r  a dose-response re la tionsh ip  to an agonist had f irs t  been established. 
A second 25g needle was prepared as before , prim ed w ith  drug so lu tion , and 
attached to a lO p l H am ilton  syringe (H am ilton  Bonaduz AG, Sw itzerland). The 
anim al was tem po ra rily  disconnected from  the resp ira to ry  apparatus by means 
o f the adaptor a ttached to the trachea l cannula and placed prone on the 
operating tab le . The f i r s t  needle was removed from  the skull and replaced by 
the  second, connected to the syringe, m ain ta in ing  the needles in a v e rtic a l 
position  to avoid unnecessary damage to brain tissue. The in jections were of 
lO p l volume, adm inistered over 10 seconds. The syringe was disconnected, 
leaving the needle in place, and the anim al was replaced in the o rig ina l 
position to  continue the experim ent.
A fte r  te rm in a tio n  o f the prepara tion  when the experim enta l 
procedures were com plete , an in je c tion  of 2 0 p l black ink was given via the 
rem ain ing needle, and a fte r an in te rva l o f 15 m inutes to  p e rm it d iffus ion  of 
the ink, the animal was decap ita ted  and the brain removed. The in jec tion  s ite  
on the cerebrum  was marked by a dark point and a coronal section was made 
through the bra in at th is  lo ca tion  and at another s ite  (3mm ro s tra l to in je c tion ) 
to  con firm  the presence of ink in  the ven tric les . The resu lts  o f experim ents in 
which sa tis fa c to ry  co n firm a tion  o f the in je c tion  s ite  could not be made were 
re jec ted .
\
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2.4.7 Post-Surg ica l E q u ilib ra tio n
A fte r  surg ical p repara tion , exposed tissue was irr ig a te d  w ith  0.9% 
w /v saline and covered where appropria te  w ith  a saline-soaked co tton  wool 
pad. The anim al was then le f t  fo r  15 m inutes fo r v e n tila to ry  param eters to 
stab ilise  a t w hich po in t the trachea l adaptor was connected to the resp ira to ry  
m on ito ring  apparatus. A fu r th e r 30 m inu te  period was allowed to  ensure tha t 
accom m odation by the anim al to  the increases in resistance and dead volume 
had occurred. In experim ents fo r which b ila te ra l vagotom y was required, the 
vagi were cu t one at a tim e  w ith  a 2  m inute in te rva l between transections to  
fa c il ita te  tra n s itio n  to  the a lte red  pa tte rn  o f breath ing such tre a tm e n t 
produced, fo llow ed by a 15 m inute equ ilib ra tion . P reparations were ro u tine ly  
viable fo r  in excess o f 3 hours.
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2.5 RESPIRATORY STUDIES
2.5.1 Respiratory Monitoring Apparatus and Calibration
The trachea o f the ra t was connected to  a Fle isch tube
pneumotachograph (Hugo Sachs E le c tro n ik , F re iberg, FRG, Model 00) via an 
adaptor which m inim ised dead volume and provided a smooth tra ns ition  o f 
d iam ete r from  the trachea to  the F le isch  tube.
The pneumotachograph is a flo w  transducer which has been
extensive ly used in the measurement o f sm all animal resp ira tion . B r ie fly , the 
p rinc ip le  o f operation is as fo llow s: in a moving gas a resistance to  flo w  is 
in troduced by means of a screen or grid  o f sm all, para lle l-g rouped channels 
w ith  a trapezo ida l cross-section. W ith in  lim its  (5-150ml sec ^ fo r  F le isch 00) 
the f lo w  through the channels is lam ina r and behaves according to  Poiseuilles 
Law , th a t is, th a t the d iffe rence  in pressure fro m  one side o f the screen to the 
o ther is p roportiona l to  flo w  ra te . The actua l d if fe re n tia l pressure developed 
depends both on flow  ra te  and the v iscos ity  o f the a ir, w hich changes w ith  
tem pera ture . To prevent condensation o f w a te r in expired a ir in the 
pneumotachograph which would a lte r the resistance to  flo w , the tube is 
surrounded by a sm all heating co il. The main body of the F le isch tube was 
m ainta ined at a tem pera ture  o f 32°C by the app lica tion  o f 4.5V DC across the 
co il.
The d iffe re n tia l pressure created by the ra t b reath ing  in  and out o f
4
the tube was measured by means of a Grass Model PT5 d if fe re n tia l pressure
transducer (Grass Instrum ents, Mass., USA). This consists o f two c y lin d rica l
cav ities  separated by a la rge, sensitive  diaphragm , a can tileve r on which 
bonded s tra in  gauges transduce changes in  m ovem ent to changes in resistance. 
Each o f the cav ities in the transducer were connected to  one side o f the
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pneumotachograph screen by rig id -w a lled  tub ing, so tha t as a ir was driven in 
and out of the pneumotachograph, the d if fe re n tia l pressure so developed 
produced an osc illa ting  vo ltage. This was displayed on a cha rt recorder via a 
Grass Polygraph (Model 79D) and th is  analogue signal provided the means of 
measuring resp ira to ry  frequency, tid a l volume and peak a ir flo w  ra te  as 
described below.
The analogue signal output from  the polygraph d rive r a m p lif ie r  was 
fed in to  an EKG Tachograph (Grass Model 7P4). In b r ie f, the ins trum ent 
d iffe re n tia te s  the vo ltag e -tim e  signal repeated ly and thereby detects both the 
tu rn ing  points o f the signal (dV /d t = 0) and the d irec tion  o f change o f the 
signal. The instrum ent is triggered  once in every com plete signal cyc le  and 
resets its  in te rna l tim e-base. When the next trigge ring  occurs, the in te rv a l 
between the tw o  events provides the basis fo r  the ca lcu la tion  o f resp ira to ry  
frequency which is displayed on the polygraph chart recorder. The EKG 
tachograph has its  own in te rna l ca lib ra tion  which was checked m on th ly .
The d if fe re n tia l pressure transducer was ca lib ra ted  by in troduc ing  a 
series o f known pressures in to  one ca v ity  by means of a m ercury m anom eter 
and noting the resu ltan t pen d e flec tion . The flo w  ra te  of a ir through the 
Fle isch tube pneumotachograph screen which produced a given d if fe re n tia l 
pressure was provided by the m anufacture rs as each is in d iv id ua lly  ca lib ra ted . 
Thus, the magnitude o f the pen de fle c tio n  produced as the ra t inspired or 
expired pe rm itted  ready ca lcu la tio n  o f the peak a ir flow  rates.
The analogue signal from  the d iffe re n tia l pressure transducer was 
also fed  in to  a Grass polygraph in te g ra to r (Model 7P10). This ins trum en t 
provides the area under the vo ltag e -tim e  func tion  and because the pen
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d e fle c tio n  (end the re fo re  vo ltage) o f the analogue signal channel is d ire c tly  
p roportiona l to d if fe re n tia l pressure and thus a ir flow  ra te , th is  in teg ra l is 
volume expired or insp ired. Since the volum e of a ir expired and inspired must 
be equal over a period longer than a very few  breaths, the in te g ra to r con tro ls  
were set so tha t the portion  of the analogue signal corresponding to  exp ira tion  
was in teg ra ted  to produce a d e flec tion  o f the in te g ra to r channel pen. The 
in te g ra to r resets a u tom a tica lly  each tim e  the analogue signal crosses zero 
vo ltage, thus the m agnitude o f the pen d e flec tion  is a d ire c t measure o f 
e xp ira to ry  t id a l volum e, w r itte n  b rea th -by-b rea th  upwards from  the baseline. 
The system as a whole was ca lib ra ted  by d riv ing  50ml o f m oist, warm  a ir 
through the heated F leisch tube over a period o f approxim ate ly 2 seconds w ith  
a syringe and noting the pen de fle c tio n  on the in te g ra to r channel. The 
ca lib ra tions were ve rifie d  once a m onth but never required a lte ra tio n  o f gain.
In use, the system provided continuous read-out o f resp ira to ry  
frequency, peak insp ira to ry  and e xp ira to ry  f lo w  ra te  and b reath -by-b reath  
e xp ira to ry  tid a l volume and these measures appear on each resp ira to ry  trace . 
M inute  volume was ca lcu la ted by m u ltip ly in g  t id a l volume by ra te  at any point 
on the trace .
2.5.2 Measures of Opioid Drug-Induced Respiratory Change
The fen tany l drugs were made up as solutions o f Im g /m l in 0.9% 
saline w ith  the help o f a drop o f 3M H C l, and stored at 4°C  fo r periods of no 
longer than one week. The d ilu ted  solutions fo r adm in is tra tion  were made up 
da ily , and dosing w ith  drug was always proceeded by a saline con tro l (0.2m l).
The drugs a lfen tan il (2 -32pg/kg), su fen tan il (0 .05-0.8pg/kg), 
fen tany l (1-16 pg/kg) and ca rfe n ta n il (0 .05-0.4pg/kg) were adm inistered as
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in travenous bolus doses in a volume of 0.1m l and washed in w ith  0.2m l saline. 
The duration  of apnea (cessation of breath ing) was p lo tted  against log dose 
(g /kg) and the dose required to  produce an apnea of 6 seconds dura tion  (defined 
as 6sA) was determ ined by in te rpo la tion  onto the regression line  drawn through 
the points.
The percentage change in frequency and tid a l volume and thus 
m inute volume at 15 seconds a fte r dosing were also p lo tted  against log dose. 
The doses producing 30% depressions (ID^g) o f frequency and of tid a l volume 
were determ ined fro m  lines o f linear regression, as were the doses required  to  
produce a 50% depression (ID^g) o f m inute volume. Dose response lines from
3-5 drug doses were ro u tine ly  drawn to determ ine these measures o f 
resp ira to ry  depressant potency.
The dose-cycles fo r each of the fen tanyls d iffe re d  according to  th e ir 
durations o f action  and were between 5 m inutes (a lfe n ta n il) and 20 m inutes 
(su fentan il). In the case o f drugs w ith  very long durations of action , the  dose 
required to cause death by cessation o f breath ing was used as an index o f 
potency ra th e r than ID^g defined above.
The potency of the drugs to pertu rb  resp ira tion  in the b ila te ra lly  
vagotomised ra t was determ ined in the same manner as in the in ta c t ra t, w ith  
a lte ra tions in the doses used as appropriate to  th is model.
The maximum percentage changes in frequency and tid a l volume 
produced by the Upjohn compounds U50,488H (100-1600pg/kg) and U69,593 
(25-400pg/kg) as i.v . bolus in jec tions were defined as ED^g and ID ^^, 
respective ly , and were s im ila rly  derived from  linear regression onto the log 
dose response p lots. Dose cycles fo r these drugs were o f 20 m inutes duration .
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Solutions o f the peptides DAGO and DPDPE in saline and IC I
174.864 fo r  intravenous or I.c .v . a dm in is tra tion  were made up da ily . ICI
174.864 was f ir s t  dissolved in an aqueous so lu tion  o f L -a rg in ine  (O .IM ; Sigma 
C hem ica l Company) then d ilu ted  1:2 in saline.
2.5.3 Blood Gas Analysis
The pH and the p a rtia l pressures o f oxygen and carbon d ioxide of 
a rte r ia l blood ( ^ ^ © 2  and P ^ C Ü 2 , respective ly ) were measured using an IL413 
pH /blood gas analyser (Ins trum en ta tion  Labora tories, W arring ton). The 
ins trum ent was ca lib ra ted  before each de te rm ina tion  by means o f the 
ca lib ra te d  bu ffe rs  and gas m ixtu res supplied by the m anufacturers.
A r te r ia l blood samples (300p l) were taken anaerobica lly , v ia  a 
th ree -w ay tap connected to  the ca ro tid  a rte ry  cannula, in to  1ml disposable 
p las tic  syringes which had been flushed w ith  sodium heparin (500U /m l) then 
closed, leaving the syringe dead space (= 20pl) f il le d  w ith  heparin. A sm all 
am ount o f blood (lOOpl) was w ithdraw n p rio r to rem oval of the main sample to  
ensure tha t fresh a rte r ia l blood only was co llec ted . The syringe was capped 
w ith  N esco film  (Nippon Shoji Kaisha, L im ite d , Japan) and the sample was 
m ixed v igorously fo r  20 seconds by ro ta tin g  the syringe between the palms o f 
the hands. The sample was analysed w ith in  5 m inutes so th a t cooling was not 
required .
A fte r  blood gas analysis, 5p l o f the residual blood was taken in to  a 
hem a to c rit m ic roca p illa ry  tube and cen trifuged  in a Compur M llO O  
m ic roce n trifug e  (C om pur-E lec tron ic  GmbH, München, FDR) fo r  5 m inutes in 
order to determ ine h em a to c rit.
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The tim e  course o f pH and a rte r ia l blood gas status was measured in 
ra ts prepared as described in  Section 2.4 and blood samples were taken 15 
m inutes a fte r surgery was com plete , a t which tim e  the animal was connected 
to the re sp ira to ry  m on ito ring  apparatus, and at 30, 60, 120 and 180 m inutes 
th e re a fte r. To ensure com p arab ility  o f in ta c t and b ila te ra lly  vagotom ised ra ts 
w ith  respect to  m aintenance o f adequate ve n tila tio n , long itud ina l studies were 
ca rried  out in both preparations.
In order to  investiga te  the nature o f the re la tionsh ip  between 
changes in resp ira to ry  m inute volume and a rte r ia l blood gas tensions induced 
by opioid drugs, a study o f the e ffe c ts  o f a lfe n ta n il given as i.v . bolus doses to 
in ta c t ra ts  was made. Blood samples were taken over a 5 second period as 
close as possible to  15 seconds a fte r  dosing w ith  saline, or 4, 8 or 16pg/kg 
a lfe n ta n il. Samples were also taken  a fte r  dosing w ith  naloxone (Im g /kg  bolus) 
15 m inutes before redosing w ith  a lfe n ta n il (16yg/kg). In these studies changes 
in re sp ira to ry  m inute volume were noted a fte r each dose.
2.5.4 Antagonism of Respiratory Responses by Bolus Doses of Naloxone
The apparent p A 2  in v ivo (Section 1.7.2.3) fo r  the pair 
a lfen tan il/na loxone  was determ ined fo r  the resp ira to ry  responses produced by 
a lfe n ta n il in the in ta c t ra t. The e ffe c ts  o f naloxone alone in opio id-na ive ra ts  
at doses up to  and including Im g /k g  were f ir s t  investigated, as were the 
responses to the fen tany ls  upon repeated dosing.
A dose-response p lo t fo r  a lfe n ta n il was obtained as described in 
Section 2.5.2. A f te r  the las t dose had been given, an i.v . bolus dose of 
naloxone (50, 200 or 800pg/kg) was adm inistered via  the r ig h t jugu la r vein 
cannula and washed in w ith  two 0.2m l a liquots o f saline. The animal was le f t  
fo r 10 m inutes a fte r which a second dose-response curve to  a lfen tan il was
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obta ined, using la rger doses o f agonist. Regression lines were drawn fo r the 
apneic and frequency, tid a l volume and m inute  volume depressive e ffe c ts  of 
a lfe n ta n il in the presence and absence o f the antagonist and dose ra tios  
ca lcu la ted  using the com parator points described fo r  each a lte red  param eter 
in  Section 2.5.2. The slopes of the regression lines fo r each param eter before 
and a fte r naloxone were compared by means o f a paired S tudent’s t- te s t,  and
4-5 independent estim ates of dose-ra tio  were obtained at each dose of 
naloxone. Schild p lo ts (Section 1.7.3.2) o f the data were drawn fo r each 
param eter and apparent in  v ivo pA ^ ca lcu la ted  from  the in te rce p t o f the 
Schild regression on the ord inate. For those data sets which produced Schild 
regression lines w ith  slopes not s ig n ific a n tly  d iffe re n t from  un ity , apparent 
pA 2  was also ca lcu la ted  by the m ethod o f T a lla rid a  and Jacob (1979), from  the 
dose-ratio  at each dose o f antagonist. The lim ita tio n s  inherent in 
de te rm ina tion  of jn  v ivo  apparent pA 2  by means of single, bolus doses of 
naloxone precluded fu r th e r work w ith  o the r agonists using th is  method.
2.5.5 Antagonism of Respiratory Responses by Infusiom of Naloxone
A new method fo r  the accurate  de te rm ina tion  o f naloxone pA 2  jn  
vivo  was developed which p e rm itte d  in fus ion  o f naloxone to  m u ltip le , steady- 
sta te  concentrations in urethane-anaesthetised ra ts . The development, 
va lida tion  and use o f the method is described below.
2.5.5.1 E stim a tion  o f the B io log ica l H a lf -L ife  o f Naloxonei
Anim als were prepared fo r  resp ira to ry  studies as previously 
described and dosed w ith  a lfe n ta n il in order to  fin d  a dose which depressed 
m inute  volume by approxim ate ly  30%. This dose was given three tim es at 5 
m inute  in te rva ls  and the mean response was defined as 100% response to  the 
tes t dose and term ed 1.0. The ra t was then dosed w ith  naloxone (200jjg /kg  i.v .
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bolus) and a fte r 5 m inutes and subsequently at 10 m inute in te rva ls  fo r 110 
m inutes, the test dose o f a lfe n ta n il was adm inistered and the resp ira to ry  
response noted. As the size o f the response increased w ith  tim e , ind ica ting  
the e lim ina tio n  of naloxone, the log o f the size o f the response compared w ith  
th a t p rio r to naloxone was p lo tted  against tim e . The slope o f the regression 
line  f i t te d  to  the points p e rm itte d  ca lcu la tio n  of the apparent e lim ina tio n  ra te  
constant, K , and the te rm in a l e lim ina tio n  h a lf- l ife ,  t | .  The experim ent was 
repeated three tim es using separate animals and an iden tica l study was also 
made in b ila te ra lly  vagotom ised ra ts  to ensure com parab ility  o f the tw o 
p reparations.
2,5.5.2 Infusion o f Naloxone to  Steady-S tate C oncentra tions
An estim ate  of the apparent volume o f d is trib u tio n  (Vq ) o f naloxone 
in the ra t was taken from  the work o f Tepperman et al., (1983). A drug 
infused at a constant ra te , (the zero order ra te  constant) w il l reach a 
s teady-sta te  blood concen tra tion  (C^g” ) in  a tim e  independent o f K and the 
ra te  o f plasma clearance (C l^) o f the drug, but equal to  approx im ate ly  five  
tim es the e lim ina tion  h a lf- l ife .  The value o f the p lateau concen tra tion  
reached is given by = K ^ /C l^
where:
C l = K p e D
Thus, any value of Cgg could be approached by a sim ple ca lcu la tion  
o f K ^. However, i t  was considered im p ra c tica l to infuse the antagonist fo r 
f iv e  e lim ina tion  h a lf- live s  in order to  obta in  a s teady-sta te  concentra tion , and 
the desired Cgg values were reached by adm in is tra tion  o f a bolus loading dose 
o f naloxone fo llow ed  by a continuous in fusion at the ra te  which alone would 
have a tta ined  the same Cgg” given over five  h a lf- live s . In th is  way, the
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required was th e o re tica lly  reached im m ed ia te ly , although a fte r  in fusion
was begun, one h a lf- l ife  was allowed in order tha t a d is trib u tio n a l equ ilib rium  
could be reached.
2.5.5.3 V a lida tion  o f Cëg~ Estim ates by Measurement o f Blood Naloxone
C oncentra tion  by HPLC
Rats were prepared as described in Section 2.4, given a bolus loading 
dose o f Im g /kg  naloxone, then infused (H arvard  Infusion Pump 56, H arvard 
Apparatus L im ite d , K en t, UK) w ith  naloxone via the le f t  jugu la r vein cannula 
at 21.25pg/m in /kg  body w e ight fo r a period equal to three e lim ina tio n  h a lf-  
lives, using a volume in fusion  ra te  o f lO y l/m in . The concen tra tion  o f naloxone i
in ra t serum was determ ined by HPLC a fte r  e x tra c tio n  and lyoph ilisa tion . The 
e x tra c tio n  recoveries o f naloxone and the close ly re la ted  compound m orphine, 
were shown by p re lim ina ry  experim ents to be id e n tica l, thus morphine was 
used as an in te rna l standard to p e rm it ca lcu la tion  o f the assay-to-assay 
recovery o f naloxone. I
Blood was obtained by decap ita tion  and co llec ted  in to  tubes 
conta in ing no anticoagu lan t. A f te r  a 1 hour c lo ttin g  tim e  a t room  '
tem pera ture  the tubes were cen trifuged  (Beckman Model J6) at 2000g fo r  20 
m inutes a t 4°C . A 5ml a liquo t o f serum so obtained was spiked w ith  m orphine j
to  give a concen tra tion  o f 62.5ng/m l. To the spiked serum sample was added 
2.5ml saturated sodium b icarbonate  b u ffe r (pH8.9) and 15ml p ropan -2 -o l/e thy l 
aceta te  ( l:1 0 v /v ) . The m ix tu re  was shaken vigorously fo r  15 m inutes a fte r 
which the phases were separated by low  speed c e n trifu g a tio n . The aqueous 
layer was discarded. To the organic laye r was added 5ml hydroch lo ric  acid 
(O.OIM) and th is  was shaken fo r  10 m inutes. A f te r  ce n trifu g a tio n , the organic 
layer was discarded and the aqueous layer re -e x tra c te d  w ith  sodium
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bicarbonate b u ffe r and p ro pan -2 -o l/e thy l acetate  as above. To the resu lting  
organic phase was added 1ml hydroch lo ric  acid (O.OIM), shaken fo r 5 m inutes, 
then cen trifuged . The fin a l aqueous layer was re ta ined and neutra lised by 
add ition  o f 50p i sodium hydroxide (0.2M). This solution was freeze-d ried  to 
zero volume and the residue resuspended in lOOpl HPLC solvent described 
below.
An a lte rna tive  method fo r  e x tra c tio n  o f drugs from  serum was also 
employed. A liquo ts  o f ra t serum (5m l) spiked w ith  m orphine and naloxone as 
described in th is section were applied to sm all C^g reverse phase columns 
(Sep-Pak, Waters Associates, USA) o f 2ml volume at 2m l/m in  a fte r  p re ­
cond ition ing  the columns w ith  p ro p a n -l-o l (6m l) and d is tille d  w a te r (6m l). The 
columns were then washed w ith  IM  H C l (5m l) then w ith  d is tille d  w a te r u n til 
the pH o f the eluate was 5. Drugs were then eluted w ith  m ethanol (12ml) at 
6m l/m in  and the organic eluates were evaporated to  dryness under reduced 
pressure before HPLC analysis o f the residue.
Morphine and naloxone were separated by reverse-phase HPLC using 
a Cj^g p-Bondapak column (see Section 2.3.1) e luted iso c ra tica liy  w ith  an 
aqueous solution o f ace tic  acid, am monia and a c e to n itr ile  (6:0.25:5% v /v ) a t a 
flow  ra te  o f 1ml m in ” ^ and detected by UV absorption at 28Gnm. M orphine 
(125, 250 and 500ng) and naloxone (250, 500 and lOOOng) standards were 
in jected  p rio r to the e x trac ted  m ateria ls  and standard curves constructed. 
The amount o f naloxone in the e x tra c t was found by m u ltip ly in g  the value 
ca lcu la ted by in te rpo la tion  o f the naloxone peak height onto the naloxone 
standard curve by the rec ip roca l o f the recovery o f m orphine, which was in 
tu rn  ca lcu la ted by in te rp o la tio n  o f the m orphine peak height onto the 
morphine standard curve. This procedure was repeated three tim es;
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c o n firm a tio n  of low er steady-sta te  blood naloxone concentrations was not 
possible using th is m ethod because o f the inadequate se ns itiv ity  o f the UV 
absorption d e te c to r.
2.5.5.4 A ccura te  D e te rm in a tio n  o f pA ^ In Vivo Using the Naloxone Infusion
M ethod
Estim ates o f pAg were made by measuring the s h ift in  the position  
o f the log dose-response lines fo r  the resp ira to ry  param eters m onitored at 
three  d iffe re n t blood naloxone concentra tions (17.2, 68.8 and 275.2nM) and 
constructing  Schild p lots. The bolus loading doses, infusion ra tes and steady- 
s ta te  blood naloxone concentra tions were ca lcu la ted  by means o f the 
re la tionsh ips given in Section 2.5.5.2. Using th is  infusion p ro toco l, a m axim um  
o f fou r dose-response curves were obtained from  each anim al, increm enting  
the naloxone between successive dose-ratio  determ inations by means o f 
loading doses o f 50, 150 or 600pg/kg naloxone fo llow ed by continuous infusions 
at the ra tes 1.06, 4.25 or 17pg /kg /m in  respective ly . A period equiva lent to  
one e lim ina tio n  h a lf- l ife  o f naloxone was allowed a fte r the s ta rt o f each 
in fusion to  p e rm it a tta in m e n t o f an equ ilib rium  and the infusions were 
m ainta ined during the subsequent re-estab lishm ent o f the dose-response 
re la tionsh ip  a t h igher agonist doses.
These values o f blood naloxone concentra tion  were used to 
antagonise the resp ira to ry  e ffe c ts  o f a lfe n ta n il, fen tany l and su fen tan il in both 
in ta c t and b ila te ra lly  vagotom ised ra ts . For ca rfen ta n il, naloxone pA^ was 
determ ined by comparison o f the c a rfe n ta n il doses, at each of the naloxone 
Cgg” values, required  to  produce cessation o f breath ing which, w ith o u t 
adm in is tra tion  o f a fu r th e r naloxone dose and provision o f tem porary  
resp ira to ry  support, would have lead to  the death of the anim al. To obta in
108
s u ff ic ie n tly  large dose ra tio s  when using naloxone to antagonise the 
resp ira to ry  e ffe c ts  o f the k opioid recep to r se lective  compounds U50,488H and 
U69,593, however, la rge r bolus loading doses (200, 600 and 2400pg/kg) and 
higher infusion rates (4.25, 17 and 68pg /kg /m in  respective ly) o f naloxone were 
used. In e ithe r case, 5-9 estim ates o f dose-ratio  at three d if fe re n t naloxone 
steady-sta te  concentra tions were obtained. Schild p lots were constructed and 
pAg ca lcu la ted.
2.5.6 Antagonism of Respiratory Responses by N-M ethyl Levallorphan
In ta c t and b ila te ra lly  vagotom ised ra ts were prepared as described 
in Section 2.4 and dosed w ith  a lfe n ta n il, su fen tan il, fen tany l or U69,593 to  
obta in  a dose response re la tionsh ip . A f te r  the last agonist dose the venous 
cannula was flushed w ith  0.2m l saline at 2 m inute in te rva ls  u n til no response 
was obtained, a t which po in t an i.v . bolus dose o f N -m ethy l-leva llo rphan  (1.0,
2.5 or 5.0m g/kg) was adm inistered and washed in w ith  saline. The anim al was 
le f t  fo r  15 m inutes a fte r  which a second dose-response curve w ith  the same 
agonist was obtained. The degree of blockade of the responses was noted fo r 
eacb antagonist dose.
In a s im ila r series o f experim ents, the properties o f the tw o  re la ted  
antagonists N -m e thy l leva llo rphan and leva llo rphan (10, 25 and 50pg/kg) were 
compared in in ta c t ra ts  using a lfe n ta n il as the agonist. The apparent 
b io log ica l h a lf- liv ^ s  o f both antagonists were also determ ined as described fo r  
naloxone in Section 2.5.5.1.
N -m ethy l leva llo rphan (250pg) was also given i.c .v . to  b ila te ra lly  
vagotomised ra ts as described in  Section 2.4.6 in order to provide a pos itive  
con tro l fo r the dosing technique. The dose-ratio  fo r blockade o f a lfe n ta n il-
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induced depression o f resp ira tion  a fte r  N -m ethy l leva llorphan i.c .v . was 
compared w ith  the e ffe c t o f saline i.c .v . end w ith  saline or N -m ethy l 
leva llorphan (5m g/kg) given sys tem ica lly  as an i.v . bolus dose.
no
2.6 CARDIOVASCULAR STUDIES
The card iovascular responses to a number o f opioid drugs employed 
in the resp ira to ry  investiga tions were characterised to  p e rm it comparisons 
w ith  th e ir  potency to  pertu rb  resp ira tion .
2.6.1 Cardiovascular Monitoring Apparatus and Calibration
The le f t  ca ro tid  a rte ry  o f the ra t was cannulated as described in 
Section 2.4.4 and connected via  a 3-way tap to  a blood pressure transducer 
(S tatham -Gould P23XL). This contains an unbonded s tra in  gauge in a 
Wheatstone bridge c irc u it .  D e fo rm a tion  by blood pressure pulses o f the m eta l 
diaphragm produces changes in the resistance o f a section o f the res is to r 
bridge c irc u it  which resu lts in changes in the balanced voltage across the 
c irc u it ,  whose size is p roportiona l to  the pressure. The output signal from  the 
transducer was displayed on the Grass polygraph and the pu lsatile  signal was 
also used to  provide a constant ind ica tion  o f heart ra te  by means o f an EKG 
Tachograph (Section 2.5.1).
The blood pressure transducer was ca lib ra ted  in an iden tica l manner 
to tha t used fo r ca lib ra tion  o f the d if fe re n t ia l pressure transducer (see Section 
2.5.1).
2.6.2 Measures of Cardiovascular Change
A lfe n ta n il (2-16pg/kg), fen tany l (0 .4-3 .2pg/kg), su fen tan il (0.05- 
0.4pg/kg) and ca rfen ta n il (0 .05-0 .2kg) were adm inistered to in ta c t and 
b ila te ra lly  vagotom ised ra ts  prepared as described in Section 2.4. Drug dosing 
pro toco ls were as described fo r re sp ira to ry  studies (Section 2.5.2). The e ffe c ts  
o f saline (0.2m l) were determ ined im m ed ia te ly  before  commencing drug 
adm in is tra tion  fo r each p repara tion.
Ill
Both acute e ffe c ts  and those o f slower onset were quan tified  by 
comparison o f the values o f systo lic  and d ias to lic  blood pressure and o f heart 
ra te  at the tim e  o f maximum change w ith  the predosing values. Mean a rte r ia l 
pressure was ca lcu la ted  as d ias to lic  pressure plus one th ird  o f the 
sys to lic /d ia s to lic  d iffe rence . Both absolute and percentage changes were 
recorded.
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2.7 STATISTICAL TESTS
Sets o f unpaired data were compared using the fo rm u la ;
- 1 - - 2
^ [ s Ë i v ÿ ^  (SEMg)^ 
where x and SEM are the mean and standard e rro r o f the mean o f n values.
Paired data were compared using the fo rm u la :
d
t  = /S D ^ 
\ n
where d and SD are the sum of the mean, and the standard dev ia tion , 
respective ly  o f the d iffe rences between n sets of values.
Where p roba b ility  (p) values are given in the te x t,  an unpaired 
student's t - te s t  was used unless otherw ise ind ica ted .
Analysis o f variance (AN O VA) was employed to  tes t fo r s ig n ifica n t 
d iffe rences in the blood gas values in long itud ina l studies and a fte r drug dosing 
only.
CHAPTER 3 
RESULTS
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3.1 P U R ITY  OF RADIO LIG ANDS
C a lib ra tion  plots fo r p u r if ic a tio n  o f radioligands by HPLC were 
always linea r, and re ten tio n  tim es d iffe re d  by less than 2% from  standard to  
standard fo r each peptide. E lu tion  p ro file s  o f labelled and unlabelled samples 
o f DAGO and DPDPE are given in Figures 3 and 4. W hilst samples such as 
these were easily separated from  im p u ritie s  by the co lle c tion  o f frac tions (see 
Section 2.3.1) o ther samples, p a rtic u la r ly  o f DPDPE contained
appreciable quan tities  o f unknown m a te ria ls .
3.2 SATURATION BINDING  IN  BRA IN  HOMÜGENATES
3.2.1 Verification of the Binding Methodology
3.2.1.1 Tim e Course o f S atu ra tion  Binding
The increase in spec ific  binding o f both [  DAGO and [^H  ]
DPDPE to  homogenates o f whole bra in and pons/m edulla regions w ith  tim e  
described a rectangu la r hyperbola (F igure 5). The tim e  required fo r  h a lf 
m axim al binding o f ligand varied w ith  ligand and homogenate and there was a 
positive  co rre la tion  between the non-spec ific  binding o f both ligands in both 
these tissue homogenates as a percentage o f the to ta l binding and the tim e  
taken fo r  h a lf m axim al spec ific  binding to  be a tta ined  (r = 0.99).
3.2.1.2 R elationship  o f S pec ific  Binding to  C oncentra tion  o f Homogenate 
The spec ific  binding o f t ^ H ^  DAGO at In M  was lin e a rly  re la ted  (r =
0.996) to  the amount' o f tissue in the incubate between the lim its  l-1 9 m g  w et 
w e igh t tissue/tube (F igure 6). Thus, w ith in  the lim its  shown, spec ific  binding 
expressed as fm o l mg ^ tissue or p ro te in  was independent o f the amount of 
tissue used to determ ine i t .  Specific binding increased more rap id ly  w ith  
increasing tissue con ten t/tube  than did non-spec ific  binding (N5B), thus the 
ra tio  o f MSB to to ta l binding decreased w ith  increasing tissue co n ten t/tube .
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Figure 4 H PLC Elution ProfUes fo r DPDPE
Peptides were separated by reverse phase HPLC using a C-18 p-Bondapak 
colum n (3.9 x 150mm) e lu ted  w ith  a lin e a r, a c e to n itr ile  gradient (15-30% over 
30 m inutes and 1ml m in" , broken line ), in 6.25% v /v  ace tic  acid/0.25%  v /v  
am m onia, pH3.2. Peptides were detected  by UV absorption at 280nm. Peak A 
shows the e lu tion  o f L H  ^DPDPE (250pC i, 5.8pg, Amersham  Batch 15) and B, 
the e lu tion  of 5pg unlabelled DPDPE, one o f three standards in jected  in order 
to  produce a standard curve. The peaks a t low er re ten tio n  tim es are a ir and 
non-re ta ined m a te ria l.
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Figure 5 Time-Dependent Increase in Specific Binding of
[ ^H ] DAGO and [ ^H] DPDPE in Homogenates of Whole
Brain and Pons and Medulla Regions of R at
C irc les represent ]  DAGO binding and squares, 3 DPDPE binding, in 
whole bra in  (closed symbols) and pons and m edulla regions (open symbols). The 
concen tra tion  o f ligand was between 2/3 and 1 and each po in t is the mean 
- SE means o f three independent experim ents.
117
1003000
GÛ( /)Z
w
C LOO
JD
I
n im
20
□
enc
"TD
E  l o
g
50 X  
g
1
JD
WaiC L
Y
mg rat whole brain contained in 2ml incubate 
(wet weight equivalent).
Figure 6 The E ffe c t of Change in Homogenate Tissue Content 
(R at Whole Brain) on Binding of 3 PAGO
[-^H ]  DAGO fo r  
three rep lica te
A pp rop ria te ly  d ilu ted  homogenate was incubated w ith  0.99nM 
60 m inutes. Each point is the mean o f four sets o f 
de term inations, and a ll standard errors o f the mean are <6% (not shown fo r 
c la r ity ) .  NSB = N on-spec ific  binding.
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3.2.1.3 N on-S pecific  Binding
The fin a l concentra tions o f naloxone (lO pM ) and diprenorphlne ( Ip M ) 
used to  define the NSB in assays invo lv ing  [^H ]  DPDPE and [^H  ]  DAGO, 
resp ec tive ly , apparently displaced a ll the sp e c ifica lly  bound rad io ligand but 
not th a t po rtion  o f label bound n on -spec ifica lly . This was shown by the 
independence o f NSB as a p roportion  o f to ta l binding from  the concen tra tion  
o f naloxone or d iprenorphlne w ith in  the concen tra tion  ranges tested.
3.2.1.4 Phase Separation
A fte r  the incubates had been passed through the g lass-fib re  f i lte rs  
and washed only once w ith  5ml a liquots o f cold T ris  H C l b u ffe r, most o f the 
unbound label was e ffe c t iv e ly  separated from  bound label, w hich was re ta ined 
on the  f i l te r .  F u rthe r washing did rem ove a sm all add itiona l amount o f labe l, 
but th is  did not produce s ig n ifica n t fa lls  in the p roportion  o f label rem ain ing.
3.2.1.5 The E ffe c t o f Solub iliser on Apparent R a d io a c tiv ity  on the F ilte rs   ^
When via ls were counted fo r  ra d io a c tiv ity  im m ed ia te ly  a fte r add ition
o f the T r ito n  X lO O /to luene so lub ilise r so lu tion  and liqu id  s c in t il la to r , a la te r 
count revealed a 2 .5 -fo ld  increase in apparent a c t iv ity  w hich was due to  a 
tim e-dependent rem oval o f labelled peptide from  the g lass-fib re  f i lte rs .  A fte r  
approx im ate ly  16 hours, no fu r th e r increase in a c t iv ity  was observed and thus, 
the v ia ls  from  la te r experim ents were counted a fte r an overn igh t incubation  o f 
the  f i lte rs  and so lubilisers.
3.2.1.6 Incubation S ta b ility  o f the T r it ia te d  Peptides
[  DAGO appeared to  possess g reat s ta b il ity  in the  in  v itro  binding 
assay. This is suggested by the s im ila r ity  o f the H PLC e lu tion  p ro files  o f the 
ligand before and a fte r incubation  w ith  Tris b u ffe r alone or w ith  b ra in  
homogenate (F igure 7). This was not the case fo r  [  ^ H ] DPDPE, however.
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Figure 7 Assessment of the Stability of ] DAGO in the
In V itro  Binding Model
A liquo ts  o f ]  DAGO (Batch 19, Am ersham ) were incubated at 25°C  w ith  
(A) Noth ing, (B) 50mM T ris  b u ffe r fo r  1 hour, (C) Rat whole bra in homogenate 
fo r  1 hour (D) R at whole brain homogenate fo r hours. The incubates were 
freeze -d ried  and analysed by H P LC  as described in  the Methods. B r ie f ly , the 
flo w  ra te  was reduced to  0 .5m i/m in  and frac tions  were co llec ted  over 1 
m inute  in te rva ls , then counted by LSC. 'ÿ ie  ordinates are fra c tio n  number and 
the abscissae are counts per m inute x 10" .
1 2 0
w hich underwent conversion to  an unknown compound w ith  a low er re ten tio n  
tim e  in HPLC a fte r a 1 hour incubation w ith  the b u ffe r alone (F igure 8B) but 
not when incubated w ith  the bra in  homogenate. The batch o f [ ^ H ]  DPDPE 
used in th is  series o f experim ents conta ined an im p u rity . A lthough the 
re te n tio n  tim e  o f unlabelled DPDPE was reduced a fte r incubation w ith  the 
reducing agent 2-m ercaptoethanol (from  13.7 to 12.5 m inutes, F igure 9) the 
reduced peptide and the im p u rity  (F igure 8B) are not id en tica l, as judged by 
th e ir  re ten tion  tim es.
3.2.2 B inding o f  T r it ia te d  Enkephalin Analogues
The spec ific  binding o f both C^H] DAGO and C^H 1 DPDPE to  whole 
bra in  and pons/m edulla membranes dem onstrated a rectangu la r hyperbolic 
re la tionsh ip  to free  ligand concen tra tion  and Scatchards p lo ts were linea r
(Figures 10-12). However, i t  was not possible to obta in  acceptable co rre la tion
3c o e ffic ie n ts  fo r  Scatchard p lo ts from  single experim ents w ith  [  H ]  DPDPE in 
pons/m edulla homogenates (F igure 13). A ccord ing ly , binding constants were 
estim ated by simultaneous analysis of the data from  five  separate experim ents 
w ith  r  = 0.59 as shown in F igure 14.
There was no s ign ifican t d iffe re n ce  between the B and values ^ max u
fo r  the \i se lective  ligand in the tw o homogenates (Table 6). W hilst th is  was 
also true  fo r  the K p  values fo r  [^ H  ]  DPDPE, the m axim um  number o f binding 
sites fo r th is ligand in homogenates o f pons/m edulla was less than one th ird  
tha t in  whole bra in. M oreover, the spec ific  binding o f [  ^ H ] DAGO in whole 
bra in homogenates a t InM  represented 91% o f the to ta l binding but the 
equiva lent value fo r  [ ^ H ]  DPDPE at its  K j^ in pons/m edulla was only 38%. 
The p ro te in  concentra tion  in whole bra in  homogenates (40.1 - 1.6mg/g w et 
w e ight) was s ig n ifica n tly  low er (p < 0.001) than th a t in homogenates of the 
pons/m edulla regions (47.8 - 0.3mg/g w et w e ight).
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F igure  8 Assessment of the Stability of ] DPDPE  
in the In V itro Binding Model
A liquo ts  o f [  H ]  DPDPE (Batch 2259-088, N .E .N /D upont) were incubated a t 
25°C w ith  (A) Nothing, (B) 50mM Tris  b u ffe r fo r 1 hour, (C) R at whole bra in 
homogenate fo r 1 hour and (D) R at whole brain homogenate fo r 1 7 | hours. 
The incubates were freeze-d ried  and analysed by HPLC as described in 
Methods. B rie fly , the flow  ra te  was reduced to 0 .5m l/m in  and fra c tion s  were 
co llec ted  over 1 m inute in terva ls , then counted by LSC. T^e ordinates are 
fra c tio n  number and the abscissae are counts per m inute  x 10 .
1 2 2
80
40
0 ± A
i  80
80 >W|
40-
j  I I I
0
II
0 4 8 12 16 20 
Retention time (mins)
Figure 9 The E ffe c t of D ithiothreito l and
2-Mercaptoethanol on the Retention Tim e of DPDPE
The HPLC system used was as described in  Methods fo r  the p u r if ic a tio n  o f 
rad io labe lled  peptides. Peak A  shows the e lu tion  o f lOpg DPDPE (]D ,7 
m inutes). Peak B shows the  e ffe c t o f d ith io th re ito l (5mM, 15 m inutes at 20 C) 
on re ten tio n  tim e  (13.7 m inutes) o f lOpg peptide and Peak C, the e ffe c t o f 2- 
m ercaptoethano l (10% v /v , 15 m inutes a t 20°C) on the re ten tio n  tim e  o f lOpg 
DPDPE (12.5 m inutes). The broken line  ind icates the p roportion  of 
a c e to n itr ile  in  the so lvent.
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F igure  10 The Binding Characteristics of [ H  ]  DAGO  
to R at Whole Brain Homogenate
The upper graph shows the concentration-dependency o f the binding. The 
points are the mean o f three rep lica tes , and some o f the points have been 
o m itte d  fo r  c la r ity . NSB = non-specific  binding. The low er graph shows the 
Scatchard p lo t o f the data, and the plots are rep resen ta tive  o f five  
independent experim ents.
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Figure 11 The Binding Characteristics of ]  DPDPE  
to  R a t Whole Brain Homogenate
The upper graph shows the concentration-dependency o f the binding. The 
points are the mean o f three  rep lica tes , and some o f the points have been 
o m itte d  fo r  c la r ity .  NSB = non-spec ific  binding. The low er graph shows the 
Scatchard p lo t o f the data, and the plots are representa tive  o f five  
independent experim ents.
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Figure 12 The Binding Characteristics o f [ ]  DAGO
in R at Pons/Medulla Homogenate
The upper graph shows the concentration-dependency of the binding. The 
points are the mean o f th ree  rep lica tes , and some o f the points have been 
o m itte d  fo r c la r ity . NSB = non-spec ific  b inding. The low er graph shows the 
Scatchard p lo t o f the data and the p lots are rep resen ta tive  o f f ive  independent 
experim ents.
126
0 3
e n
euQ)
\
“Oc3OCD
LUû-
OCL,
Q
JOm
0 2
01
O
o ~r=0*52 
K d = 2 0 ' 2 n M  
Bmax=4-15 fmol mg 
tissue-1
0 0*5 10 1*5 
DPDPE specifically bound 
(fmol mg tissue-l).
20
Figure 13 Scatchard Plot of the Binding of [  ] DPDPE
to Homogenate of R at Pons and Medulla Regions
The points are the means o f th ree  rep lica tes . The p lo t is ty p ic a l o f the resu lts  
obtained when a tte m p tin g  to  sa tu ra te  ^ op io id  receptors in homogenates o f 
these regions o f ra t b ra in : the binding param eters ca lcu la ted  from  the p lo t 
could not va lid ly  be used as representing the true  values since the c o e ff ic ie n t 
o f linea r regression, r , is too sm all, thus the line is s ta t is t ic a lly  s ig n ific a n tly  
d iffe re n t from  a s tra ig h t lin e  (p > 0.1).
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3.3 IN H IB IT IO N  STUDIES
For displacement experim ents using [ ^H ] DAGO and a lfen tan il, 
the re  were no s ig n ifican t d iffe rences between the K j values or H il l slopes 
obtained in whole bra in (36.8 -  l.S nM ; -0.85 -  0,02) and pons/m edulla 
homogenates (39.8 - 3.7nM; -0.81 - 0.05), p e rm ittin g  comparison between K jP  
and K j^  values obtained fo r the other drugs.
For lo fe n ta n il, the K j values and H il l  slopes obtained fro m  short (1 
hour) and long (17.5 hour) incubations w ith  e ith e r t ^H  1 DAGO or Î ^ H l DPDPE 
were not s ig n ifica n tly  d iffe re n t and the data fo r each t r it ia te d  ligand were 
pooled.
Figures 15 and 16 show in graphica l fo rm  the H il l  p lo ts produced by 
in h ib itio n  o f the  spec ific  binding o f [ ^H  ID A  GO and [ ^H  ] DPDPE by five  
drugs o f the fen tany l series.
The m a jo rity  o f in h ib ition  studies produced H il l p lo ts w ith  slopes and 
co e ffic ie n ts  o f linea r regression near un ity  (Table 7). The H il l  slopes fo r 
lo fe n ta n il, however, were m arkedly g rea te r than 1. The rank order o f 
a ff in it ie s  o f the 6 drugs tested a t the p and <5 opioid binding sites showed 
m inor d iss im ila r itie s , but the c lear trend was tha t compounds w ith  the highest 
a ff in it ie s  had the lowest s ite  s e le c tiv ity  values (Table 7). The d iffe rences 
between the K jP  values fo r each drug were s ign ifican t in every case (p < 0.02) 
excep t fo r m orphine and fen tany l, which had s im ila r a ff in it ie s  fo r the p s ite . 
The same was true  fo r the Kj5 values, but the d iffe rences were also 
s ig n ifica n t fo r m orphine.
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Figure 15 H ill Plots fo r Five Drugs of the Fentanyl Series
a t the R at ti Opioid Binding Site
The p lo ts represent the d isp lacem ent o f [ ^ H ]  DAGO spec ific  binding at K „  
from  homogenatps o f ra t pons and m edulla  regions by lo fe n ta n il (closeo 
c irc les ), c a rfe n ta n il (open c irc les), su fen tan il (closed squares)^ fen ta ny l (open 
squares) and a lfe n ta n il (triang les). The points are the mean - SE mean o f a t 
leas t fo u r sets o f tr ip lic a te  dete rm ina tions and the lines are f i t te d  by lin e a r 
regression, B and B are the sp e c ific  binding o f t r i t ia te d  ligand in the
presence and absence, respec tive ly , o f displacing drug. K j values are  
ca lcu la ted  fro m  the data as described in Methods.
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Figure 16 H ill Plots for Five Drugs of the Fentanyl Series at the
R a t  ^ Opioid Binding Site
The p lo ts are o f the d isp lacem ent o f DPDPE spec ific  binding at 0.5K q
from  ra t whole bra in  homogenate by ca rfe n ta n il (open c irc les), lo fe n ta n il (open 
triang les), su fen tan il (squares), fen ta ny l (closed c irc les), or a lfe n ta n il (closed 
triang les). The 'j^oints are the mean - 5E mean o f at least three sets of 
t r ip lic a te  dete rm ina tions and the lines are f i t te d  by linear regression. B and 
B are the spec ific  binding o f t r i t ia te d  ligand in the presence and absence, 
rA p e c t iv e ly ,  o f d isp lacing drug. K j values are ca lcu la ted  fro m  the p lo ts as 
described in  Methods.
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There was a strong co rre la tion  (r = 0.87) between the log o f the 
a f f in ity  o f the fen tany l drugs fo r  the ]i s ite  and the log o f the p s ite  
s e le c tiv ity  (F igure 17). C a rfe n ta n il possessed cha rac te ris tics  which resu lted  in 
dev ia tion  from  the trend o f the values fo r  the other four drugs. When 
ca rfe n ta n il is excluded, the co rre la tio n  fo r  the  rem ain ing drugs is very strong 
(r = 0.999).
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Figure 17 Correlation Between ii A ffin ity  and p
Selectivity for the Fentanyls
1
K . values were determ ined as described in Methods. Each po in t is the mean o f 
at least fou r de term inations and standard e rro r values have been o m itted  fo r  
c la r ity .  These can be found in  Table 7. The drugs are ind icated by the in it ia l 
le tte rs  o f th e ir  names. The broken line  shows the co rre la tion  drawn w ith o u t 
the data fo r  ca rfe n ta n il, and the solid  lin e  includes a ll the points.
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3.4 RESPIRATORY STUDIES
3.4.1 E ffe c ts  o f Fentanyls on R esp ira tion  in  the In ta c t, Anaesthetised R a t
A dm in is tered  as i.v . bolus doses to the non-vagotom ised (or ’in ta c t')  
ra t, a lfe n ta n il, su fen tan il and fen tany l a ll produced an apnea of im m ediate  
onset and dose-related dura tion . In add ition , both resp ira to ry  frequency and 
t id a l volum e, and thus m inute volum e, were depressed in a dose-related 
manner, and rep resen ta tive  traces are shown in Figures 18-20. N e ith e r saline 
p rio r to  drug dosing, nor naloxone given to  the opioid-naive anim al, had any 
observable e ffe c t on resp ira tion . However, naloxone was able to reverse a ll 
the re sp ira to ry  e ffe c ts  o f the agonists, a lthough at increased agonist doses the 
responses could be re insta ted  (Figures 18B and 19B).
Q u a lita tiv e ly , the responses to  these three drugs were s im ila r, bu t i t  
was c lea r th a t at doses o f su fen tan il, a lfe n ta n il and fen tany l which produced 
equ iva lent depressions of m inute volume at the comparison point o f 15 seconds 
post-dosing, fen tany l was more po ten t in producing apnea than the o ther tw o 
drugs. F u rthe rm ore, o f the three drugs, on ly a lfe n ta n il appeared to  produce 
marked changes in  resp ira to ry  tim in g , ie : the  p roportion  o f each resp ira to ry  
cyc le  splent in insp ira tion  and e xp ira tio n . This was ind ica ted  by the large 
d iffe rences in peak insp ira to ry  and e xp ira to ry  a ir flow  ra te  a fte r  marked doses 
o f a lfe n ta n il, an e ffe c t not observed w ith  e ith e r su fen tan il or fen tany l.
The resp if’a to ry  responses to  c a rfe n ta n il and lo fe n ta n il were 
q u a lita tiv e ly  very d iffe re n t from  those produced by the o ther drugs o f the 
fen ta ny l series. C a rfe n ta n il did not produce apnea even at doses which 
subsequently led to  resp ira to ry  a rres t (F igure 21), a lthough breath ing could 
read ily  be re -s ta rted  by the a dm in is tra tion  o f naloxone and the provision of 
resp ira to ry  support fo r  a short tim e . Therefore , w h ile  the potency of
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Figure 18 Respiratory Effects of Acutely-Administered
Alfentan il in the In tact R at: Antagonism by Naloxone Infusion
A ra t (390g) was prepared as described in Methods and dosed w ith  a lfe n ta n il 
(Panel A ). The anim al was dosed w ith  naloxone (50pg/kg bolus fo llow ed  by a 
continuous in fus ion  o f 1 .06pg/m in /kg) and fo llow ing  an e qu ilib ra tion  period o f 
30 m inutes a series o f responses to  a lfen tan il at h igher doses was obtained 
(Panel B). Change in resp ira to ry  param eters was assessed 15 seconds a fte r  
dosing w ith  agonist (See Table 8). The upper pa rt o f each panel shows 
frequency, the centre , peak a ir flow  ra te  and the low er, e xp ira to ry  t id a l 
volume.
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Figure 19 Respiratory Effects of Acutely-Administered
Sufentanil in the In tact R at; Antagonism by Naloxone Infusion
A ra t (320g) was prepared as described in the te x t  and dosed w ith  su fen tan il 
(Panel A). The anim al was then dosed w ith  naloxone (200pg/kg bolus fo llow ed 
by a continuous in fus ion  o f 4 .25pg /m in /kg ), and fo llo w in g  an e qu ilib ra tio n  
period o f 30 m inutes a series o f responses to su fen tan il a t higher doses was 
obtained (Panel 8 ). Change in  resp ira to ry  param eters was assessed 15 seconds 
a fte r dosing w ith  agonist (see Table 8). The upper part o f each panel shows 
frequency, the centre , peak a ir  flo w  ra te  and the  low er, e xp ira to ry  t id a l 
volume.
1 3 8
t/Va
Fentanyl (pg/kg i.v. bolus)
Y -----
r120
-90 bpm 
60
■
15 secI---------- 1
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Ilm l
Figure 20 Respiratory E ffects of Acutely Administered
Fentanyl in the In tact R at
A ra t (360g) was prepared as described in  Methods. A zero response to  saline 
was dem onstrated before dosing w ith  fen ta ny l as shown. Change in  resp ira to ry  
param eters was assessed 15 seconds a fte r  dosing (see Table 8). The responses 
were rap id ly  reversed by naloxone (N X , 200pg/kg). The upper pa rt o f each 
panel shows resp ira to ry  ra te , the centre , peak a ir  flo w  ra te  and the low er, 
exp ira to ry  t id a l volume. The inset shows reversa l o f the resp ira to ry  e ffe c ts  o f 
fen tany l by naloxone.
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Figure 21 Respiratory E ffects of Acutely-Administered
Carfentanil In the In tact R at
The anim al was dosed w ith  ca rfe n ta n il w ith  the e ffe c ts  shown in Panel A. The 
upper part o f each trace  shows frequency, the cen tre , peak a ir  f lo w  ra te  and 
the low er, e xp ira to ry  tid a l volum e. When resp ira to ry  a rrest occurred, 
naloxone (50pg/kg bolus, fo llow ed  by a continuous in fusion o f 1 .06pg /kg /m in  
fo r 30 m inutes) was given, and the anim al m echan ica lly ven tila ted  u n til 
spontaneous breath ing  resumed. In the presence of a steady s ta te  
concen tra tion  o f naloxone, the procedure was repeated w ith  increased doses o f 
ca rfe n ta n il and naloxone (Panel B). The lig h te r areas o f the trace  represent 
ch a rt speed increased by 10-fo ld .
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ca rfe n ta n il to  produce given depressions o f m inute volume could not read ily  be 
quan tified , measures o f antagonism by naloxone o f the resp ira to ry  depression 
produced by ca rfe n ta n il were la te r obta ined.
L o fe n ta n il also fa ile d  to  produce apnea, but unlike ca rfe n ta n il, 
frequency appeared to be se le c tive ly  depressed, w ith  l i t t le  e ffe c t upon tid a l 
volume. In add ition , the e ffe c ts  of lo fe n ta n il were long -lived , and were not 
read ily  reversed even by com para tive ly  large bolus doses o f naloxone 
(800pg/kg; F igure  22). Because o f these properties, the resp ira to ry  depressant 
ch a rac te ris tics  o f lo fe n ta n il were not explored fu r th e r, and a lfe n ta n il, 
su fen tan il and fen ta ny l were se lected fo r  the most de ta iled  study.
3.4.2 Potency o f the Fentany ls  to  P e rtu rb  R esp ira tion  in  the  In ta c t R a t
The potency of a lfe n ta n il, fen ta ny l and su fen tan il to  produce apnea 
of 6 seconds duration , to  depress frequency o r tid a l volum e by 30% or m inute 
volume by 50% at 15 seconds a fte r  dosing were assessed as described in 
Section 2.5.2. Values fo r 6sA, ID^g frequency and t id a l volum e and ID ^ q 
m inute volume were ro u tin e ly  ca lcu la ted  from  the traces fo r each ra t by 
means o f log dose response p lo ts. An exam ple is given in F igure  23 (upper 
panels) which shows not only th a t such p lo ts were linear, but also th a t pa ra lle l, 
rig h tw ard  sh ifted  plots could be obtained a fte r  naloxone (low er panels). 
Potency values in pg/kg were converted to  m olar doses fo r  the purposes o f 
com parison between” the drugs and are shown in Table 8, toge the r w ith  the 
slopes o f the dose-response functions fo r  each a lte red  param eter.
There were c lear q u a lita tive  d iffe rences in the resp ira to ry  responses 
to the three agonists. W hilst su fen tan il was equipotent in p roduction o f apnea 
and depression o f m inute volum e, as Indexed by the 6sA and ID ^ q values.
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Figure 23 Log Dose Response Plots fo r the Respiratory Effects
o f A lfentanil in the In tact R at: Antagonism by Naloxone Infusion
A dose-response re la tionsh ip  fo r  the production  o f apnea and depression o f 
re sp ira to ry  param eters by a lfe n ta n il was established as described in  Methods 
(upper panel). A f te r  recovery, naloxone was adm inistered (50 ]ig /kg  i.v . bolus 
fo llow ed  by an in fusion  at 1 .06pg /kg /m in ) and a fte r a 30 m inute  e qu ilib ra tio n  
period, a fu r th e r series o f responses to  higher doses o f the agonist was 
obta ined (low er panel). The ordinates are -log  a lfe n ta n il dose (g /kg) and the 
abscissae are dura tion  in sections fo r apnea and percentage depression of the  
o the r param eters ind ica ted . The slopes o f each pa ir o f dose-response curves 
are s im ila r and the dose-ratios are given in  parentheses.
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respec tive ly , m ore a lfe n ta n il was required to  depress m inute volume by 50% 
than to  produce an apnea o f 6 seconds dura tion . For fen tany l, th is ra tio  o f 
potency values was 3 -fo ld . W ith respect to  the con tribu tion  to  depression o f 
m inute  volume made by the two components, frequency and tid a l volume, 
d iffe rences between the drugs were also apparent, w ith  depressions o f tid a l 
volume being predom inant fo r  su fen tan il, and depressions o f frequency fo r  
fen ta ny l, although these d iffe rences were not large.
I t  is d if f ic u l t  to compare d ire c tly  the potency of ca rfen tan il w ith  
th a t o f the other drugs because o f d iffe rences in the methods used to  assess 
re sp ira to ry  depressant e ffe c ts  (Section 2.5.2) but the size o f the single dose o f 
ca rfe n ta n il required to  produce a fa ta l resp ira to ry  arrest was 0.56 -
O.G7nmoles/kg.
3.4.3 Repeated Dosing w ith the Fentanyls
There were no ind ica tions o f the development o f acute to lerance to  
the resp ira to ry  e ffe c ts  o f a lfe n ta n il (F igure 24), fen tany l (F igure 25) o r 
su fen tan il (F igure 26). However, in  each case the con tribu tion  to  m inute  
volume depression made by t id a l volume depression became sm aller (and th a t 
made by frequency depression, la rge r) during the establishm ent o f the second 
dose response re la tionsh ip .
3.4.4 Respiratory Changes Induced by U50,488H and U69,593 in the In tact R at
The se lective  k opioid recep to r agonists U50,488H and U69,593 
produced dose-related increases in resp ira to ry  frequency and para lle l 
decreases in  t id a l volum e, leaving m inute volume essentia lly unchanged. Both 
drugs produced q u a lita tiv e ly  id e n tica l e ffe c ts  and a representative  trace  fo r 
U69,593 is shown in F igure 27. N e ith e r drug at any dose gave rise to  an apneic
145
APNEA
■ I I I ■ I
5-6 54 52 5-0 48 46
20 •
TIDAL VOLUME
5-6 S4 5-2 5-0 48 46
FREQUENCY
52 5 0 48 46
-10
60
40
2 0
0
MINUTE VOLUME
I
J  L_ I ...l... J L
5*6 S4 5*2 5*0 4*8 46
F igure  24 Lack of Acute Tolerance to  A lfentanil
Rats o f body w e igh t 410 - 17g were dosed w ith  a lfe n ta n il (3.125 -  25.0yg/kg
i.v .) to  ob ta in  a dose-response curve (open symbols). A f te r  30 m inutes the ra ts  
were dosed again and a second dose-response curve was constructed (closed 
symbols) in order to  tes t fo r  the poss ib ility  o f the development o f acute 
to le rance . There was no s ig n ifican t change in the potency o f a lfe n ta n il to  
pertu rb  re sp ira tion  on repeated dosing (paired t- te s t) .  The ordinates are -log  
dose (g/kg) and the abscissae percentage depression o f the param eter 
ind ica ted , exce jÿ  fo r  apnea, whose dura tion  (seconds) is given. The points 
represent mean -  SE mean o f fo u r independent dete rm ina tions.
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Figure 25 Lack of Acute Tolerance to Fentanyl
Rats o f body w eight 387 -  24g were dosed w ith  fen tany l (0.8 - 6 .4yg /kg  i.v .) to  
ob ta in  a dose-response curve (open symbols). A fte r  30 m inutes the ra ts  were 
dosed again and a second dose-response curve was constructed (closed 
symbols), in order to  tes t fo r the poss ib ility  o f the development o f acute 
to le rance . There were no s ig n ific a n t changes in  the  potency o f fen ta ny l to  
produce apnea or to  depress frequency or m inute  volume on repeated dosing 
but the tid a l volume ID^n was increased (p < 0.05, paired t- te s t) . The 
ordinates are -log dose (g /kg) and the  abscissae percentage depression o f the 
param eter ind icated, except fo r  apnea, whose duration (seconds) is given. The 
points represent mean - SE mean o f six independent de te rm ina tions.
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F igu re  26 Lack o f  A cu te  Tolerance to  S ufentan il
R ats o f body w e ight 340 -  6g were dosed w ith  su fen tan il (0 , l-0 .4 ] jg /k g  i.v .)  to  
obta in  a dose-response curve (open symbols). A fte r  30 m inutes, the  ra ts  were 
dosed again and a second dose-response curve was constructed (closed 
symbols), in  order to  tes t fo r  the poss ib ility  o f the developm ent o f acute 
to le rance . The ord inates are -log  dose (g/kg) and the abscissae, percentage 
depression o f the param eter ind ica ted , except fo r apnea, whose dura tion  
(seconds) is given. The points represent mean - SE o f fo u r independent 
dete rm ina tions. There was no s ig n ifica n t change in the potency o f su fen tan il 
to  pertu rb  resp ira tion  on repeated dosing (paired t- te s t) .
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Figure 27 Respiratory E ffects of U69,593 in the In tact Rat;
Antagonism by Naloxone Infusion
A ra t (460g) was prepared as described in  the  te x t  and dosed w ith  U69,593 (25- 
lOOpg/kg) as ind icated in the upper panels, fo llow ed  by naloxone (SOOyg/kg 
bolus plus a continuous in fusion  o f 17yg /m in /kg ). A f te r  30 m inutes the ra t was 
dosed w ith  agonist at higher doses (4G0-1600yg/kg) w ith  the e ffe c ts  shown in 
the low er panels. The upper p o rtion  o f each trace  shows resp ira to ry  
frequency, the centre , peak a ir  f lo w  ra te  and the low er, exp ira to ry  t id a l 
volume.
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response ch a ra c te ris tic  o f the fen tany l series. The onset o f changes was rapid 
(< 10 seconds) but m axim al e ffe c ts  occurred between 30 seconds and 2 m inutes 
a fte r  dosing. The duration of ac tion  was s im ila r fo r  the two drugs, ranging 
fro m  5 m inutes at low doses to  20 m inutes at the highest doses employed.
The slopes o f the dose response p lo ts fo r  increases in  frequency and 
decreases in tid a l volume were s im ila r, both  fo r  each drug and between the 
drugs (p > 0.05). However, U69,593 was approx im ate ly  9 -fo ld  more potent in 
p roduction  o f e ithe r frequency or tid a l volum e changes than U50,488H (Table 
9).
3.4.5 Antagonism of the Respiratory Effects of A lfentanil
by Bolus Doses of Naloxone
Dose-ratios were determ ined fo r each measured resp ira to ry  
param eter a t each o f three d if fe re n t bolus doses of antagonist (50, 200 and 
800yg/kg). The range o f dose ra tio s  fo r  antagonism of apnea and m inute  
volume depression are given in  Table 10, and the Schild p lots o f these data are 
shown in F igure  28. The apparent pA^ values were ca lcu la ted  by tw o  methods. 
In the  f ir s t ,  a line  o f linear regression was f it te d  to  the w eighted means of the 
points o f the Schild p lo t, and the single value o f the in te rce p t on the ord ina te  
taken as apparent p A 2 * In the second, the K g  value was ca lcu la ted by d iv id ing  
the m olar dose o f antagonist by the (dose ra t io - 1 ) and the log o f the resu ltan t 
taken as an estim ate  o f apparent pA ^. This procedure was repeated fo r each 
dose-ra tio  obtained to  provide a mean value fo r  apparent pA^. A  comparison 
o f the slopes o f the  Schild p lo ts and apparent pA 2  values obtained by the tw o  
methods is given in  Table 10. The apparent pA 2  fo r  antagonism of apnea was 
s ig n ific a n tly  g rea te r than th a t fo r  blockade o f m inute volume depression (p < 
0.02). The data points fo r  antagonism o f depressions o f frequency and tid a l 
volume have been o m itte d  fro m  F igure 28 fo r c la r ity , but apparent p A 2  values
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Table 9 Potency of k Selective Compounds to 
A lte r Respiration In the Intact Rat
Potency (nm oles/kg body weight)
Frequency
(ED^O)
T ida l Volume 
GD3 0 )
U50,488H 1990 - 640 2880 - 680
(38.5 -  5.1) (29.5 -  3.1)
U69,593 92.2 -  11.4 137 - 16.2
(48.0 - 6 . 6 ) (35.4 ± 1.9)
Values are the mean -  SE mean o f 5-8 independent determ inations. The slopes 
o f the log dose response p lots are given in  parentheses.
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fo r  these tw o components were s lig h tly  low er (7.45 - 0.06) and g reate r (7.89 -
0.09) resp ec tive ly , than tha t fo r blockade o f m inute volume depression. In no 
case was the slope of the Schild p lo t s ig n ifica n tly  d iffe re n t from  u n ity  and 
only sm a ll changes in  the value o f apparent pA^ resu lted  fro m  using the second 
m ethod (u n it slope m ethod) to  ca lcu la te  i t .
Using bolus doses o f naloxone to  antagonise a ifen tan il-induced  
re sp ira to ry  changes, i t  was noted th a t fo r every param eter the  slopes o f the 
log dose response p lo ts obta ined in the presence o f antagonist were g reate r 
than the  equ iva lent values in  the  naloxone-naive anim al, although these 
changes were not s ig n ifica n t. For exam ple, apnea log dose response p lo ts had 
slope 15.1 - 2.8 p rio r to , and 19.3 -  4.8 a fte r naloxone (p > 0.05, paired t- te s t) .  
This problem  was considered insurm ountable and provided the ra tiona le  fo r  the 
developm ent o f the naloxone in fusion  p ro toco l to  determ ine pA ^.
3.4.6 D evelopm ent o f the  Naloxone In fusion  P ro toco l
3.4.6.1 Naloxone Pharm acokinetics
The dura tion  o f ac tion  o f naloxone to  antagonise the m inu te  volum e 
depressant e ffe c ts  o f a standard dose o f a lfe n ta n il is illu s tra te d  in  F igure 29, 
and a rep resen ta tive  p lo t fro m  which naloxone k^ and t i  w ere taken in  F igure  
30. The values o f k^ and t?  determ ined fro m  fo u r independent experim ents 
were 2,12 x 10"^ -  0.16 x 10” ^ m in “ ^ and 32.7 - 2.5 m inutes respective ly . A 
value fo r  o f 8000ml kg~^ was taken from  the lite ra tu re , thus plasma 
naloxone clearance was ca lcu la ted  t o ' be 170ml/m in*"^kg“ ^, p e rm ittin g  
ca lcu la tion  o f zero o rder in fusion ra te  constants, k g , required  to  produce the 
desired s teady-sta te  naloxone concentra tions in  the blood o f the ra t.
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Figure 30 Kinetics o f Naloxone Elim ination from the
R at A fte r  i.v . Bolus Dosing
Male W /A ra ts  (3^b-340g) were prepared fo r  resp ira to ry  studies as described in 
Methods. The mean o f three  responses to  a standard dose o f a lfe n ta n il 
producing approx im ate ly  30% depression o f m inute volume was defined as 1.0. 
A f te r  naloxone (200pg/kg) repeated dosing w ith  a lfe n ta n il a t 10 m inu te  
in te rva ls  produced responses whose m agnitude gradua lly increased tow ards the 
pre-naloxone con tro l (log 1.0 = 0). The h a lf- l ife  o f naloxone m vivo  was 
ca lcu la ted  fro m  the slope o f te rm in a l phase as illu s tra te d  above, and the p lo t 
is represen ta tive  o f fou r de te rm ina tions made.
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3.4.6 .2 P ilo t Naloxone Infusion and E x tra c tio n  Studies
The infusion p ro toco l described in 2.5.5.2 was used to provide 
steady s ta te  blood naloxone concentra tions which approxim ated to  those 
concentra tions obtained a fte r a single naloxone dose o f Im g /kg . R esp ira tory 
responses to a single dose o f a lfe n ta n il were unchanged throughout the in fusion 
period, supporting the  steady-sta te  nature o f naloxone concen tra tion .
Naloxone and the in te rn a l standard m orphine were ex trac ted  
from  serum as described in  Section 2.5.5.3. F igure 31 shows the separation by 
H PLC  o f morphine and naloxone standards; a sm all im p u rity  in the stock 
naloxone (Peak I in F igure 31a) was shown not to  be the agonist m orphine 
(F igure  31c) and the tw o  compounds were w e ll separated, having re te n tio n  
tim es o f 3.8 and 6.5 m inutes fo r  m orphine and naloxone, respective ly .
Standard curves fo r  the measurement o f the m orphine and 
naloxone content o f samples were always linea r and the drug content o f 
e x trac te d  serum samples was determ ined from  the peak heights o f each 
component as previously described (Section 2.5.5.3).
E lu tion  p ro files  o f tw o  e x tra c ts  are illu s tra te d  in  F igure  32. 
The figu re  shows th a t w h ils t acceptab le  reso lu tion  o f both naloxone and the 
in te rna l standard m orphine could be obta ined a fte r  the extensive e x tra c tio n  
described in Sectidh 2.5.5.3, the degree o f con tam ina tion  of the  Sep-Pak 
eluates was too great to  p e rm it adoption o f th is  one-step p u r if ic a tio n  method.
Recoveries o f m orphine and naloxone were 86.4% and 83.2% 
respec tive ly , va lid a tin g  the  use o f the recovery o f the morphine in te rna l 
standard to ca lcu la te  naloxone recovery. The mean value o f the ca lcu la ted
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Figure 31 Séparation of Morphine and Naloxone by H PLC
Reverse-phase HPLC using a C ,n  column and iso c ra tic  e lu tion  was perform ed 
as described in  Methods. Chrom atogram s (a) and (b) show the e lu tion  p ro files  
o f 5yg naloxone (N) and 2.5pg m orphine (M) respec tive ly . Naloxone c lea rly  
contains a m inor im p u rity  (I). In order to  show tha t the antagonist was not 
contam inated w ith  agonist, m orphine, 0.125pg m orphine was in jec ted  w ith  5pg 
naloxone. C hrom atogram  (c) shows th a t the im p u rity  was not m orphine. That 
morphine (1 .25pg) and naloxone (2 .5pg) can be m ore than adequately resolved 
is illu s tra te d  in  chrom atogram  (d).
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naloxone concentra tions in the blood o f ra ts (n = 4) a t steady s ta te  a fte r 
in fusion was 0.123 - 0.006^g /m l w hich compared very favourably w ith  the 
value pred ic ted  to  be reached using the pharm acokinetic  param eters (Section 
3.4.6.1) o f 0.125pg /m i. The close agreem ent o f the measured and p red ic ted  
antagon ist concentra tions supported the use o f the in fus ion  m ethod to  obta in  
q u a n tita tive  and m eaningful measures o f antagonism in v ivo , nam ely p A 2 *
3.4.7 Naloxone pA^ in In tact Rats
3.4.7.1 Comparison o f Naloxone pA ^ fo r  A lfe n ta n il D eterm ined by Bolus
Dosing and Infusion P ro toco ls
The values fo r  pA^ obta ined by the tw o  antagonist dosing methods 
were m arkedly d iffe re n t and th is  is illu s tra te d  in F igure 33. W hils t the slopes 
o f the Schild p lots in  both cases were never s ig n ific a n tly  d iffe re n t from  un ity , 
the pAg value fo r antagonism of apnea was increased from  7.90 -  0.07 (bolus 
dosing p ro toco l) to  9.05 - 0.05 (in fus ion  p ro toco l) and th a t fo r  antagonism of 
m inute volume depression fro m  7.54 - 0.06 to  8.83 -  0.043, respective ly . The 
pAg fo r  antagonism o f changes in  frequency and tid a l volum e were s im ila r ly  
increased.
I t  is w o rthy  o f note tha t using the naloxone in fusion p ro toco l, the 
slopes o f the log dose response p lo ts were a lm ost iden tica l in  the presence and 
absence o f the antagonist (see F igure  23), w hich was not the case when 
naloxone was given âs a single bolus in je c tio n  (Section 3.4.5).
3.4.7.2 Naloxone pA p fo r  the Fentanyls and Upjohn Compounds Using the
Infusion P ro toco l
Naloxone pAg was determ ined fo r  antagonism of apnea production 
and depression o f frequency, t id a l volum e and m inute volume by means o f the
1 6 0
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Figure 33 Schild Plots for the Comparison
o f Naloxone pA^ Determined by Bolus Dosing and Infusion Protocols
+Dose ra tios were obtained as described in Methods. The points are the  mean - 
SE mean o f 5 to  9 dete rm ina tions o f dose ra t io  fo r antagonism o f apnea (open 
c irc les) and of m inute volume depression (closed c irc les) fo r  bolus doses o f 
naloxone (A) and fo r naloxone infused to steady state concentrations (B). The 
lines were f it te d  to the weighted means o f each point by linear regression. 
p A 2  or apparent pA^ values given in the te x t were ca lcu la ted  from  the 
ind iv idua l dose-ratio  oata points by means o f the u n it slope method.
1 6 1
in fusion p ro toco l fo r  a lfe n ta n il, su fen tan il and fen tany l. An exam ple o f the 
Schild p lo ts so obtained is given fo r  su fen tan il in F igure 34. For ca rfe n ta n il, 
p Ag was determ ined by means o f comparison o f the doses producing 
re sp ira to ry  a rres t (Section 2.5,2) and fo r  the Upjohn compounds, by means of 
th e ir  e ffe c ts  on frequency and tid a l volume alone. The values so determ ined 
are given in  Table 11. In the case o f U50,488H, the low  s o lu b ility  and low  
potency o f the compound precluded de te rm ina tion  o f fu l l  Schild p lo ts, hence 
no values fo r  slope are present in  the tab le .
The pA^ values fo r apnea were id e n tica l fo r the drugs which produced 
th is  re sp ira to ry  e ffe c t. However, there  were s ig n ifican t d iffe rences between 
the pA^ values fo r antagonism o f m inute volume depression, w ith  the 
d iffe re n ce  between the highest, th a t fo r  su fen tan il and the low est, th a t fo r 
fen tany l representing a 3 -fo ld  d iffe rence  in  the potency o f naloxone to  block 
th is  e ffe c t.
The pAg values fo r  antagonism o f the e ffe c ts  o f these fen tany ls  on 
frequency and tid a l volume were always s ig n ifica n tly  low er and g rea te r, 
respec tive ly , than the pA^ value fo r  m inute  volume depression fo r  the same 
compound. Fo r no param eter, however, was the slope o f the  Schild p lo t, where 
appropria te , s ig n if ic a n tly  d iffe re n t fro m  un ity .
In the case *of the Upjohn compounds, the pA ^ values fo r  blockade o f 
th e ir  e ffe c ts  on frequency and t id a l volume by naloxone were not s ig n ific a n tly  
d if fe re n t fo r  each drug, and fu r th e r, the values were s im ila r fo r  both the 
drugs. M oreover, the range o f values (7.6 - 7.7) represents more than one 
order o f m agnitude reduction  in the potency o f naloxone to  antagonise the 
resp ira to ry  e ffe c ts  o f U50,488H or U69,593 as compared w ith  antagonism of 
the e ffe c ts  o f fen ta ny l drugs on resp ira tion .
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Figure 34 Schild Plots for the Antagonism of the Respiratory
Effects q f Sufentanil by Naloxone Infusion in the In tact R at
D ose-ratios were obta ined as described in Methods. The points are the  mean - 
SE mean o f three to  six de te rm ina tions o f dose-ratios fo r  depression o f t id a l 
volume (squares), apnea dura tion  (c irc les ), depression o f m inute  volum e 
(hexagons) and depression o f frequency (triang les). The slopes of the lines 
f i t te d  to  the w eighted means of each po in t by linea r regression are given in  
parentheses and do not d if fe r  s ig n if ic a n tly  fro m  un ity .
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3.4.8 E ffe c ts  o f O pio id  Drugs on R esp ira tion  in  the B ila te ra lly  Vaqotomîsed R a t
The three  fen ta ny l drugs, a lfe n ta n il,  fen tany l and su fen tan il a ll 
produced dose-related depressions o f frequency and tid a l volum e, and thus 
m inute  volum e, when adm in istered as i.v . bolus doses to the b ila te ra lly  
vagotom ised ra t. The e ffe c ts  were o f rap id  onset, and m axim ised 10-15 
seconds a fte r  dosing. The apnea ch a ra c te ris tic  of such drugs given to  the 
in ta c t ra t was abolished by transec tion  o f the vagi, and a trace  representa tive  
o f these e ffe c ts  is given fo r  fen ta ny l in  F igure  35. The decrease in frequency 
fro m  approx im ate ly  1 2 0 bpm to  60bpm which resu lted  from  b ila te ra l vagotom y 
was accompanied by an equ iva len t increase in tid a l volume from  
approx im ate ly  2ml to  4m l, so th a t m inu te  volum e was w e ll-m a in ta ined  in  th is  
p repara tion .
C a rfe n ta n il produced s im ila r re sp ira to ry  responses in the b ila te ra lly  
vagotom ised ra t and in ta c t ra t,  being o f slow onset and causing eventual 
re sp ira to ry  a rres t at high doses. A ll e ffe c ts  fo r the fen tany ls  could be 
reversed by naloxone.
U nlike  the fen tany ls , U50,488H and U69,593 did not induce s im ila r 
re sp ira to ry  changes in  the s low er-b rea th ing  p repara tion. Far fro m  producing 
tachypnoea as in the in ta c t ra t, U69,593 fa ile d  to  produce any response up to  
200pg/kg and U50,488H a t 1600pg/kg reduced frequency by approx im ate ly  
1 0 % in  a reproducib le  and na loxone-revers ib le  manner.
3.4.9 Potency o f the F en tany l D rugs to  Depress R esp ira tion  in  the
Bilaterally Vagotomised R at
The potencies o f su fen tan il, a lfe n ta n il and fen tany l to  depress m inute 
volum e in  the b ila te ra lly  vagotom ised ra t  were reduced compared w ith  th e ir 
potencies in  the In ta c t p repara tion  (Table 12). In the case of sufentan il and
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Figure 35 Respiratory Effects of Acutely-Administered
Fentanyl in the B ilaterally Vagotomised R at
A ra t (410g) was prepared and b ila te ra lly  vagotom ised as described in Methods, 
then dosed w ith  fen ta ny l (8-32pg/kg), wit;h the  e ffe c ts  shown in  Panel A . The 
anim al was then dosed w ith  naloxone (N X , 50pg/kg bolus fo llow ed  by a 
continuous in fusion  o f 1 .06pg /m in /kg  fo r  30 m inutes) a fte r  which a series o f 
responses to  higher doses o f the agonist was obtained (64-256 pg/kg. Panel B). 
The darker areas o f the trace  represent ch a rt speed reduced to  one ten th . The 
upper p a rt of each panel shows frequency, the centre , peak a ir flow  ra te  and 
the  low er, e xp ira to ry  t id a l volum e.
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a lfe n ta n il, th is  amounted to  a 6 - fo ld  and 2 - fo ld  fa l l respective ly  in m inute  
volume depressant a c tiv ity  (p < 0.01). The potency o f ca rfen ta n il to produce 
fa ta l re sp ira to ry  a rres t was also reduced 1.7 fo ld , the size o f the single dose 
requ ired  to  produce th is  e ffe c t increasing fro m  0.56 - 0.07nm oles/kg in in ta c ts  
to  0.96 - 0.20nm oles/kg in the b ila te ra lly  vagotom ised ra t. W h ils t fo r  fen tany l 
the decrease in potency was some 50% compared w ith  tha t in in ta c t ra ts , the 
change was not s ta t is t ic a lly  s ig n ifica n t.
For a ll th ree drugs, the fa l l in potency re la ted  p r im a rily  to  a 
reduction  in th e ir a b ility  to depress re sp ira to ry  frequency, th is  being so 
m arked fo r  su fen tan il tha t i t  was not possible to  obtain re liab le  estim ates o f 
ID ^q fo r  th is  param eter. A lthough tid a l volume ID^g values were also 
reduced, the  change was only s ig n ifica n t fo r  su fen tan il (p < 0 . 0 1 ).
The slopes of the log dose response p lo ts fo r each drug were s im ila r 
in the tw o  ra t preparations w ith  a 36% increase in the a lfe n ta n il m inute 
volume dose response slope being the most notew orthy change, (p < 0.05) and 
th is  was la rge ly  accounted fo r  by a corresponding increase in the slope o f the 
fu n c tio n  fo r  depression o f t id a l volum e.
3.4.10 Naloxone pA^ in B ilaterally Vagotomised Rats
In order to  substantia te  the comparison o f pA ^ values w ith  those 
obta ined in  in ta c t ra ts , the b io log ica l h a lf- l ife  o f naloxone in the b ila te ra lly  
vagotom ised ra t was determ ined using a lfe n ta n il as agonist, as described in 
Section 2.5.5.1 and shown to  be 34.1 - 4.9 m inutes, s im ila r to  the value in 
in ta c t ra ts  (32.7 - 2.5 m inutes).
1 6 8
Naloxone pA^ values fo r antagonism o f the resp ira to ry  e ffe c ts  of the 
fen ta ny l drug series were determ ined in the b ila te ra lly  vagotom ised ra t as 
previously described (Section 2.5.5.4) and given in Table 13.
There were h ighly s ig n ifica n t reductions in the pAg fo r  antagonism o f 
m inute  volume depression produced by su fen tan il, a lfe n ta n il and ca rfen ta n il 
compared w ith  the equ iva lent values in in ta c t ra ts; th a t fo r  fen tany l was 
unchanged. The drug fo r which the change in m inute volume pA^ was la rgest 
(su fen tan il) also dem onstrated the g reatest decrease (6 -fo ld ) in m inute volume 
depressant potency upon b ila te ra l vagotom y. Conversely, the sm allest 
decrease in potency to  depress m inute volume (1 .5-fo ld ) upon vagotom y was 
observed fo r the only drug not to  show a s ign ifican t change in naloxone pA^ 
fo r  th is  param eter (fen tany l), although co rre la tion  between these tw o 
measures was poor (r = -0.70).
Most o f the reduction  in pAg fo r  antagonism o f m inute volume 
depression a fte r b ila te ra l vagotom y re la ted  to  h igh ly s ig n ifica n t fa lls  in the  
t id a l volum e pAg (Table 13), whereas pA 2  fo r  blockade o f frequency depression 
rem ained unalte red fo r  any compound investiga ted .
There were no s ig n ifica n t changes in the slopes o f the log dose 
response p lo ts fo r  any drug and fo r  any param eter a fte r naloxone as compared 
w ith  the slope prioF  to  the antagonist, except fo r  the frequency func tion  fo r 
a lfe n ta n il (78.4 -3.8 before and 66,5 -  4.0 a fte r  naloxone; p < 0.01, paired t -  
tes t) and th is change was q u a n tita tiv e ly  sm all. Thus, dose ra tios were 
obta ined from  seria l p lo ts which did not deviate  s ig n ifica n tly  from  para lle lism .
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3.4.11 Antagonism  o f M inu te  Volum e Depression by N -M e th y l Leva llo rphan
3.4.11.1 Intravenous N -M e th y l Leva llo rphan
N -m ethy l leva llo rphan ( l-5 m g /k g ) g iven to  in ta c t ra ts, a fte r  a dose- 
response re la tionsh ip  to a fen ta ny l agonist had f ir s t  been established produced 
tw o m ajor changes in the subsequent re sp ira to ry  response to  agonists. F irs tly , 
the apneic responses to a lfe n ta n il, fen tany l and su fen tan il were com plete ly 
abolished even at the low est antagonist dose, and the resp ira to ry  responses 
w hich rem ained were ind istingu ishab le  fro m  those in the b ila te ra lly  
vagotom ised ra t. A represen ta tive  trace  is given in F igu re  36. Secondly the 
potencies o f the agonists to depress m inute volume were reduced and the 
degree o f reduction  was re la ted  to  the dose o f N -m e thy l leva llorphan in a 
rectangu lar hyperbo lic  fashion. This e ffe c t was m ost c lea rly  seen fo r  
su fen tan il, w ith  the m axim um  dose-ra tio  o f 6  obta ined at a dose o f antagonist 
o f 5mg/kg (F igure 37). W hilst the antagonist also produced blockade o f the 
m inute volume depressant potency o f a lfe n ta n il and fen ta ny l, the  maximum 
dose-ratios obtained were much sm a lle r than w ith  su fen tan il (Table 14). The 
antagonist also had no e ffe c t on the resp ira to ry  resonses to U69,593 in the 
in ta c t ra t. Fu rthe rm ore , in the  b ila te ra lly  vagotom ised ra t, N -m e th y l 
leva llo rphan had l i t t le  e ffe c t on the a b ility  o f the fen tany ls  to  produce 
depressions o f m inute volume (F igure 37, Table 14) w ith  the exception o f a 
sm all but s ig n ifican t reduction  in the potency o f a lfe n ta n il a t 5mg/kg 
antagonist (p < 0.05).
N -m ethy l leva llorphan alone produced trans ien t, dose-re la ted e ffe c ts  
on tid a l volume which were not blocked by naloxone (Im g /kg ). A gon ist dosing 
was not recommenced u n til resp ira to ry  param eters had re turned  to  th e ir pre­
antagonist values.
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Figure 36 Effects of N -M ethyl Levallorphan on Respiratory
Responses to A lfentanil
An in ta c t ra t was dosed w ith  a lfe n ta n il (4 -16pg/kg) w ith  the e ffe c ts  shown in 
A. A bolus dose o f N -m e th y l leva llo rphan (Im g /kg ) was given and a fte r 10 
m inutes the anim al was re-dosed w ith  a lfe n ta n il as before (B). The tra ce  is 
represen ta tive  o f the fou r experim ents ca rried  out.
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Figure 37 Antagonism of Sufentanil-Induced Depression of
Respiration by N -M ethyl Levallorphan in In tact
and B ilaterally Vagotomised Rats
Rats were dosed w ith  su fen tan il as described in  Methods, and IDcg fo r  
depression o f m inute volume was determ ined before and approx im ate ly  1 0  
m inutes a fte r a bolus dose (1, 2.5 or 5.0m g/kg) o f N -m e th y i leva llo rphan in 
in ta c t (closed c irc les) o r b ila te ra lly  vagotom ised preparations (open c irc les). 
Each ra t was used once and the points are the mean - SE mean o f three 
determ inations.
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5.4.11.2 Comparison o f the Potency o f Levallorphan and N -M e thy l 
Leva llorphan
The nature o f the re la tionsh ip  between dose of N -m e thy l leva llo rphan 
and the degree o f antagonism o f m inute volume depression produced by the 
fen tany ls  was shown to be non-linear (Section 3,4.11.1) and th is was compared 
w ith  th a t fo r  the parent compound, leva llorphan, also adm inistered 
in travenously.
A dose o f lO pg/kg leva llo rphan produced a degree o f antagonism of 
the resp ira to ry  depressant e ffe c ts  o f a lfe n ta n il s im ila r to th a t a fte r Im g /k g  
N -m ethy l leva llorphan. However, when the doses o f leva llo rphan and the 
quaternary compound were increased in the same manner, marked d iffe rences 
in th e ir  antagon istic potencies were apparent (F igure 38), which were 
a ttr ib u te d  to  d iffe rences in th e ir  d is tr ib u tio n a l cha rac te ris tics .
The b io log ica l h a lf- live s  o f the two compounds were determ ined as 
fo r naloxone (Section 2.5.5.1) and shown to  be m arkedly sm a lle r fo r
leva llorphan (12.6 -  4.2 m inutes) than fo r  N -m ethy l leva llorphan (115 -  16 
m inutes).
3.4.11.3 In trace re b rove n tricu la r N -M e th y l Levallorphan
In order to dem onstrate th a t i.v . N -m ethy l leva llorphan was ac tive
only in the periphery, and also to  act as a positive  con tro l fo r  the freehand
in tra ce reb ro ven tricu la r (i.c .v .) a dm in is tra tion  technique (Section 2.4.6) N - 
m e thy l leva llorphan (250pg i.c .v .) was used to antagonise the m inute  volume 
depressant e ffe c ts  o f a lfe n ta n il in the  b ila te ra lly  vagotom ised ra t, and 
compared w ith  5mg/kg N -m e thy l-leva llo rphan  i.v . (F igure 39), The absolute 
dose o f antagonist given i.c .v . was 1 0 - fo ld  less than given i.v ., ye t the degree 
o f antagonism was more than 3 -fo ld  g reate r. Saline had no e ffe c t 
adm inistered by e ithe r rou te  on the a lfe n ta n il m inute volume dose response 
re la tionsh ip .
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Figure 38 Antagonism of the Respiratory Depressant E ffects of
A lfentanil by Levallorphan and N -M ethyl Levallorphan
Rats were dosed w ith  a lfe n ta n il as previously described in  Methods and IDcm 
fo r depression o f m inute volum e was determ ined. 10 M inutes a fte r  dosing w itn  
bolus doses o f leva llo rphan (10-50pg/kg, closed triang les) or N -m ethy l 
leva llo rphan (l-5 m g /k g ) in  in ta c t ra ts (closed c irc les) o r in b ila te ra lly  
vagotom ised ra ts  (open c irc les ) the m inute volume fo r a lfe n ta n il was
again determ ined and dose ra t io  ca lcu la ted . The points are the mean -  SEM o f 
3-4 dete rm ina tions.
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Figure 39 Antagonism of A lfentanil Minute Volume Depression
by N -M ethyi Levallorphan Administered i.v . and
i.c .v . in the B ilaterally Vagotomised R at
Rats were prepared as described in  Methods and dosed w ith  a lfe n ta n il i.v . in 
order to  determ ine ID cn fo r m inute volume depression. When given i.v ., 
m axim a l antagonism obta ined w ith  N -m e th y i leva llorphan (N -M e-L ) at a dose 
o f 5m g/kg was not s ig n ific a n tly  g reate r than saline co n tro l. G iven i.c .v ., N - 
M e-L  produced 5 -fo ld  antagonism o f the depressant e ffe c ts  o f a lfe n ta n il a t a 
dose 10-fo ld  low er than tha t given i.v . ^S ig n ifica n tly  g rea te r than saline 
co n tro l. The bars represent mean -  SE mean of 3-5 independent 
dete rm ina tions.
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3.4.12 E ffe c ts  o f R ecep to r-S e lec tive  A gon ist and A ntagon is t Peptides 
on R esp ira tion
3.4.12.1 Intravenously A dm in is te red  Peptides
A single dose o f DAGO ( lô p g /k g  i.v .) produced both apnea and 
depression o f m inute volum e. However, when the dose was increased 
progressive ly to  128pg/kg, the apnea was no longer present and fu rthe rm o re , 
the apnea produced by a lfe n ta n il p rio r to  DAGO was also abolished.
A m ore deta iled  study o f th is  in te ra c tio n  was made. A f te r  an i.v . 
dose o f DAGO o f 250pg/kg to  the in ta c t ra t, the potency o f a lfe n ta n il to 
depress m inute  volum e fe l l  by 50% (F igure 40 A) and the apnea 
c h a ra c te ris tic a lly  produced by a lfe n ta n il in th is preparation was not observed. 
A s im ila r tre a tm e n t w ith  DAGO given between m inute volume log dose 
response p lo ts fo r a lfe n ta n il in the b ila te ra lly  vagotom ised ra t, in  con tras t, 
revealed l i t t le  in fluence  o f the peptide on the resp ira to ry  responses to  
a lfe n ta n il (F igure 40B). F igure  40C shows the progressive, dose-re la ted 
a ttenua tion  o f both the apneic and m inute volume depressant responses to  
DAGO.
A dm in is tered  in travenously , the peptide DPDPE had no observable 
e ffe c t on resp ira tion  in  the in ta c t ra t at doses up to 512pg/kg. This was 
con firm ed  in  th ree  experim ents.
S im ila r ly , the  antagon ist peptide IC l 174,864 (Im g /k g  i.v .) was unable 
to b lock the resp ira to ry  depressant e ffe c ts  o f fen tany l in the in ta c t ra t,  and 
the m inute volume ID ^g  values before  and a fte r  the antagonist were 25.3 -  
7.0nm oles/kg and 23.1 - 4.4nm oles/kg, respective ly . N e ithe r the antagonist 
alone nor the L -a rg in ine  veh ic le  possessed re sp ira to ry  a c t iv ity .
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Figure 40 The E ffec t of DAGO on Respiratory Responses to
A lfentanil and DAGO
The potency o f a lfe n ta n il to  depress m inu te  volum e in the in ta c t ra t (A ) (open 
c irc les ) is s lig h tly  reduced a fte r  p re trea tm e n t w ith  DAGO (250pg/kg) (closed 
c irc les). In add ition , apnea is abolished. In the  b ila te ra lly  vagotomised ra t 
DAGO has no e ffe c t, and does not a lte r re sp ira to ry  responses to  a lfe n ta n il (B). 
O rdinates are -log dose (g /kg) and abscissae, percentage depression o f m inute 
volum e, DAGO alone (C) produced apnea (squares) and depression o f m inute 
volume (triang les), but acute to lerance to these e ffe c ts  is apparent a t high 
doses. The abscissae are percentage depression o f m inute volume and apnea 
duration  (seconds). The points are the mean - SE mean o f three or fou r 
independent de te rm inations.
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3.4,12.2 In tra ce re b ro ve n tricu la rly  A dm in is te red  Peptides
A dm in is te red  i.c .v ., DPDPE produced dose-related depressions o f 
both resp ira to ry  frequency and tid a l vo lum e. The e ffe c ts  were slow to  
m axim ise and were rap id ly  reversed by Im g /kg  naloxone i.v ., bu t not by 
lO pg/kg  naloxone (F igure 41). A t  the tim e  o f maximum e ffe c t, lOOpg DPDPE 
i.c .v . (n = 6 ) produced depressions o f frequency and tid a l volume o f 2 0  - 2 % 
and 1 0  - 1 % respec tive ly , g iv ing  m inu te  volum e depression o f 28 -  1 %.
I t  was not possible to  fu r th e r investiga te  the recep to r invo lvem ent in 
th is  e ffe c t w ith  IC I 174,864 because even at low  doses (1-lO pg) adm inistered
i.c .v . the antagonist alone produced fa ta l resp ira to ry  depression. Six a ttem p ts  
were made w ith  th is  resu lt.
3.4.13 Modulation of the Respiratory Responses to A lfentanil by Morphine
The resp ira to ry  responses to  m orphine adm inistered i.v . were s im ila r 
to  those produced by the fen tany ls  (Section 3.4.1) but the slopes o f the log 
dose response p lots fo r  depression o f m inute  volume were ty p ic a lly  much low er 
fo r  m orphine (35 - 5), than fo r  the  fen tany ls  (eg: 63 -  10 fo r  su fen tan il). 
A ccord ing ly , ID ^g values fo r  depression o f m inute volume were determ ined fo r 
morphine, ra th e r than ID ^^ . When a single dose o f morphine was given 
repeated ly a t in te rva ls , the apnea dura tion  became progressively shorte r and 
the degree o f depression o f m inute  volum e sm aller. To investiga te  the 
mechanisms invo lved in  the  developm ent o f th is  rapid reduction  in se n s itiv ity , 
the a b ility  o f morphine to  a lte r  the resp ira to ry  responses to  a lfe n ta n il was 
studied.
When dose response p lo ts fo r a lfe n ta n il were constructed before and 
a fte r  a m orphine dose response p lo t, the  apnea in response to  a lfe n ta n il was
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abolished and the potency o f a lfe n ta n il to  depress m inute volume was reduced, 
w ith  dose ra tio  2.4 - 0.6 (n = 6 ). However, when a subsequent dose response 
p lo t fo r  morphine was obtained the dose ra tio  was much g rea te r (77 - 46) than 
th a t fo r  a lfe n ta n il (F igure 42). S ta tis t ic a l analysis using paired t- te s ts  showed 
th a t w h ils t a lfen tan il ID^g values were not s ig n ifica n tly  increased by morphine 
(p > 0 .1 ) the values fo r depression o f m inute  volume by m orphine fro m
tw o  successive dose response p lo ts were h ighly s ig n ific a n tly  increased (p < 
0.02).
3.4.1 4 Blood Gas Analysis: Tim e Course and the E ffects of A lfentanil
in Intact and Bilaterally Vagotomised Rats
In no study did the rem oval o f seria l blood samples, to ta llin g  <2ml 
over 3 hours, resu lt in  s ig n ifican t fa lls  in the h em ato c rit, w hich rem ained close 
to 50% o f whole blood volum e.
The resp ira to ry  param eters frequency, t id a l volum e and the product, 
m inute  volume were noted im m ed ia te ly  p rio r to  the rem oval o f an a rte r ia l 
blood sample, and the tim e  course o f these values over a 3 hour period 
dem onstrated l i t t le  change. W hils t the resp ira to ry  values fo r  b ila te ra lly  
vagotom ised ra ts were typ ica l fo r  tha t prepara tion, those fo r  in ta c t ra ts  were 
g rea te r fo r  tid a l volume and less fo r  frequency than was genera lly  the case fo r 
the m a jo rity  o f the resp ira to ry  studies reported  in th is w ork. This was due to 
the  in te rfe re n ce  w ith  the vagus nerve which was in ev itab le  during ca ro tid  
a rte ry  cannulations. However, resp ira tion  was w e ll m ain ta ined over the 3 hour 
period o f the study.
The pH and a rte r ia l blood gas tensions were measured in para lle l w ith  
the resp ira to ry  param eters reported  above, and the tim e  courses o f P ^C O ^,
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Figure 42 Modulation by Morphine of the Respiratory 
Responses to A lfentanil
Rats were dosed w ith  a lfe n ta n il (closed c irc les) to establish a dose-response 
re la tionsh ip , and ca lcu la ted . M orphine was then given (40, 160 and
640pg/kg) at 10 m inute in te rva ls  (closed squares) and determ ined. A f te r  
1  hour, the ra t was redosed w ith  a lfe n ta n il as before (open c irc les), then w ith  
morphine (open squares). H igher doses o f m orphine were required  on the 
second occasion than on the f ir s t  to  produce the same degree o f m inute 
volume depression (p < 0 , 0 2 ) but the potency of a lfe n ta n il was not s ig n ific a n tly  
reduced (p > 0.1). Points represent mean - SE mean of six independent 
determ inations.
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and pH are shown in F igure 43. For a il param eters measured, the 
la rgest changes were observed during the 30 m inutes fo llow ing  connection o f 
the trachea l cannula to  the F le isch tube. This equ ilib ra tion  period was always 
p e rm itte d  in resp ira to ry  studies p rio r to dosing w ith  drugs. The changes during 
the 30 m inutes equ ilib ra tio n  were g rea te r fo r in ta c t than fo r  b ila te ra lly  
vagotom ised ra ts, according w ith  the observation th a t hype rve n tila tio n  was 
o fte n  induced during surgery in the fo rm e r prepara tion, but not in the la t te r .  
A f te r  the equ ilib ra tion  period, no s ig n ifica n t changes in a rte r ia l pH or P ^C O ^ 
were seen during the fo llo w in g  2.5 hours o f the study, ne ithe r were there 
d iffe rences between the values in in ta c t and b ila te ra lly  vagotom ised ra ts , 
co n firm ing  the com parab ility  o f the tw o preparations. There was, how ever, a 
tim e-dependent downward trend  in the P ^ 0 2  in both groups o f ra ts , but th is  
decrease became s ig n ifica n t, fo r  b ila te ra lly  vagotom ised ra ts  only, a t the last 
t im e  po in t o f 3 hours. There were no tim e-dependent changes in  any o f the 
o ther measures made in a rte r ia l blood: b icarbonate concen tra tion , to ta l CO 2 , 
base excess or standard b icarbonate.
A lfe n ta n il adm inistered as an i.v . bolus produced dose-related 
decreases in  ^ ^ ^ 2  and pH and increases in  P ^ C 0 2  measured in blood samples 
taken close to 15 seconds post-dosing (F igure 44). Naloxone (Im g /k g ) given 15 
m inutes p rio r to the highest agonist dose (16m g/kg) com p le te ly  abolished both 
the resp ira to ry  changes as measured from  the traces and fro m  the a rte r ia l 
blood samples. C orre la tions  between log a lfe n ta n il dose and the absolute 
value o f the a rte r ia l blood param eter a fte r  dosing were r  = 0.9994 fo r  pH, r  = 
0.99988 fo r  P ^ C 0 2  and r  = 0.9998 fo r  P ^ 0 2 * The precision o f repeated 
measurement o f various param eters in a large sample was as fo llow s: pH -
0.005 un its ; P ^ C 0 2  - Im m H g; P ^ 0 2  - Im m H g.
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Figure 43 Blood Gas and pH Changes During Spontaneous Breathing
Through the Respiratory Monitoring Apparatus
A rte r ia l blood pH and p a rtia l pressures o f CO^ (Py^CO^) and Og were
determ ined in 350pl samples at the tim es indicatecT on the ord inate : the 
com pletion  o f surg ical p repara tion  is m arked by S. The points represent the 
mean -  SE mean o f dete rm ina tions in 5 anaesthetised animals whose vagus 
nerves were in ta c t (solid lines) or b ila te ra lly  transected (broken lines).
*  S ign ifican tly  d iffe re n t from  values at 30 m inutes.
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Figure 44 Acute E ffects of A lfentanil on A rteria l
Blood Parameters in the Intact R at
A rte r ia l blood samples were taken 15 seconds a fte r saline or drug as ind ica ted . 
The histogram s are the mean - SE mean o f five  independent determ inations.
*  S ig n ifican tly  d if fe re n t from  saline; + = s ig n ifican tly  d iffe re n t from  highest 
agonist dose.
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3.5 C AR D IO VASC U LAR  STUDIES
The card iovascular responses to a lfen tan il, fen tany l and sufentan il 
adm in istered as i.v . bolus doses to the in ta c t ra t were q u a n tita tiv e ly  s im ila r, 
com pris ing an im m edia te  and dose-related fa l l in both heart ra te  and blood 
pressure, fo llow ed  by a slow re tu rn  to  values equal to or s lig h tly  h igher than 
those p rio r to  dosing. The secondary pressor responses were absent w ith  
ca rfe n ta n il and were most marked w ith  fen tany l.
In the b ila te ra lly  vagotom ised ra t, the responses were monophasic 
and pressor, and were dose-related fo r  a ll drugs except fo r ca rfe n ta n il. In 
both preparations, dosing w ith  drug was preceded by a saline con tro l which 
ro u tin e ly  produced a trans ien t and sm all change in heart ra te  and blood 
pressure. A ll drug responses could be blocked by a 15 m inute  p re trea tm en t 
w ith  naloxone (200pg/kg). W hilst both systo lic  and d ias to lic  blood pressure 
were recorded, only values fo r mean a rte r ia l blood pressure are given in the 
figures, and th is was ca lcu la ted  as described in Section 2,6.2. R epresentative  
traces o f the card iovascular responses o f in ta c t and b ila te ra lly  vagotom ised 
ra ts  to drugs o f the fen tany l series are shown in  Figures 45-48 and the mean 
data is illu s tra te d  in the fo rm  o f h istogram s in Figures 49-52.
Mean pre-dosing card iovascular param eter values were fo r in ta c t ra ts  
as fo llow s, w ith  those fo r  b ila te ra lly  vagotomised animals in parentheses: 
heart ra te  385 - 18 (421 - 23); d ias to lic  pressure 53.7 - 3.4 (51.6 - 3.2); sys to lic  
pressure 101 - 3.7 (99.4 - 4.8); mean a rte r ia l pressure 69.4 - 3.1 (67.8 - 3.5). 
The values are the mean - SE mean o f 20 preparations, and pressure values are 
in mmHg.
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Figure 45 Cardiovascular E ffects of A lfentanil in Intact
and B ilaterally Vagotomised Rats
Rats were prepared as described in Methods and dosed w ith  a lfen tan il as 
ind icated, preceded by a saline (S) c o n tro l. The lower portion  of each trace 
shows the a rte r ia l blood pressure measured fro m  the ca ro tid  a rte ry  and the 
upper portion , heart ra te  d iffe re n tia te d  from  the pressure signal. Section A 
illus tra tes  the card iovascular e ffe c ts  in the in ta c t p repara tion, and B, the 
con tras ting  responses in the b ila te ra lly  vagotom ised ra t. Each animal was 
used fo r only one drug, and the traces are represen ta tive  o f four to six such 
experim ents.
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Figure 46 Cardiovascular E ffects of Fentanyl in Intact 
I and B ilaterally Vagotomised Rats
Rats were prepared as described in Methods and dosed w ith  fen tany l as 
ind ica ted , preceded by a saline (S) c o n tro l. The low er po rtion  o f each trace  
shows the a rte r ia l blood pressure measured fro m  the ca ro tid  a rte ry , and the 
upper po rtion , hea rt ra te  d iffe re n tia te d  from  the pressure signal. Section A 
illu s tra te s  the card iovascu la r e ffe c ts  in the in ta c t p repara tion , and B, the 
con tras ting  responses in the b ila te ra lly  vagotom ised ra t. A ll responses were 
m arked ly reduced by a 15 m inute  p re trea tm e n t w ith  naloxone (N X , 200pg/kg). 
Each anim al was used fo r  only one drug, and the traces are represen ta tive  o f 
f iv e  such experim ents.
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Figure 47 Cardiovascular E ffects  of Sufentanil in In tact
and Bilaterally Vagotomised Rats
Rats were prepared as described in Methods and dosed w ith  su fen tan il as 
ind icated, preceded by a saline co n tro l. The low er po rtion  o f each trace  shows 
the a rte r ia l blood pressure, measured from  the ca ro tid  a rte ry , and the upper 
po rtion , heart ra te  d iffe re n tia te d  from  the pressure signal. Section A 
illu s tra tes  the card iovascular e ffe c ts  in the in ta c t p repara tion, and B, the 
con tras ting  responses in the b ila te ra lly  vagotomised ra t. Each anim al was 
used fo r  only one drug, and the traces are represen ta tive  o f four to six such 
experim ents.
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Figure 48 Cardiovascular E ffects  of Carfentanil in In tact
and B ilaterally  Vagotomised Rats
Rats were prepared as described in Methods and dosed w ith  ca rfe n ta n il as 
ind icated, preceded by a saline (S) c o n tro l. The lower po rtion  o f each trace  
shows the a rte r ia l pressure measured fro m  the ca ro tid  a rte ry  and the upper 
portion , heart ra te  d iffe re n tia te d  from  the pressure signal. Section A 
illu s tra tes  the card iovascu lar e ffe c ts  in the in ta c t p repara tion , and B, the 
contrasting  responses in the b ila te ra lly  vagotom ised ra t. Each anim al was 
used fo r only one drug, and the traces are rep resen ta tive  o f fou r to six such 
experim ents.
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Figure 49 Quantification of the Cardiovascular E ffects of A lfentanil
Anim als were set up as described in  Methods. Panel A  shows the diphasic 
response fo r both mean a rte r ia l pressure and heart ra te  in in ta c t ra ts . Split 
bars denote the m axim um  depressions and elevations a t each dose. Panel B 
shows the monophasic pressor response in  b ila te ra lly  vagotom ised ra ts . A ll 
responses are blocked by a 15 m inute  p re trea tm e n t w ith  naloxone (NX, 
200}jg/kg). The bars ind ica te  the mean - SE mean o f five  independent 
de te rm ina tions.
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Figure 50 Quantification of the Cardiovascular E ffects of Fentanyl
Anim als were set up as described in the  Methods. Panel A shows the biphasic 
response fo r both mean a rte r ia l pressure and heart ra te . S plit bars denote the 
m axim um  depressions and e levations a t each dose ind ica ted  in  the key. Panel 
B shows the monophasic pressor response in b ila te ra lly  vagotom ised ra ts . A ll 
responses are blocked by a 15 m inute  p re trea tm en t w ith  naloxone (N X , 
200pg/kg). The bars ind ica te  the mean - SE mean o f six independent 
de te rm ina tions.
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Figure 51 Quantification of the Cardiovascular E ffects of Sufentanil
Anim als were set up as described in Methods. Panel A shows the  biphasic 
response fo r  both mean a rte r ia l pressure and heart ra te . S plit bars denote the 
m axim um  depressions and e levations a t each dose ind icated in the key. Panel 
B shows the monophasic pressor response in b ila te ra lly  vagotom ised ra ts . A ll 
responses are blocked by a 15 m inute  p re trea tm en t w ith  naloxone (N X , 
200pg/kg). The bars Ind icate  the mean - SE mean o f five  independent 
determ inations.
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Figure 52 Quantification of the Cardiovascular
Effects o f Carfentanil
Panel A shows the monophasic response fo r both mean a rte r ia l pressure and 
heart ra te  in in ta c t ra ts . Panel B shows the responses in b ila te ra lly  
vagotom ised ra ts . The magnitudes o f a ll responses are reduced by a 15 m inute 
p re trea tm e n t w ith  naloxone (NX, 200pg/kg). The bars ind ica te  the mean - SE 
mean o f fou r independent de term inations.
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The rank o rder o f potency o f the fen tany l drugs to produce depressor 
responses in the in ta c t ra t was the same as fo r the production  of resp ira to ry  
depression, and was ca rfe n ta n il > su fen tan il > fen tanyl > a lfe n ta n il. The 
potencies o f su fen tan il, fen ta ny l and a lfe n ta n il to produce 2 0 % depressions o f 
heart ra te  and mean a rte r ia l pressure are given in Table 15, toge the r w ith  
th e ir  potencies to produce apnea and to depress resp ira to ry  m inute  volume.
An analogy can be drawn between the d iss im ilar ra tios  o f the potency 
o f the  fen tany ls  to produce apnea and to  depress m inute volume (Section 3.4.2) 
and between th e ir  potencies to  depress heart ra te  and mean a rte r ia l pressure 
(M AP) by 20%. W hilst su fen tan il was equipotent in producing the tw o 
card iovascu lar responses, more a lfe n ta n il was required to  depress MAP by 20% 
than HR by 20%. For fe n ta n y l, th is  d iffe re n ce  in potency was g reate r s t i l l ,  
but in no case was the potency ra t io  as great as the apnea/m inute volume 
d iffe rences  fo r  fen ta ny l (Table 8 ). However, the ra tio  o f m inute  volume and 
M AP-depressant potency values revealed tha t at equ i-resp ira to ry  depressant 
doses, the rank order o f e ffe c t on the card iovascular system was a lfe n ta n il > 
fen tany l > su fen tan il. M oreover, w h ils t the depressor e ffe c ts  on the 
card iovascu lar system were abolished by vagotom y, the potency o f the drugs 
to  produce the rem ain ing responses (pressor only) were unchanged (see Figures 
49-51).
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4.1 R A D IO LIG A N D  B INDING  ASSAYS; METHODOLOGY
The widespread use of recep to r binding methods using rad io lebe lled  
op io id  ligands has led to  many valuable d iscoveries and is a testam ent to the 
v e rs a tility  o f what are, in p ra c tica l term s, re la tiv e ly  sim ple techniques. 
However, in  order fo r the resu lts o f such studies to  be m eaningfu l, i t  is 
necessary th a t some basic precautions be taken, and more w e ight can be 
a ttached to  the outcom e o f binding experim ents in which such caveats have 
been observed.
4.1.1 The Importance of Radioligand Purity
The t r it ia te d  peptides were pu rified  by HPLC before use in order to  
co n firm  the id e n tity , concen tra tion  and spec ific  a c t iv ity  o f the compounds 
supplied. W hilst l^H  1 DAGO was always su itab le  fo r use according to  these 
spec ifica tions, considerable b a tch -to -ba tch  va ria tions  in concen tra tion , p u r ity
3and on tw o occasions, id e n tity  o f the [ H 1 DPDPE supplied were found. I t  is 
apparent from  the lite ra tu re  th a t many workers do not p u r ify  th e ir  
rad io ligands before use (Itzhak et 1982; Spain e t ^ . ,  1985; D e lay-G oye t e t 
^ . ,  1985; Same and Kenner, 1987; Itzhak and Pasternak, 1987) w h ils t others 
consider, th is  aspect s u ff ic ie n tly  im p o rta n t to  describe th e ir  procedures fo r  
p u r if ic a tio n , fo r  exam ple, by gel chrom atography (Mosberg e t ^ . ,  1983; 
A kiyam a ^  ^ . ,  1985) or by HPLC (Magnan e t ^ . ,  1982; C o tton  e t a l., 1985; 
Robson e t a l., 1985; M cD ow ell and K itche n , 1986). C le a rly , the use o f im pure 
ligands or those whose id e n tity  is unconfirm ed could lead to  erroneous 
conclusions concerning binding s ite  he te rogene ity  or a f f in ity .  In a recent 
rev iew  (Brown e t W., 1986) i t  has been emphasised th a t inadequacies in the 
q u a lity  co n tro l procedures o f suppliers o f rad io labe lled  peptides are frequent 
and th is  underscores the need fo r p rio r p u r if ic a tio n .
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4.1.2 T im e Course o f L igand Binding
V e r if ic a tio n  o f the tim e  required fo r  equ ilib rium  binding o f rad io ligand 
in bra in homogenates is im p o rta n t both in sa tu ra tion  binding and in in h ib itio n  
studies. In the f ir s t  case, inadequate incubation lengths must produce under­
estim ates o f B ^ ^ ^  and may also give rise to curved Scatchard p lo ts since the 
tim e  to  plateau binding varies w ith  ligand concentra tion  (W eiland and 
M o lin o ff, 1981). For the same reasons, too short an incubation may produce 
poor estim ates o f K j fo r  unlabelled compounds in in h ib itio n  experim ents and 
also to  curved H il l p lo ts. The tim e  course experim ents reported  in  Section
3.2.1.1 show tha t w h ils t a 60 m inute incubation is adequate to  obta in  >95% o f 
the m axim um  binding fo r t DAGO, th is  is not the case fo r sa tu ra tion
3binding studies w ith  I  H 1 DPDPE, where i t  is lik e ly  th a t values fo r B ^ ^ ^  may 
have under-estim ated the true  m axim a by 10-15%.
There is a good co rre la tio n  (r = 0.99) between the tim e  taken fo r  h a lf-  
m axim a l spec ific  binding to be achieved fo r both the t r it ia te d  peptides in 
homogenates o f whole bra in  and o f pons and m edulla regions and the degree o f 
non-specific  binding exh ib ited .
4.1.3 S ta b ility  o f  Radioligands
N ot only should the radioligands used in binding studies be checked fo r  
p u r ity  p rio r to  use but also fo r  id e n tity  a fte r  incubation (Leslie  e t a l., 1980), 
an aspect apparently neglected by the m a jo rity  o f workers in th is  area, 
although ligand degradation during binding assays precludes establishm ent o f a 
true  equ ilib rium  (Speth e t W., 1986). The achievem ent o f p la teau binding fo r  
I^H  ] DAGO and P h  1 DPDPE in  tim e  course experim ents (3.2.1.1) suggests 
th a t s ig n ifican t degradation o f the ligands does not occur even in periods o f 
tim e  g rea te r than those ro u tine ly  used fo r  sa tu ra tion  binding or in h ib itio n  
experim ents in bra in  homogenates and th is  is confirm ed by the s ta b ility  studies
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reported  in Section 3.2.1.6. However, [^ H  ] DPDPE incubated w ith  Tris b u ffe r
alone displayed a paradoxical in s ta b ility , in  tha t the size o f a m inor peak
representing an im p u rity  in the s ta rting  m a te ria l increased in size a fte r
3incubation and the size o f the peak representing [ H I DPDPE decreased. I t  is 
possible th a t the  m inor peak at low er re ten tio n  tim e  was DPDPE in  which the 
disulphide bond was reduced to  su lphydryl groups, since th is  is the most lab ile  
po rtion  o f the m olecule, and fu rth e rm o re , such a chem ical change would 
produce an increase in  the p o la r ity  o f the peptide and thus a reduced re ten tio n  
tim e  in reverse-phase HPLC. In support o f th is  hypothesis, incubation o f 
unlabelled DPDPE w ith  a reducing agent (Section 2.3.5.5) resu lts  in a fa l l in 
the re ten tio n  tim e  o f the trea ted  m a te ria l.
4.1.4 Other Observations Relating to the Ligand Binding Methodology
The b u ffe r in  which opioid rad io ligand binding studies are perfo rm ed is
usually TRIS H C l fo r both peptides (C o rb e tt et a l., 1984) and non-peptide
opioids (Gommeren and Leysen, 1982). This is because binding in physiolog ica l
media is seldom sa tis fa c to ry  (Bourhim  et ^ . ,  1985), probably because of the
e ffe c ts  o f cations, most notab ly sodium (P e rt and Snyder, 1974) on the binding
o f opioid agonists to  membrane-bound receptors in v itro . W h ils t there have
been occasions where good co rre la tions  between a f f in ity  in v itro  and
tissues
pharm acological a c t iv ity  in  v ivo  (Hayes et a l., 1987) and in  iso la te d ^K o s te riitz  
e t ^ . ,  1980) have been found, i t  should not be assumed th a t binding w ill always 
be a good co rre la te  o f the b io log ica l e ffe c ts  o f a compound (Hollenberg, 1985; 
De M ontis  e t ^ . ,  1987).
During rad io ligand binding experim ents i t  is usual, though not fo rm a lly  
co rre c t, to  assume th a t the fre e  concentra tions o f rad io ligand, and in 
in h ib ition  experim ents o f unlabelled com peting ligands also, are as ca lcu lated.
2 0 0
For sa tu ra tion  binding and most inh ib ition  assays described in th is  thesis the 
assumption th a t free  concen tra tion  was equal to  tha t concen tra tion  added is 
p robably reasonable, since the amount o f rad io ligand bound, (or the depletion) 
was <1% fo r   ^ DAGO and DPDPE. However, fo r  those unlabelled
ligands used in co m p e titio n  experim ents whose a ff in ity  was g rea te r than th a t 
o f the t r it ia te d  ligand fo r  the binding s ite , there  may have been s ig n ifica n t 
dep le tion o f the co m p e tito r. This is because the in it ia l concen tra tion  o f 
co m p e tito r was o f necessity low , and thus the actua l free  concentra tions, on 
the basis o f which IC^Q and K j values were ca lcu la ted , may have been low er 
than those added. This problem  could not be addressed w ith o u t a sensitive 
assay fo r  free  unlabelled ligand concen tra tion  ( fo r lo fe n ta n il and ca rfen ta n il 
m ost notab ly) and the poss ib ility  th a t some K j values at the 6  b inding s ite  are 
in  e rro r must be accepted. The issue o f ligand depletion and its  consequences 
is rev iew ed in a recen t a r t ic le  (G oldste in and B a rre tt, 1987).
Scatchard analysis is the most fre qu e n tly  used method fo r  es tim a tion  o f 
the K p  and B ^ ^ ^  values fo r  a rad io ligand . Whereas the use o f the slope o f 
th is  fun c tio n  to  ca lcu la te  a f f in ity  is not in question, considerable debate has 
centred  on the issue o f ex trap o la tion  o f the Scatchard p lo t to  the ord ina te  in 
order to  obta in  a measure o f 8 ^^^^ (K lo tz , 1982; Laduron, 1983; Mendel and 
Mendel, 1985). K lo tz  (1982) suggests th a t in order to  va lida te  the 
e x trap o la tion  i t  is necessary f ir s t  to p lo t the log o f free  ligand concen tra tion  
against am ount o f spec ific  binding. This should produce a sigm oidal curve, and 
only those data sets dem onstra ting a d is tin c t in fle c tio n  and an approach to  a 
p lateau should be fu r th e r analysed by means of Scatchard p lo ts. When th is  
sim ple tes t was perfo rm ed on sa tu ra tion  data sets from  binding studies w ith  
[ ^ H 1 DAGO and E ^H  1 DPDPE, these c r ite r ia  were m et.
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4.2 SATURATION BINDING STUDIES
Despite the d if f ic u lt ie s  tha t high non-spec ific  binding o f [ ^ H l  DPDPE 
in homogenates o f pons/m edulla presents, the re la tiv e ly  low number o f 6  sites 
shown in Table 6  is in  agreem ent w ith  the find ings o f Robson e t ^ . ,  (1985) who 
used single concentra tions o f the re la t iv e ly  unselective 6  s ite  ligand 1
D A D L, w ith  unlabelled DAGO to  suppress p s ite  binding in order to estim ate  
the binding capacity  o f homogenates o f m edulla in ra t. In th e ir  study, th is  
region conta ined approx im ate ly  one th ird  the number o f g receptors per un it 
tissue w e t w e igh t o f the  num ber in  whole brain homogenates. However, since 
the authors used a single t r i t ia te d  ligand concen tra tion  there  was no way to  
d istingu ish between the e ffe c ts  o f d iffe rences in a f f in ity  and d iffe rences in 
the concen tra tion  o f <S binding sites on the apparent values o f the binding 
observed. The study reported  in th is  thesis overcomes th is  problem . S im ila r ly , 
although ne ithe r o r K p  values fo r  [ ^H1 DPDPE binding in pons/m edulla
are given by Mansour e t (1986) the authors dem onstrated using an 
autoradiographic technique th a t the ove ra ll density o f 6  b inding sites was 
re la tiv e ly  low  in those bra in  regions.
The K p  values quoted fo r  t ^ H ^  DPDPE binding in whole ra t bra in 
however, o f l l . l n M  (Mansour e t a l., 1986) and 10.5nM (D e lay-G oyet ^  ^ . ,  
1985) are s im ila r to  those reported  in  Table 6  but are g rea te r than the value 
reported  by C o tton  e t a l., (1985) o f 5.3nM. This d iffe rence  is probably a 
re f le c tio n  o f the species and s tra in  d iffe rences in the receptors, p a r tic u la r ly  in 
regard to  the § s ite  (Table 16). Such s tra in  and species d iffe rences in the 
a f f in ity  o f ligands fo r  the p s ite , however, appear to  be less m arked. For 
exam ple, the a f f in ity  o f [^ H  1 DAGO fo r  the p site  in both whole bra in and 
pons/m edulla regions (Table 6 ) is in  close agreem ent w ith  de te rm ina tions made 
by o ther groups in ra t (G illan  and K o s te r litz , 1982; Mansour e t a l., 1986) and in 
o the r species (Table 16). F u rthe r, the s im ila r ity  o f the B ^ ^ ^  values fo r E^ Hl
2 0 2
DAGO in homogenates o f whole bra in and o f pons/meduIla regions (Table 6 ) is 
also supported by the findings o f Robson et (1985) but as in the case o f 6  
binding, no o r K p  values, only re la tiv e  binding capacities are given. The
Bmax value in whole bra in  fo r 1 DAGO (Table 6 ) is very s im ila r to  th a t 
reported  by G illan  and K o s te r litz  (1982) and Robson et (1985) have 
reported  th a t the num ber o f p binding sites in medulla is s im ila r to th a t in 
whole bra in . This find ing  is also supported by Chang et a l., (1979) who showed 
also th a t there  were a t least tw ice  the density o f p sites than 5 sites in  th is  
bra instem  region.
In sum m ary, the  resu lts  o f the sa tu ra tio n  binding experim ents co n firm  
th a t the number o f 6  binding sites in pons/m edulla regions is low  compared 
w ith  p sites and w ith  p and 6  sites in  whole bra in, made using the most s ite - 
se lec tive  ligands c u rre n tly  availab le  fo r  the  p and 5 binding sites.
W hilst d iffe rences in  the reg iona l d is tr ib u tio n  o f opioid binding sites do 
not p e rm it f irm  conclusions to  be drawn concerning the ro le  th a t ce rta in  
recepto rs may play in the m ed ia tion  o f resp ira to ry  depression, i t  can 
te n ta tiv e ly  be suggested fro m  the low  num ber o f 6  sites in pons/m edulla, 
regions o f im portance w ith  respect to  re sp ira to ry  co n tro l (Section 1.4.2), th a t 
<5 sites may be less im p o rta n t than p s ites in  th is  e ffe c t.
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Table 16 A ffin ities  of [ ^H]DAGO and [ ] DPDPE for
the p and 6 Sites Measured by Saturation Binding 
Studies in Brains From D ifferen t Species
[ H ] DAGO Binding (p Site)
K p  (nm) Species Reference
1.09 -  0.12 Rat G illan  and K o s te r litz  (1982)
1.4 R at Mansour e t a l., (1986)
1 . 0 R at Itzhak and Pasternak (1987)
1.04 - 0.06 R abbit Robson e t a l., (1985)
0.96 -  0.16 Guinea Pig K o s te r litz  and Paterson (1981)
1 . 1  - 0 . 2 M arm oset Yeadon and K itchen  (1987)
[ ^H ] DPDPE Binding ( 6  S ite)
K p  (nm) Species Reference
1 1 . 1 R at Mansour e t ^ . ,  (1986)
10.5 -  2.4 Rat D e lay-G oyet e t ^ . ,  (1985)
5.3 - 0.6 Rat C o tton  e t a l., (1985)
4.2 D unk in -H a rtie y
G uinea-P ig
C o rb e tt e t a l., (1984)
2.7 -  0.2 H a rtle y  
Guinea Pig
James and G oldste in (1984)
1 . 6  -  0.3 M arm oset Yeadon and K itche n  (1987)
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4.3 IN H IB IT IO N  STUDIES WITH F E N T A N Y L-L IK E  DRUGS
The p and  ^ b inding site  a ff in it ie s  and site se le c tiv itie s  o f th is  sm all 
series (F igure 2) o f 4 -an ilinop ipe rid ine  drugs (fentanyls) have not previously 
been determ ined in a single, consisten t assay system using ra t brain 
homogenates and no values have been found in the lite ra tu re  derived from  
in h ib itio n  o f the binding in  ra t bra in homogenates o f h ighly se lec tive  
radioligands. Nevertheless, i t  has been w ide ly assumed from  the high 
potencies o f these drugs as analgesics (Table 3) tha t they are a ll p se lective  
(Casy and P a r f i t t ,  1986; Tyers, 1980; Wuster et ^ . ,  1979) and James and 
Goldste in (1984) used su fen tan il s p e c ific a lly  as a p se lec tive  ligand in order to  
suppress the p binding o f the non-equ ilib rium  antagonist S-FNA to  guinea-pig 
bra in  homogenates. On the basis o f the resu lts  o f the in h ib itio n  studies using 
h igh ly recep to r-se lec tive  radioligands reported in Section 3.3, however, i t  is 
c lea r th a t o f the fen ta ny l series tested, only a lfe n ta n il and fen ta ny l its e lf  
possess appreciable s e le c tiv ity  fo r  the p binding s ite . C a rfe n ta n il is 
unselective, having equal a f f in ity  a t the p and 6  binding sites w h ils t lo fe n ta n il 
and su fen tan il are m odestly p se lec tive  in ra t brain homogenates.
I t  is d i f f ic u l t  to  compare these new data w ith  exis ting  reports  in the 
lite ra tu re  because o f the d iffe re n ce  in the  methods used by various groups to  
determ ine a f f in ity .  For exam ple, w h ils t Gommeren and Leysen (1982) 
reported th a t the rank order o f a ff in it ie s  o f ca rfe n ta n il, su fen tan il, fen tany l 
and a lfe n ta n il in  ra t bra in  homogenate were the same as in Table 7, th e ir K .4 1
values o f 0.16, 0.5, 18 and 158nM resp ec tive ly , are not com parable because the 
labelled  ligand its e lf ,  lo fe n ta n il,  was a t th a t tim e  o f undefined s ite  s e le c tiv ity . 
The same was true  o f the K j values fo r  fen ta ny l, lo fe n ta n il and ca rfen ta n il o f 
4, 0.21 and 0.17nM, respec tive ly , determ ined against I ^ H ]  su fen tan il binding 
in ra t fo reb ra in  homogenate (To llenaere  e t a l., 1986). Magnan e t a l., (1982) in 
contrast used the h igh ly se lec tive  ligand [ ^ H 1 DAGO in guinea-pig bra in
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homogenates and obtained K j values fo r su fen tan il and fen tany l o f 1 . 6  and 
7.0nM w ith  y se le c tiv it ie s  o f 14 and 22, respective ly . The se le c tiv it ie s  were 
defined by a comparison o f K j values against [^H  ] DAGO and [^H  ] D ADL 
binding, the la t te r  used w ith o u t p suppression. Magnan e t a l., (1982) also 
dem onstra ted th a t fen tany l and su fen tan il had neg lig ib le  a ff in it ie s  fo r the k 
binding s ite , as judged fro m  the high K j values determ ined fro m  in h ib itio n  o f 
the binding o f the poo rly -se lec tive  ligand [^H  ] e th y lke tocyc lazoc ine . The low  
k a f f in ity  o f the drugs o f the fen tany l series is also supported by James and 
G oldste in  (1984) who showed th a t the s e le c tiv ity  o f su fen tan il fo r  p over k 
sites in guinea-pig brain homogenates was >2 0 0 , again determ ined using 
poo rly -se lec tive  ligands (d ihydrom orphine and e thy lke tocyc lazoc ine ). In 
add ition , F ros t and Wagner (1984) using I^^C l c a rfe n ta n il as a ligand fo r 
positron-em ission tom ography in  human bra in  in v ivo  estim ated  the s e le c tiv ity  
o f th is  compound fo r  p over k sites as >250.
A lthough the rank order o f a f f in it ie s  fo r  the series o f unlabelled drugs 
(Table 7) were not in com plete coincidence at the p and ô binding sites,the  
c lea r trend  was th a t as p a f f in ity  increased, p s e le c tiv ity  decreased, so th a t 
a lfe n ta n il, fo r  exam ple, was se lec tive  fo r  p over 6  sites approx im ate ly  600:1 
m aking a lfe n ta n il the most p p re fe rr in g  ligand reported  to  date. The rank 
order o f a ff in it ie s  o f the fen tany l drug series is lo fe n ta n il = c a rfe n ta n il > 
su fen tan il > fen tany l > a lfe n ta n il, co n firm in g  the fragm en ta ry  evidence 
ava ilab le  in  the lite ra tu re .4
In h ib itio n  studies w ith  lo fe n ta n il were perform ed using 1 hour and 17.5 
hour incubations because Leysen e t ^ . ,  (1978) have shown th a t th is  compound 
has an ex trem e ly  slow ra te  o f d issociation from  opioid binding sites ( t |  = 208 
m inutes). I f  th is  were also true  in  ra t b ra in  homogenate, then approx im ate ly  5 
h a lf- live s  or 17.5 hours would be required fo r  lo fe n ta n il to  reach equ ilib rium
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w ith  the binding sites in  v it ro . The resu lts  in th is  thesis show th a t there were 
no s ig n ifica n t d iffe rences in the K j values at the p and g sites determ ined 
fro m  short or long incubations, suggesting a more rap id  a tta in m e n t o f 
e qu ilib rium , in  d isagreem ent w ith  the find ings of Leysen et a l., (1978).
Because o f the d if f ic u lt ie s  encountered w ith  the use o f [^ H  ] DPDPE as 
a ligand in homogenates o f pons/m edulla regions o f ra t bra in (Section 3.2.2) i t  
was not possible to  determ ine K j values a t the 6  s ite  in th is  bra in  region w ith  
the fen ta ny l drugs. However, i t  is lik e ly  th a t th is binding s ite  is id e n tica l 
w herever in  the b ra in  i t  is found, and th is  was dem onstrated to  be the case fo r 
a lfe n ta n il, whose a t the p s ite  was the same determ ined both in  whole bra in  
and pons/m edulla  homogenates. The s im ila r ity  o f the binding sites in d if fe re n t 
b ra in  regions is also supported by Leysen and Laduron (1978) who showed th a t 
the K j fo r  fe n ta n y l was the same in several regions o f ra t b ra in.
The studies described in  th is  thesis show not only th a t the a ff in it ie s  o f 
the fen ta ny l series are m arked ly d iffe re n t, which m igh t be expected on the 
basis o f the d iffe rences in  th e ir  potencies as analgesics (Table 3) bu t also th a t 
the drugs possess w ide ly  d iffe r in g  se le c tiv it ie s  fo r  the p and 6  b inding sites.
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4.4 EFFECTS OF OPIOID DRUGS ON RESPIRATION IN THE
INTACT, ANAESTHETISED RAT
4.4.1 The Fentanyl Drug Series
A dm in is tered  as intravenous bolus doses in to  the r ig h t jugu lar vein,
a lfe n ta n il, fen tany l and su fen tan il produce apnea o f a lm ost im m edia te  onset
and dose-related duration , in  add ition  to  reducing frequency, t id a l volume and
thus m inute  volume (Section 3.4.1). The rap id  onset o f e ffe c ts  is consistent
w ith  the conclusions drawn by others using d iffe re n t agonists tha t these are, a t
least in p a rt, re flexogen ic  (Fennessy and R a ttra y , 1971; Sapru e t 1981;
W ille tte  and Sapru, 1982a) and invo lve  the vagus nerve (Sapru et ^ . ,  1981;
Dashwood e t a l., 1983; M artynova and Medvedev, 1986). The speed o f onset o f
the response is also in  accord w ith  the suggestion tha t the re fle x  component o f
the response to in travenously adm in istered opioids is m ediated via opioid
receptors in  the periphery (Dashwood et ^ . ,  1983) probably located in the
pulm onary vasculature (K iang e t ^ . ,  1983). W ille tte  and Sapru (1982a) suggest
th a t w h ils t the receptors invo lved are ce rta in ly  opioid in  nature, they are
probably probably also receptors which can evoke the 
J -re fle x  (P a in ta l, 1970 ; Section 1.4.4.3).
The duration  o f re sp ira to ry  depressant action o f a ll the drugs o f the 
fen tany l series pa ra lle l the  durations o f e ffe c tiv e  analgesia in ra ts (Cookson 
and Towse, 1981; Janssen, 1982), bu t the absolute durations of action  appear to  
re la te  b e tte r to  the ra tes o f o ffs e t o f the drugs fro m  opioid receptors m v itro  
(Leysen et W., 1983) than to  th e ir  e lim ina tio n  ha lf- lives  in v ivo  (Section 1.5.4). 
Thus, a t these low  doses, th e ir  actions are probably te rm ina ted  by re ­
d is trib u tio n  and d ilu tio n  ra th e r than by m etabo lic  in a c tiva tio n  or e lim ina tio n  
(Drummond, 1984). The persistance o f resp ira to ry  depression a fte r ca rfe n ta n il 
and lo fe n ta n il, which rendered these tw o drugs d if f ic u l t  to compare w ith  the 
rem ainder o f the series, presum ably resu lts  from  th e ir slow rates o f o ffse t 
from  opioid receptors (Leysen et a l., 1978).
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When the potencies o f the fen tany l drugs to produce apnea o f 6  seconds 
duration  and to depress m inute volume by 50% (Section 3.4.2) are compared 
w ith  th e ir a ff in it ie s  a t p end 6  b inding sites jn  v itro  (Section 3.3) the 
co rre la tions  o f apnea potency w ith  p and 6 ' a ff in it ie s  are s im ila r (r = 0.993 and 
r  = 0.985, respec tive ly ). C o rre la tions  between m inute  volum e depressant 
potency and p and 6  a f f in ity  were also s im ila r (r = 0.872 and r  = 0.847) thus i t  
is not possible to  d istinguish p from  6  roles in the production  o f the 
re sp ira to ry  e ffe c ts  on the basis o f th is  simple comparison w ith  the binding 
data m v it ro . M ore illu m in a tin g  is the com parison o f the potency o f the drugs 
to  produce apnea w ith  th e ir  analgesic potency in the ta il-w ith d ra w a l tes t in 
ra ts  (Janssen, 1982). The receptors m ediating  analgesia in th is  model are 
believed to be p (Tyers, 1980) and the  strong co rre la tion  between these 
measures o f potency (r = 0.999) suggests a p recep to r invo lvem ent in the 
p roduction  o f apnea by the  fen tany ls . The co rre la tion  between the potency to 
produce analgesia and depression o f m inute  volume is less strong (r = 0.92) and 
no recep to r assignment can be made on th is  basis alone. However, the potency 
ra tios  o f su fen tan il and a lfe n ta n il to  produce apnea (32) o r depression o f 
m inute volum e (43) are much closer to  th e ir  a f f in ity  ra tio s  a t the p s ite  (51) 
than a t the 6  s ite  (1050).
The potency ra tios  o f su fen tan il, a lfe n ta n il and fen tany l to  produce 
apnea ( 6 sA) and to  depress m inute volume (ID^g) (Table 8 ) are d iss im ila r, 
suggesting th a t the drugs may not have id e n tica l mechanisms o f ac tion . The 
a b ility  o f a lfe n ta n il to  produce dose-related decreases in a r te r ia l pH and PO^ 
and increases in PCO 2  (Section 3.4.14) con firm s th a t the e ffe c ts  o f a lfe n ta n il, 
and by in fe rence  those o f the  other drugs o f the fen tany l series, represent a 
re sp ira to ry  and not ju s t a v e n tila to ry  depression, as defined in  Section 1.4.1.
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4.4.2 k Receptor Selective Compounds
The Upjohn company compounds U50,488H and U69,593 are both 
reported  to be h igh ly se lec tive  fo r  the k binding site  in v itro  (G lllan  e t 
1985; L ah ti e t a i., 1985). The lite ra tu re  is inconsistent regarding the e ffe c ts
o f k recep to r se lec tive  compounds on resp ira tion . For exam ple, w h ils t
Le igh ton  e t (1987) reported  th a t ne ithe r U50,488H nor another h ighly 
se lec tive  k agonist, PD 117302, had any e ffe c t upon the resp ira to ry  ra te  o f 
ra ts , in accord w ith  the find ings o f Hayes et (1985). C a s tillo  et (1986) 
showed th a t U5G,488H given to  ra ts  produced a 70% e levation  in frequency. 
This e ffe c t supports the e a rlie r w ork o f Goode et al., (1979) in  which the 
e ffe c t o f the k agonist, pentazocine, in  ra ts  was to  produce a 2 - fo ld  increase 
in basal re sp ira to ry  frequency, and contrasts w ith  the find ings o f M a rtin , ^  
^ . ,  (1976) th a t ke tocyc lazoc ine  does not a lte r the resp ira to ry  ra te  o f the 
ch ron ic  spinal dog. As only ra te  was measured i t  is thus not possible to
ascerta in  w hether or not there  were a lte ra tio n s  in m inute volume in response
to  these k agonists. In the studies reported  in th is  thesis, w h ils t the k 
se lec tive  compounds produced m arked e levations in resp ira to ry  ra te , 
rec ip roca l reductions in  t id a l volum e resu lted  in l i t t le  or no change in m inute  
volum e a t any dose (Section 3.4.4). That these findings apparently co n tra d ic t 
some o f those in the lite ra tu re  re in fo rces  the view  o f Ward and Holaday (1982) 
th a t measures o f frequency alone are inadequate ind ica to rs  o f resp ira to ry  
change.
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4.5 QUANTITATIVE ANTAGONISM OF OPIOID-INDUCED RESPIRATORY
EFFECTS IN INTACT RATS USING NALOXONE
4.5.1 Repeated Dosing with the Fentanyls
For a lfe n ta n il, su fen tan il and fen ta ny l, m inute  volume depressant 
potency was unchanged upon repeated dosing, as was the potency to  produce 
apnea. The lack o f acute to lerance to  a lfe n ta n il is supported by the w ork o f 
Brown e t ^ . ,  (1980) who reported  th a t th is  compound produced consistent 
depressions o f m inute volume in  rabb its , even a fte r as many as four dose 
response curves. There fo re , w h ils t changes in m inute  volum e and production  
o f apnea are consistent measures o f resp ira to ry  pe rtu rba tion  the changes in 
the re la tiv e  con tribu tions  o f depressions o f frequency and t id a l volume to  fa lls  
in  m inute volume on repeated dosing (Section 3.4.3) render these param eters 
less re liab le  as ind ica to rs  in the in ves tiga tion  o f recep to r invo lvem ent by 
q u a n tita tive  studies o f antagonism, since the dose ra tios fo r these measures 
may be a rte fa c tu a lly  high or low . This can give rise to  in co rre c t assignment 
o f recep to r invo lvem ent in resp ira to ry  depression. For example, when ra te  
alone was used as a measure o f re sp ira to ry  depression, the m ethod o f 
measurement its e lf  in fluenced the apparent co n tribu tio n  o f p and 5 receptors 
to  depressions o f frequency (Ward and Takem ori, 1983).
4.5.2 Effect of Naloxone on Opioid-Nadve and Opioid-Treated Rats
Naloxone had no e ffe c t on the  re sp ira tion  o f anaesthetised rats a t doses 
g rea te r than those used in studies o f antagonism  reported in th is  thesis. Olsen
(1987) showed th a t opioid antagonists produced increases in  m inute  volume in 
ra ts  which were severely hypoxic o r hyperca rb ic , thus the absence of e ffe c ts  
reported  in th is  thesis suggests th a t the blood gas status o f the ra ts  were at or 
near norm al resting  values p rio r to  drug adm in is tra tion . In contrast, when 
pentobarbitone is used as the  anaesthetic in ra ts , naloxone subsequently 
produces resp ira to ry  s tim u la tio n  which did not occur w ith  urethane as 
anaesthetic (Mauser and Chapman, 1987).
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The lack o f acute to lerance to  the fen tany ls  and o f e ffe c ts  o f naloxone 
on op io id-na ive ra ts  perm its  the va lid  de te rm ina tio n  o f naloxone dose-ratios 
and the a ttr ib u tio n  o f the sh ifts  in  the dose response curve solely to  the 
antagonist.
When naloxone was adm inistered a t the end o f the f ir s t  a lfe n ta n il dose 
response re la tionsh ip , rapid reversa l o f the resp ira to ry  depressant e ffe c ts  
occurred, o ften  fo llow ed  by a trans ien t e leva tion  o f m inute volume above the 
p re -a lfe n ta n il value. This is not w ith o u t precedent and both Sowell e t a l., 
(1979) and Beubler (1980) have reported  naloxone-induced ’resp ira to ry  
overshoot’ a fte r depressions produced by opioids. W h ils t th is  e ffe c t has been 
in te rp re te d  as evidence fo r  the in h ib itio n  o f resp ira tion  by endogenous opioids 
released during hypoxia or hypercard ia  (Beubler, 1980) a s im p le r explanation 
involves only the re ins ta tem en t o f the norm al h ype rve n tila to ry  response to  
e levations in P ^ C 0 2  a fte r exogenous opio id-induced re sp ira to ry  in h ib ition  is 
released by naloxone.
4.5.3 Criticisms of Apparent pA2 Determinations Using Bolus Poses
of Naloxone
A dm in is tra tio n  o f single, bolus doses of antagonists in order to  
determ ine an equ iva len t to a pAg (apparent PA 2 ) in  v ivo  has been much used in 
an a tte m p t to  dete rm ine  opioid recep to r invo lvem ents in  analgesia (Cox and 
W einstock, 1964; Hayashi and Takem ori, 1971; Takem ori e t W., 1972) and 
re sp ira to ry  depression (M cG illia rd  and Takem ori, 1978; F lo rez  and Pazos, 
1982; Pazos and F lo rez , 1983; Pazos and F lo rez , 1984). W idely d iffe r in g  values 
fo r  apparent PA 2  have been reported , even when using the same 
agon ist/an tagonist pa ir to  investiga te  the same pharm aco log ica l e ffe c t. This 
resu lts from  d iffe rences in  the dosing p ro toco l fo r  the antagon ist and between 
the animals used by d iffe re n t groups. The blood concen tra tion  o f naloxone in
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such a s itu a tio n  is never known and is constan tly  changing so th a t the value of 
apparent pA ^ is c ru c ia lly  dependent upon the h a lf- l ife  and volume of 
d is tr ib u tio n  fo r  naloxone and upon the tim e  a t which the degree of antagonism 
is measured (T a lla rida  e t 1978). F u rthe rm ore , the apparent pAg does not 
re f le c t  the a f f in ity  o f naloxone fo r  the opioid receptors a t which the agonists 
are acting . These fundam enta l problems present extrem e d if f ic u lt ie s  in the 
comparison o f the resu lts o f d if fe re n t groups and m ore im p o rta n tly , i t  is never 
possible w ith  such an antagonist dosing p ro to co l to  assign w ith  any degree o f 
c e r ta in ty  the recepto rs invo lved in  the e ffe c t under inves tiga tion  (T a lla rida  et 
a l., 1978). In recogn ition  of the problems associated w ith  the tim e-dependency 
o f de te rm ina tion  o f apparent pA^ using the bolus dosing p ro toco l, T a lla rida  et 
a l., (1978) have developed a m ethod o f analysing the way the degree o f 
antagonism by naloxone a lte rs  w ith  tim e . This ensures th a t apparent pA^ is 
determ ined a t the tim e  o f peak antagon istic  e ffe c t when the concen tra tion  o f 
antagonist a t the re ce p to r s ites is assumed to  be p roportiona l to  the dose 
adm inistered. A lthough an im provem ent, th is  m ethod o f de te rm in ing  p A 2  s t i l l  
produces values which are p roportiona l to , ra th e r than equal to , the a f f in ity  o f 
naloxone fo r  the recep to r sites in question.
W ith  regard to  the apparent pAg de te rm ina tion  fo r  naloxone and 
a lfe n ta n il (Section 3.4.7.1) i t  was apparent th a t th is  m ethod would be 
unsa tis fac to ry , even to  compare pAg values between drugs. F irs tly , the slopes 
o f the dose response p lo ts fo r a lfe n ta n il in the presence o f naloxone were 
g rea te r than those in  its  absence so th a t dose-ratios were determ ined fro m  
pairs o f dose response p lo ts which deviated fro m  para lle lism  thus breaching a 
basic requ irem ent fo r  va lid  measurem ent o f pA 2  (F inney, 1964). Secondly,the 
second dose response p lo ts o ften  dem onstrated an upward cu rva tu re  a t h igher 
doses, reducing the le g itim a cy  o f deriv ing  potency values from  such data by 
linea r regression (Section 2.5.2). These slope increases were a ttr ib u te d  to  the
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tim e-dependent reduction  in antagonism as naloxone was e lim ina ted  during the 
establishm ent o f the second dose response re la tionsh ip , and coupled w ith  the 
assumption th a t th is d if f ic u lty  would be exacerbated by the use o f longer- 
ac ting  agonists such as su fen tan il and fe n ta n y l, provided the ra tio na le  fo r the 
developm ent o f the naloxone in fusion  p ro toco l to  determ ine pA^ (Section 
2.5.5).
4.5,4 The Naloxone Infusion Protocol
The development of an in fusion p ro toco l fo r naloxone to  provide known, 
steady-s ta te  concentra tions o f antagonist in the blood o f ra ts  overcomes fo r 
the f i r s t  tim e  many o f the problem s inherent in the bolus dosing p ro toco l 
(Section 4.5.3). The h a lf- l ife  o f naloxone antagonism was assumed to  be equal 
to  the h a lf- l ife  o f e lim ina tio n  and th is  is borne out by the s im ila r ity  o f the 
value to  those determ ined by o ther w orkers (Tepperman, e t ^ . ,  1983; T a lla rida  
et W., 1978). That the h a lf- l ife  o f naloxone is s lig h tly  g rea te r in the urethane- 
anaesthetised ra t (Section 3.4.6.1) than in conscious ra ts  (T a lla rida  e t a l., 
1978) is to  be expected because th is  anaesthetic has been reported  to  
compromise renal and hepatic fu n c tio n  in ra ts  (Maggi and M e li, 1986).
The close agreem ent o f the blood concen tra tion  o f naloxone a fte r 
in fusion as determ ined by HPLC (Section 3.4.6.2) and as ca lcu la ted  on the 
basis o f the pharm acokinetic  data supports the estim a te  o f naloxone plasma 
clearance. Both the lin e a r ity  o f the dose response p lo ts to  the fen tany l drugs 
in  the presence o f the naloxone in fus ion  and the constancy o f the magnitude of 
the response to  a single dose o f agonist over a period equ iva lent to  three h a lf-  
lives fo r  naloxone s trong ly  suggests th a t the blood naloxone concen tra tion  does 
not change s ig n ific a n tly  during the de te rm ina tion  o f dose-ratio . Tepperman e t 
^ . ,  (1983) have shown th a t the pharm acok ine tic  param eters o f naloxone in the 
ra t are independent o f dose up to  lO m g/kg  i.v . and th is  perm its  the a lte ra tio n
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o f bolus loading doses and in fusion ra tes to  a tta in  d iffe re n t desired steady- 
s ta te  blood naloxone concentra tions. The concentrations a tta ined  never 
reached or exceeded those which have been reported to  resu lt in the 
invo lvem ent o f naloxone w ith  non-opioid recep to r types (Sawynok e t W., 1979).
4.5,5 Naloxone pA^ Using the Infusion Protocol
The naloxone pA ^ values fo r antagonism o f the production  o f apnea by 
the th ree  drugs are id e n tica l, suggesting an id e n tica l recep to r in te ra c tio n  fo r  
the drugs in th is  e ffe c t.  However, the pAg values fo r  blockade of m inute  
volum e depression are c le a rly  d iffe re n t (Table 11) ra is ing the poss ib ility  th a t 
d if fe re n t recepto rs  are invo lved both fo r th is  e ffe c t as compared w ith  apnea 
and fu r th e r, fo r  each o f the drugs in  the series. The higher pA^ value fo r  
apnea than fo r  m inute  volume using the naloxone infusion p ro toco l against the 
agonist a lfe n ta n il supports the find ings w ith  th is  drug using bolus doses o f 
naloxone (Section 3.4.7.1). The p A 2  d iffe rences fo r antagonism o f the tw o  
e ffe c ts  are s im ila r in  both naloxone dosing protoco ls, thus the d iffe rences are 
confirm ed using tw o  m ethodolog ica l approaches.
W hilst d iffe rences  in  pA 2  are o ften  in te rp re ted  as an in d ica tion  th a t 
d iffe re n t recep to r populations are invo lved in the m ed ia tion  o f tw o  responses 
(Cox and W einstock, 1964) cau tion  must be employed to  a tte m p t to exclude 
other possible reasons fo r  p A 2  d iffe rences before making such an assignment 
(T a lla rida  and Jacob, 1979; Leslie , 1987). For example, Brown and P leuvry 
(1981) have shown th a t the re sp ira to ry  depression produced by a lfe n ta n il in the 
ra b b it is more sensitive  to  the antagon is tic  properties o f naloxone than th a t 
produced by fen ta ny l, which supports the findings presented in th is  thesis. 
H owever, Brown and P leuvry (1981) proposed th a t th is  d iffe rence  re la tes to  
the  low er a f f in ity  o f a lfe n ta n il than fen ta ny l fo r  opioid binding sites in v it ro . 
This is c le a rly  not the case, because the degree o f antagonism re fle c ts  the 
a ff in ity
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of the antagonist, not the agonist, fo r the sites o f action (Arunlakshana and 
Schild, 1959), M oreover, su fen tan il has higher a f f in ity  fo r  opioid binding sites 
in  v itro  than a lfe n ta n il (Section 3.3 ) ye t the re sp ira to ry  e ffe c ts  o f the fo rm e r 
are m ore easily antagonised by naloxone than those o f a lfe n ta n il (Table 11).
The low er p A 2  fo r  antagonism o f the m inute volume depressant e ffe c ts  
o f fen tany l compared w ith  equiva lent values fo r the o ther drugs cannot be 
explained by the presence o f resp ira to ry  depressant m etabo lites , because 
Schneider and Brune (1986) have shown th a t the m ost po ten t fen tany l 
m e tab o lite , 4 -hydroxy-phenethyl fen ta ny l is 1 0 - fo ld  less a c tive  on the 
e le c tr ic a lly  s tim u la ted  iso la ted  guinea-pig ileum  prepara tion  than the parent 
compound its e lf .  The poss ib ility  exists, however, th a t the p A 2  d iffe rences fo r  
antagonism o f m inute volume depression produced by the fen tany ls  arise out o f 
a d if fe re n tia l a b ility  o f drugs o f the series to  a lte r  the pharm acokinetic  or 
pharm acodynam ic param eters o f naloxone. G a rre tt et a l., (1986) showed tha t 
m orphine low ered the apparent volume o f d is trib u tio n  and plasma clearance o f 
naloxone in dogs. Aga inst a s im ila r e ffe c t fo r  the fen ta ny l series are the 
observations th a t seria l dose response p lo ts  fo r  the agonists were pa ra lle l a t 
each blood naloxone concen tra tion , and the constancy o f the pA 2  values fo r  
antagonism o f apnea produced by a ll th ree drugs (Table 11). In add ition , the 
p A 2  d iffe rences fo r  antagonism o f m inute  volume do not re la te  to  the method 
used to  dete rm ine  the p A 2  values from  the data. Schild p lo ts  fo r antagonism 
o f the re sp ira to ry  e ffe c ts  were linear, w ith  slopes not s ig n ific a n tly  d if fe re n t 
fro m  un ity , va lida ting  the de te rm ina tion  o f p A 2  fro m  ra th e r than from  the 
in te rcep t on the ord ina te  (T a lla rida  and Jacob, 1979; T a lla rida  e t a l., 1979; 
Roerig e t ^ . ,  1987). There were no s ig n ifica n t d iffe rences between the pA 2  
values determ ined by the tw o methods, however, which is not the case when 
the slope o f the Schild p lo t deviates m arkedly from  1 (R oerig , e t a l., 1987).
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D iffe rences  in the pA^ values fo r tw o e ffec ts  could also arise i f  the 
antagonist d is tribu tes  unevenly between the sites at which the agonists act to 
produce various responses. Against such a poss ib lity  in th is  instance, however, 
M cG illia rd  and Takem ori (1978) reported  tha t naloxone d is tribu tes fa ir ly  
evenly throughout the ra t and Tepperman e t ^ . ,  (1983) have shown th a t a fte r 
periphera l adm in is tra tion  s lig h tly  g rea te r concentrations of naloxone are found 
in the  bra in than in trunk blood. Thus i t  is not possible to  explain the pAg 
d iffe rences fo r  the fen tany ls  by these means.
The pAg values fo r  antagonism of the resp ira to ry  e ffe c ts  o f the Upjohn 
compounds U69,593 and U50,488H were id e n tica l to each o ther, but were more 
than one pA^ un it low er than those fo r  the  in te ra c tio n  o f naloxone w ith  the 
fen tanyls, c le a rly  in d ica ting  d iffe re n t opioid recepto r invo lvem ents fo r the 
tw o  drug classes. The evidence the re fo re  supports the assertion th a t m ore 
than one opioid recep to r is invo lved in  depression o f m inute  volume and 
production  o f apnea by the fen tany ls  and another, d iss im ila r recep to r is 
invo lved in the production  o f the re sp ira to ry  e ffe c ts  o f the Upjohn compounds.
4.5.6 Interpretation of pA^ Values in the Intact Rat
4.5.6.1 Naloxone A ffin ity for Multiple Opioid Receptors
The co rre c t in te rp re ta tio n  o f the meaning o f the pA 2  values and 
assignment o f the recep to r invo lvem ents in the resp ira to ry  e ffe c ts  o f the 
opioid drugs investiga ted  depends upon a knowledge of the a f f in ity  o f naloxone 
fo r  the various opioid recep to r types, because the p A 2  re fle c ts  the a ff in ity  o f 
naloxone fo r  the recep to r a t which the antagon ist acts to  b lock the e ffe c ts  of 
the agonist. I f  an agonist acts s im ultaneously a t two receptors to  produce an 
e ffe c t, w hich is possible because both p and 6  receptors can ex is t on the same 
neuron (Egan and N orth , 1981), then the naloxone pA 2  fo r  antagonism o f th is  
e ffe c t would lie  somewhere between the a ff in it ie s  o f naloxone fo r the two
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sites invo lved. The a ff in ity  o f naloxone fo r the m u ltip le  opioid recepto rs  jn  
vivo has not previously been determ ined, but many estim ates have been made 
in  v it ro  both in  binding studies (Wood e t ^ . ,  1981; Magnan e t 1982; James 
and G oldste in , 1984; Cheney and L a h ti, 1987) and in isolated tissues (Lord et 
^ . ,  1977; Shaw e t ^ . ,  1982; Sm ith, 1987; C la rk  e t 1988) (Table 17). There 
is general agreem ent in the lite ra tu re  th a t the a ff in ity  o f naloxone fo r  p 
receptors determ ined in various species by radioligand binding studies or 
iso la ted  tissue experim ents is approx im ate ly  In M , ranging from  0.72nM (James 
and G oldste in , 1984) to  1 . 8 nM (Magnan e t ^ . ,  1982) in brain homogenates and 
from  0.78nM (B ianche tti e t ^ . ,  1982) to  4.2nM (Shaw et a l., 1982) in iso la ted 
tissues. However, there  appears to  be considerable controversy regarding the 
5/k s e le c tiv ity  o f the antagonist under d iffe re n t conditions. For example. 
Sm ith (1987) reported  the recep to r s e le c tiv ity  o f naloxone using isolated 
tissues to  be p > 5 > k , w ith  5 and k a ff in it ie s  o f 9.6 and 15.9nM, respec tive ly . 
In con tras t to  th is, James and G oldste in (1984) employed guinea-pig bra in 
homogenates to  determ ine the 5 and k a ff in it ie s  o f naloxone, g iv ing  values o f 
13 and 2.9nM, respective ly .
A lthough there is disagreem ent concerning the a f f in ity  o f naloxone fo r  
the 6  s ite , th a t fo r  the k recep to r appears to  be less disputed, w ith  o ther 
reported  values o f 17nM (C la rk  e t ^ . ,  1988), 18nM (Magnan e t a l., 1982) and 
28nM (Cheney and L a h ti, 1987). The k a ff in it ie s  determ ined by C la rk  e t a l.,
(1988) and Cheney and L a h ti (1987) were based upon work in  which the h ighly 
k -se le c tive  opioids PD 117303 and U69,593 respective ly , were used.
A common assumption in the de te rm ina tion  o f pAg both in  v it ro  and ]n  
v ivo  is th a t the  antagonist concen tra tion  a t the recepto r is equal to  th a t in the 
bath ing  medium (Kenakin and Beek, 1987). However, th is  w ill not be the case
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i f  there  is a mechanism fo r the rem oval o f antagonist from  the recep to r- 
conta in ing  com partm en t. A t  low  bathing medium concentra tions o f 
antagonist, w hich are less than fo r the saturable rem oval process, the 
actua l concen tra tion  o f antagonist a t the recep to r w il l be low er than the 
ca lcu la ted  value. As the antagonist concentra tion  is increased in the 
construc tion  o f the Schild p lo t, the rem oval process becomes saturated and the 
tw o concentra tions become equal. This has the net resu lt o f producing curved 
Schild p lo ts (Kenakin and Beek, 1987) and under-estim ates o f p A 2 * A lthough 
the Schild p lo ts  g iven in th is thesis number only th ree  points, the re  are no 
ind ica tions of cu rva tu re  between blood concentra tions o f naloxone ranging 
from  17-275nM, thus i t  is not unreasonable to assume equivalence of blood and 
recep to r com partm ent naloxone concentra tions.
4.5.6 .2 Assignm ent o f R ecepto r Invo lvem ents in Opioid-Induced R esp ira to ry
E ffe c ts  in the In ta c t R a t
The fo llo w in g  assumptions have been made: the a ff in it ie s  o f
naloxone fo r  p and k recepto rs  are close to  the lite ra tu re  values c ite d  in  
Section 4.5.6 . 1  and tha t fo r the 6  recep to r is low er than tha t fo r the p 
recep to r. F u rthe r, th a t the  measured and ca lcu la ted  blood naloxone 
concentra tions (3.4.6.2) are equiva lent to  those at the recep to r.
The naloxone pAg values fo r  antagonism o f apnea by the fen tany ls  
are close to  9, representing naloxone K p  o f = In M . These pA 2  values strong ly  
suggest th a t the  recep to r m ed ia ting  apnea fo r  a ll the  fen tany ls  is o f the p 
type. This recep to r assignment is in con tras t w ith  the  proposal o f M artynova 
and Medvedev (1986) who suggested th a t both p and 6 ' receptors were involved 
in th is e ffe c t.  However, th e ir  conclusion rests upon the c la im  tha t D A D L is
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h ighly se lec tive  fo r 6  receptors which is not generally accepted (James and 
G oldste in, 1984; Feuerste in , 1985; Same and Kenner, 1987; De M ontis e t a l., 
1987). M oreover, the production  of apnea by the h ighly p -re ce p to r se lective  
peptide DAGO, but not by the h igh ly 6  -re ce p to r se lective  peptide, DPDPE 
(Section 3.4.12.1) in in ta c t ra ts  s trong ly supports the conclusion th a t p 
receptors alone are responsible fo r  the m ed ia tion  of apnea by opioids upon 
in travenous in je c tio n . The lack o f apneic e ffe c ts  o f h ighly se lec tive  k agonists 
ru les out any invo lvem ent o f the k recep to r sub-type in the m ediation  o f th is 
response.
The Upjohn compounds U69,593 and U50,488H both produced increases 
in  re sp ira to ry  frequency and depressions o f t id a l volume and the naloxone pAg 
values fo r  antagonism o f both these e ffe c ts  by both drugs are e n tire ly  in 
accord w ith  a pure k recep to r invo lvem ent. The pA^ values ranged from  7.55 - 
7.72 (Table 11), in  close agreem ent w ith  the naloxone pAg in  v itro  fo r the 
e ffe c ts  o f the h ighly k -rece p to r se lec tive  agonist PD 117302 upon the iso la ted 
guinea-pig ileum  o f 7.78 - 0.09 (C la rk  e t ^ . ,  1988) and w ith  the k recep to r 
binding a f f in ity  o f naloxone ]n  v it ro  o f 28 -  7nM (Cheney and L ah ti, 1987). 
This la t te r  value would be expected to give rise to  a naloxone pAg value close 
to  7.55.
The recep to r assignments fo r  the m inu te  volume depressant e ffe c ts  of 
the fen tany ls  are c le a rly  d if fe re n t from  those fo r apnea p roduction. The high 
naloxone pAg value fo r  su fen tan il in th is  regard s trong ly  suggests a p recep to r 
invo lvem ent, but the low er values fo r  a lfe n ta n il, fen ta ny l and ca rfe n ta n il 
(Table 11) im p ly  agonist in te rac tions  w ith  both a p recep to r and another opioid 
recep to r fo r  which naloxone has low er a ff in ity .  This is not considered lik e ly  to  
be a k recep to r because o f the evidence po in ting  to  the very low  a f f in ity  o f
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drugs o f the fen tany l series fo r  th is recep to r type (Magnan e t 1982; James 
and G oldste in, 1984; F rost, 1986) and the lack o f m inute volume depressant 
e ffe c ts  o f se lec tive  k agonists reported  in th is  thesis. The proposal th a t the 
p u ta tive  low er a f f in ity  recep to r is o f the <5 type appears to be fraugh t w ith  
d if f ic u lt ie s  in view  o f the high p s e le c tiv ity  o f some o f these compounds, most 
no tab ly  a lfe n ta n il (Section 3.3), However, according to  Hollenberg (1985), 'the  
non-concordance o f the ED^g fo r a b io log ica l response and the estim ated 
by measuring the binding o f agonists is probably the ru le , ra the r than the 
excep tion '.
F u rthe r, in  a recent rev iew , Feuerste in  (1985) suggests th a t a t 
s u ff ic ie n tly  high concentra tions, even h igh ly recepto r se lec tive  compounds 
may show some in te ra c tio n  w ith  th e ir  non-pre ferred  sites. The hypothesis th a t 
a 6 -rece p to r, or a t least a non-p recep to r, in te ra c tio n  con tribu tes  to  m inute  
volum e depression by fen ta ny l and c a rfe n ta n il is less con trove rs ia l in v iew  o f 
the high a f f in ity  fo r  the  6 sites in v it ro  fo r  the  la t te r  compound and its  lack o f 
binding s ite  s p e c ific ity . In add ition , the 6  recep to r se lective  peptide, DPDPE, 
produces depression o f resp ira tion  a fte r  i.c .v . adm in is tra tion , which is 
reversed by la rge, bu t not by sm all, doses o f naloxone (Section 3.4.12.2; see 
also Section 4.8).
The recep to r assignments thus fa r  made accord w ith  a hypothesis 
concerning the potency o f the drugs to  produce apnea and to depress m inute  
volume in the in ta c t ra t. The potency ra tio  fo r  these tw o  e ffe c ts  fo r  
su fen tan il (Table 8 ) suggests th a t apnea makes a considerable co n tribu tio n  to  
the m inute  volume depressant p roperties o f th is drug in the in ta c t ra t. This 
contrasts m arked ly w ith  the potency ra tio s  fo r a lfe n ta n il and, most notab ly, 
fo r  fe n ta n y l. For th is  la t te r  compound, apneas o f several seconds were o ften
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produced by low doses of fen tany l w ith  l i t t le  depression of m inute volum e, 
suggesting th a t apnea does not make a substantia l co n tribu tio n  to  the 
subsequent depression o f m inute  volum e. I f  apnea is pure ly p -re ce p to r 
m ediated and con tribu tes  d if fe re n t ia l ly  to  the depressions o f m inute volume 
produced by the drugs o f the fen ta ny l series, and i f ,  fu r th e r, the re  is a 
co n trib u tio n  fro m  both a p and a non-p recep to r m ediating m inute  volum e 
depression, then th is  could expla in  the s im ila r it ie s  between the naloxone pA^ 
values fo r  antagonism o f apnea and the d iffe rences in the naloxone pAg values 
fo r  blockade o f m inute volum e depression. M oreover, th is  hypothesis is 
testab le , fo r  b ila te ra l vagotom y removes both the apnea (Section 3.4.8) and 
the p -re ce p to r m ediated co n trib u tio n  th is  e ffe c t makes to  depression o f 
m inute volum e. This constitued  the ra tio na le  fo r the de te rm ina tion  o f 
naloxone pA^ in  b ila te ra lly  vagotom ised ra ts .
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4.6 QUANTITATIVE ANTAGONISM OF THE RESPIRATORY EFFECTS OF DRUGS
OF THE FENTANYL SERIES IN THE BILATERALLY VAGOTOMISED RAT
4.6.1 Changes in the Respiratory Depressant Properties of Opioid
Drugs in the Bilaterally Vagotomised Rat
The apnea ch a ra c te r is tic a lly  provoked by the fen ta ny l drugs in the 
in ta c t ra t is abolished by b ila te ra l vagotom y a t ce rv ica l leve l, and th is  
accords w ith  work using other opioid drugs (Sapru e t £ l., 1981; W ille tte  and 
Sapru, 1982a; Dashwood et a l., 1983; G au tre t and S chm itt, 1985). A lthough in 
a ll studies in which non-peptide opio id  agonists were employed the authors 
reported  th a t m inute  volume depression s t i l l  occurred a fte r  vagotom y, no 
q ua n tita tive  comparisons o f the potency o f drugs to  reduce m inute  volume in 
in ta c t and b ila te ra lly  vagotom ised ra ts  have appeared in the lite ra tu re . 
However, W ille tte  and Sapru (1982a) suggested th a t because the degree o f 
re sp ira to ry  depression produced by a single dose o f morphine was greate r in  
the  in ta c t ra t than in  the b ila te ra lly  vagotom ised prepara tion  th a t there  were 
both vagaliy-dependent and vagal-independent components o f the resp ira to ry  
response to opioids adm inistered in travenously.
The shorte r ac ting  compounds, a lfe n ta n il, fen tany l and su fen tan il a ll 
produced dose-related depressions o f m inute  volume whose m agnitude 
m axim ised 10-15 seconds a fte r dosing, supporting the choice of 15 seconds 
a fte r  dosing as the tim e  po in t a t w h ich  the percentage depression o f m inute 
volume in the in ta c t ra ts was ca lcu la ted . This coincidence o f tim e -po in ts  
provides ju s t if ic a tio n  fo r  the comparison, o f drug potencies in the tw o  
preparations.
The potencies o f the fen tany l drugs to  depress m inute  volume were a ll 
reduced a fte r b ila te ra l vagotomy (Table 12). The ra tio s  o f m inute volume
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ID ^q values a fte r and before vagotom y were 6  fo r sufentan il and 1 . 6  fo r 
fen tany l, supporting the hypothesis (Section 4 .5 .6 .2) th a t fo r su fen tan il, apnea 
made a considerable co n trib u tio n  to  m inute volume depression in in ta c t ra ts, 
in con tras t w ith  the p red ic tion  fo r fen ta ny l, based upon the apnea/m inute 
volume potency ra tios  (Table 8 ).
Responses s im ila r to  those seen in  the b ila te ra lly  vagotom ised ra t could 
be obtained in the in ta c t ra t  i f  repeated doses of e ithe r DAGO or m orphine 
were given p rio r to  a lfe n ta n il (Section 3.4.12.1 and 3.4.13). This could be 
explained by postu la ting  the rap id  developm ent o f tolerance to the e ffe c ts  o f 
opioids on the receptors m ed iating  apnea (Fennessy and R a ttra y , 1971; K iang 
e t ^ . ,  1983). For a lfe n ta n il, the reduction  in potency to  depress m inute  
volum e a fte r  DAGO or m orphine was reduced by a s im ila r degree to tha t a fte r 
b ila te ra l vagotom y, supporting the suggestion above. The large decrease in 
m inute volume depressant potency fo r  m orphine a fte r p rio r exposure to the 
same drug (Section 3.4.13) im p lies th a t apnea made a sizeable co n tribu tion  to  
m inute volume depression fo r  m orphine. This probably re la tes to  the 
re la tiv e ly  poor lip id  so lu b ility  o f m orphine (Kaufm an ^  1975) which is an
in d ica to r o f the ease w ith  which opioid compounds access the CNS a fte r 
periphera l adm in is tra tion  (Jacobsen e t ^ . ,  1977), The d if fe re n tia l changes in 
potency o f the fen tany ls  to  depress m inute  volume a fte r b ila te ra l vagotom y 
are not exp licab le  in the same term s because th e ir lip id  so lu b ilitie s  are very 
s im ila r to each o the r (Table 3) and the d iffe rences which do exis t do not 
co rre la te  w ith  the rank order o f changes in potency fo r a lfe n ta n il, su fen tan il 
and fen tany l.
For a ll the fen tany l drugs in th is  prepara tion, depressions of m inute 
volume were produced p r im a rily  by reductions in tid a l volum e, con tras ting  
w ith  the findings in the in ta c t ra t, in  which frequency and tid a l volume were 
depressed more equally.
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The k-se lec tive  compounds, U69,593 and U50,488H had l i t t le  e ffe c t on 
resp ira tion  in the b ila te ra lly  vagotom ised ra t. A t high doses, however, U50, 
488H produced sm all (<10%) reductions in frequency. W hilst th is e ffe c t was 
reversed by naloxone and was thus ev iden tly  opioid recep to r m ediated, its  
s ign ificance  was considered sm all, occurring  at doses which in the in ta c t ra t 
produced a doubling o f resp ira to ry  ra te .
4.6.2 Assignm ent o f R ecepto r Invo lvem ents in  Fentanyl-Induced
R esp ira to ry  Depressions in  the  B ila te ra lly  Vagotom ised R a t
The naloxone pA ^ values fo r  antagonism o f the  m inute  volume 
depressant e ffe c ts  o f su fen tan il, a lfe n ta n il and c a rfe n ta n il are h ighly 
s ig n ific a n tly  reduced a fte r b ila te ra l vagotom y, suggesting th a t the recep to r 
invo lvem ents in th is e ffe c t are d if fe re n t than in the in ta c t ra t. The largest 
fa l l  in pAg is seen fo r  su fen tan il; th is  is in accord w ith  both the findings th a t 
p -re ce p to r m ediated apnea made a la rge co n tribu tio n  to  m inute volume 
depression in  the in ta c t ra t and the 6 - fo ld  fa l l in potency to  depress m inute 
volum e a fte r  b ila te ra l vagotom y. The size o f the component of the response 
th a t was made by the recep to r fo r  which naloxone has low er a ff in ity ,  
(proposed to be the non-p, perhaps 5, recep to r), is increased in the absence of 
the apneic response. This is also true  o f a lfe n ta n il, a lthough the reductions in 
both pAg and potency to  depress m inute  volume a fte r  vagotom y are sm aller 
than w ith  su fen tan il, in accord w ith  the sm a lle r con tribu tion  th a t the vaga liy - 
dependent p roportion  o f the response made to  m inute volum e depression in  the 
in ta c t ra t. For fen ta ny l, the compound fo r  which the apneic co n tribu tio n  to  
m inute  volume depression was concluded to  be the least o f a ll the series in 
in ta c t ra ts on the basis o f the apnea/m inute  volume potency ra tio s , there was 
no s ig n ifican t change in naloxone pAg. Despite the d iffe rences in the 
b reath ing patte rns o f in ta c t and b ila te ra lly  vagotom ised ra ts , the  tw o
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preparations are considered comparable because the tim e  course o f blood gas 
param eters (Section 3.4.14) and naloxone pharm acokinetics (Section 3.4.10) 
were very s im ila r.
I t  w il l be noted tha t no a tte m p t has ye t been made to assign recep to r 
invo lvem ents to  the depressions o f the separate components o f m inute  volume 
depressions, frequency and tid a l volum e. This is because the d iffe rences in 
naloxone pA^ fo r  these e ffe c ts  fo r  any drug are so large th a t i t  is d i f f ic u l t  to  
expla in  how they could represent true  recep to r d issociation constants fo r 
naloxone fo r blockade o f the reductions o f these param eters. For exam ple, 
the pA^ values fo r antagonism o f t id a l volume and frequency reductions fo r 
a lfe n ta n il were 9.29 and 8.67, respective ly , in the  in ta c t ra t, and 8.71 and 8.35 
respective ly  in the b ila te ra lly  vagotom ised ra t. On th is basis, however, i t  
could be cautiously suggested th a t the p recep to r con tribu tion  to t id a l volum e 
depression was g rea te r than tha t to reduction  in frequency by the drugs o f th is  
series, w ith  the recep to r fo r w hich naloxone has low er a f f in ity  making a la rge r 
c o n tribu tio n  to depressions o f frequency than to  tid a l volume. W hils t i t  is not 
considered ju s tif ie d  on the basis o f the data obtained to  propose th a t p 
receptors se le c tive ly  m ediate  t id a l volum e depressions and 5 receptors, 
frequency depressions in response to opioids, ju s t such an assignment was made 
by M orin-Surun et W., (1984b) on the basis o f the results o f research in  which p 
and Ô se lec tive  peptides were adm inistered i.p . to  unanaesthetised ra ts . 
C aution is advised, however, because o f the undeniable in te rna l physiolog ica l 
links between frequency and tid a l vo lum e, and because o f the changes in the 
re la tiv e  co n trib u tio n  made by depressions o f frequency and tid a l volume to  
reductions in m inute  volum e produced by the fentanyls upon repeated dosing 
(Section 4.5.1).
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4.7 ANTAGONISM OF OPIOID-INDUCED RESPIRATORY RESPONSES
BY N-METHYL LEV ALLORPHAN
Q uaternary opioid antagonists have been used w ith  increasing frequency 
to a tte m p t to  loca te  the site(s) o f ac tion  o f opioid agonists (B ianche tti e t a l., 
1982; Brown, 1985; B ia nch e tti et al .^, 1985; Brown and Goldberg, 1985; 
B ia nch e tti e t a l., 1986) because they do not read ily  cross the b lood-bra in  
b a rrie r, bu t re la tiv e ly  l i t t le  work using these pharm acodynam ica lly- 
constra ined too ls has appeared in the lite ra tu re  in respect o f the resp ira to ry  
e ffe c ts  o f opioids. In those few  reports  availab le , quaternary compounds 
which are re la tiv e ly  poorly excluded from  the CNS a fte r  periphera l dosing 
have been used (Dashwood et ^ . ,  1983; W ille tte  e t 1983).
N -M e th y l leva llo rphan is p resently  the best-constra ined quaternary 
antagonist availab le  (B ianche tti e t ^ . ,  1986), fa ilin g  to  p re c ip ita te  the opioid 
w ithd raw a l syndrome in m orphine-dependent ra ts  even a fte r s.c. doses o f 
50m g/kg. A lthough compounds conta in ing  a quaternary n itrogen  atom, 
includ ing  N -m e thy l leva llo rphan, can produce e ffe c ts  on the autonom ic 
nervous system, presum ably because o f th e ir s tru c tu ra l homology to 
ace ty lcho line  (W ille tte  e t a l., 1983; Brown and Goldberg, 1985; Douglas and 
K itchen , 1988) the doses used in the w ork reported  in  th is  thesis are too sm all 
to produce long-lasting  cho linom im e tic  e ffe c ts  (Helen Douglas, Personal 
C om m unication).
Apneic responses to  a lfe n ta n il, fen ta ny l and su fen tan il were com ple te ly  
blocked by the lowest doses o f N -m e th y l leva llo rphan used (Section 3.4.11) and 
the m inute  volume depressant e ffe c ts  o f the drugs were reduced in a dose- 
dependent fashion. The m axim um  m inute  volume ID ^g dose ra t io  obta inable 
varied w ith  the agonist employed, being g rea test fo r  su fen tan il and low est fo r 
fen tany l in the in ta c t ra t.  This con firm s the periphera l lo ca tion  of the
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receptors which m ediate  apnea and fu r th e r, tha t the co n tribu tio n  th is  response 
makes to  m inute volume depression varies w ith in  the fen tany l series. 
M oreover, i t  con firm s tha t there  is a ce n tra lly -m e d ia te d  component to the 
m inute  volume depressant e ffe c ts  o f these opioid agonists given periphera lly .
The depressions o f m inute volum e produced by a lfe n ta n il, fen tany l and 
su fen tan il in the b ila te ra lly  vagotom ised ra t are m ediated e n tire ly  in the CNS, 
because no s ig n ifican t antagonism could be obtained by intravenous doses o f 
N -m e th y l leva llo rphan, except at 5m g/kg w ith  a lfe n ta n il, and th is  blockade 
was sm all in m agnitude. The lack o f antagonism of the re sp ira to ry  e ffe c ts  o f 
the  fen tany ls  in  th is  prepara tion  suggest th a t the re  is no periphe ra lly -m ed ia ted  
co n trib u tio n  to  m inute  volume depression except v ia  the vagus nerve, and th is 
is confirm ed by the  lack o f re sp ira to ry  e ffe c t o f the peptides, DAGO and 
DPDPE, in  the b ila te ra lly  vagotom ised ra t.
The in a b ility  o f N -m e th y l leva llo rphan to  produce s ig n ifican t 
antagonism o f the re sp ira to ry  e ffe c ts  o f the k -rece p to r se lective  compound 
U69,593 (Section 3.4.11) suggests tha t the sites o f ac tion  o f th is drug are 
w ith in  the CNS. I t  is the re fo re  somewhat surpris ing th a t the  responses to  U50, 
488H and U69,593 were abolished by b ila te ra l vagotom y (Section 3,4.8) and i t  
can only be concluded th a t e ffe re n t vagal impulses are required  fo r the 
rea lisa tion  of th e ir  e ffe c ts .
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4.8 CENTRAL ADMINISTRATION OF OPIOID COMPOUNDS
P eriphera lly  adm inistered DPDPE or the ô opioid recep to r se lective  
antagonist peptide IC I 174864 (C o tton  et 1984) both fa ile d  to in fluence 
resp ira tion  or to  antagonise the resp ira to ry  e ffe c ts  o f fen ta ny l, respec tive ly . 
H owever, the naloxone pA^ study in in ta c t and b ila te ra lly  vagotom ised ra ts 
(Section 3.4.7 and 3.4.10) suggested the invo lvem ent o f both p and a non-p, 
probably 6  , recep to r in the m ed iation  o f fen tany l drug induced re sp ira to ry  
depression. F u rthe r, the studies using N -m e th y l leva llorphan c le a rly  ind icated 
the cen tra l loca tion  o f both pu ta tive  recep to r types. Because in travenously 
adm inistered peptides access the CNS poorly (Rapoport e t ^ . ,  1980) and 
because the only non-peptide 6  re ce p to r antagonist availab le , 16-m ethyl 
cyprenorphine (Sm ith, 1987) has poor 6  s e le c tiv ity , i t  was considered necessary 
to  explore the pu ta tive  ce n tra lly - lo ca te d  6  recep to r component by means o f 
in tra ce re b ro ve n tricu la r adm in is tra tions o f DPDPE and IC I 174864.
In order to  va lida te  the 'freehand ’ i.c .v . adm in is tra tio n  technique 
employed (Porreca e t ^ . ,  1984), the degree o f antagonism produced by N - 
m ethy l leva llorphan given i.v . was compared w ith  tha t a fte r  i.c .v . 
adm in is tra tion . Saline con tro ls  had no e ffe c t upon a lfe n ta n il induced 
resp ira to ry  depression in the b ila te ra lly  vagotom ised ra t, but a 500yg i.c .v . 
dose o f the quaternary antagonist produced a greate r degree o f antagonism 
than a 5mg/kg dose given i.v . (Section 3.4.11.3). This suggests tha t in  those 
experim ents in which visual co n firm a tion  o f the co rre c t p lacem ent o f the 
cannulae by in je c tio n  o f black ink was made, a cen tra l ac tion  o f N -m e th y l 
leva llo rphan was dem onstrated.
When DPDPE was adm inistered i.c .v . (Section 3.4.12.2) a depression o f 
m inute volume was produced, p r im a rily  as a resu lt o f reduction  in  re sp ira to ry
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frequency, according w ith  the recep to r assignment te n ta tive ly  suggested in 
Section 4.6.2. Fu rthe rm ore , high but not low intravenous doses o f naloxone 
rap id ly  reversed the DPDPE-induced depression o f m inute volum e. This 
antagonist dose-dependency is considered to be strong, through c ircu m s ta n tia l 
evidence th a t DPDPE is acting  v ia   ^ receptors, in view of the much low er 
a f f in ity  o f naloxone fo r the 5 s ite  compared w ith  the p site (Hughes, 1981).
Despite the conclusion tha t a 5 recep to r component could ex ist in 
opioid-induced resp ira to ry  depression, i t  did not prove possible to  b lock the  
e ffe c ts  o f DPDPE by the 6  recep to r antagonist IC I 174864 adm inistered i.c .v . 
This was a resu lt o f the extrem e to x ic ity  o f the peptide antagonist (Section 
3.4.12.2) w hich may have been the expression o f the p agonist properties o f IC I 
174864 in  v ivo (Cohen e t ^ . ,  1986) in con tras t w ith  its  reported  6  s e le c tiv ity  
in  v it ro  (C o rb e tt et W., 1984). In tr ig u in g ly , i t  has recen tly  been reported  th a t 
doses o f IC I 174864 as high as 150pg i.c .v . in ra ts fa ile d  to labe l 6  sites in  v ivo  
(R ichards and Sadee, 1986) w hich brings in to  question the mode o f ac tion  o f 
th is  compound.
The work w ith  DPDPE however, does strong ly  suggest tha t there  are 6  
opioid receptors in the CNS w hich can m ediate resp ira to ry  depression, thus i t  
must be considered possible th a t these receptors are ac tiva ted  by the 
fen tany ls  in add ition  to  ce n tra lly - lo ca te d  p receptors in order to  produce 
depressions o f m inute volume. I f  th is  is the case, th is  find ing  lends credence 
to the recep to r assignments made in Section 4 .5 .6 . 2  and 4,6.2 on the basis o f 
the d iffe rences in naloxone pA^ values fo r  drugs o f the fen tany l series.
231
4.9 THE CARDIOVA5CU-AR EFFECTS OF THE FENTANYLS AND
POSSIBLE INFLUENCES ON THEIR RESPIRATORY PROPERTIES
I t  was not the purpose o f th is  thesis to  investiga te  in de ta il the recep to r 
mechanisms invo lved in the card iovascu lar changes produced by drugs o f the 
fen ta ny l series. However, i t  has been suggested th a t opioid-induced e ffe c ts  
upon the card iovascular system may be re fle c te d  in resp ira to ry  a lte ra tions , 
and vice versa (Feuerste in, 1985). W hilst i t  is possible to  e lim ina te  the 
in fluence  o f resp ira to ry  change on the card iovascu lar system by the use o f 
p ithed, a r t if ic ia l ly  ve n tila te d  ra ts  (M ilm e r and Clough, 1983) the reverse is not 
p ra c ticab le . In view o f th is lim ita t io n , the e ffe c ts  o f a lfe n ta n il, fen ta ny l, 
c a rfe n ta n il and su fen tan il on heart ra te  and a rte r ia l blood pressure in in ta c t 
and b ila te ra lly  vagotom ised ra ts  were studied and quan tified  (Section 3.5).
The rap id  onset o f the b radycard ic and hypotensive responses to  the 
fen tany ls  in  the in ta c t ra t p a ra lle l the re sp ira to ry  apnea discussed in Section
4.4.1 and i t  is lik e ly  th a t both re sp ira to ry  and card iovascular responses in th is  
regard are m ediated in the same manner (W ille tte  and Sapru, 1982b). This is 
supported by the observation th a t both apnea and the acute e ffe c ts  of the 
opioids on the card iovascu lar system are abolished by b ila te ra l vagotom y 
(Section 3.5) and blocked by periphera l adm in is tra tion  o f quaternary opioid 
antagonists (Dashwood ^  a l., 1983). F u rthe rm ore , the naloxone apparent pAg 
determ ined by means of bolus doses o f the antagonist against the e ffe c ts  o f 
DAGO upon heart ra te  in the in ta c t ra t was 7.89 - 0.12 (Helen Douglas, 
Personal C om m unication), This value is close to  tha t determ ined in the same 
manner fo r  the apneic response to  a lfe n ta n il o f 7.90 -  0.07 (Section 3.4.5) 
co n firm ing  th a t both responses have a common recep to r m ediation  (p) and a 
common ascending neural connection.
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In con tras t to the resp ira to ry  response to  the fen tanyls, su fen tan il, 
a lfe n ta n il and fen tany l its e lf  a ll produced secondary pressor responses on the 
card iovascu la r system . M oreover, the potencies o f the drugs to produce these 
secondary e ffe c ts  were unaltered by vagotom y, suggesting th a t the c e n tra lly -  
m ediated card iovascu lar and resp ira to ry  e ffe c ts  o f the fen tany ls  in th is 
p repara tion  do not have a common mechanism. The opioid recep to r types 
m ed ia ting  these secondary card iovascu lar responses are unknown.
W hils t the rank order o f potencies o f the drugs o f the fen ta ny l series to  
produce changes in heart ra te  and blood pressure were the same as fo r  the 
re sp ira to ry  responses, the rank order o f the e ffe c ts  on the card iovascu lar 
system at equ i-resp ira to ry  depressant doses was d iffe re n t from  the order o f 
the PA 2  values (Section 3.5). Thus i t  is not possible to  expla in  the apparently  
d if fe re n t recep to r involvem ents fo r  the drugs on the resp ira to ry  system by 
suggesting a d if fe re n tia l in fluence  o f the drugs on the card iovascu lar system .
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4.10 THE jj-  ISORECEPTOR CONTROVERSY
I t  has been reported th a t there is a common, high a f f in ity  binding site  
in bra in  which mediates the analgesic e ffe c ts  of peptide and non-peptide 
opioids (Pasternak, 1981). This has been te rm ed the isoreceptor and i t  has 
been fu r th e r proposed tha t ^ 2  and <5 receptors m ediate opioid-induced 
re sp ira to ry  depression (L ing e t a l., 1985). The existence o f and Pg 
isoreceptors has not as ye t found general acceptance (H o ilt et 1985; Dray, 
Nunan and W ire, 1987), the evidence fo r  th is  sub-division being o rig in a lly  based 
on the resu lts o f rad io ligand binding studies (W olozin and Pasternak, 1981; 
Zhang and Pasternak, 1981; B ua tti and Pasternak, 1981), The biphasic 
in h ib itio n  p lo ts o f the binding o f [ H 1 D A D L by morphine or vice versa have 
been in te rp re te d  as ind ica ting  the existence o f the p^ binding site  but i t  has 
subsequently been shown th a t these find ings are explicab le  in term s of p and ^ 
b inding only (Rothman, 1986; Same and Kenner, 1987). F u rthe r, although some 
workers have reported  se lec tive  antagonism o f morphine-induced analgesia by 
the proposed Pj^-selective antagonist, naloxonazine (Pasternak and Hahn, 1980) 
w ith o u t e ffe c t on m orphine-induced re sp ira to ry  depression (L ing et al., 1983) 
others have been unable to reproduce th is  find ing  (Rourke and Shaw, 1984). 
M oreover, D ray and Nunan (1984) have shown tha t jn  v ivo , naloxonazine does 
not possess s e le c tiv ity  even fo r  the classica l p recepto r, but also acts as a 
5 antagonist.
I t  has also been cla im ed tha t the opioid analgesic m eptazino l (Stephens 
e t ^ . ,  1978) displays s e le c tiv ity  in  v itro  (B lu rton  e t ^ . ,  1983) and in  v ivo 
(Spiegel and Pasternak, 1984) fo r  the p u ta tive  p^ recep to r. However, B ill et 
a l., (1983) and C ow lrick  and Shepperson (1985) have concluded th a t the 
exp lanation  fo r the lim ite d  a b ility  o f m eptazino l to induce resp ira to ry  
depression lies w ith  its  cho linom im e tic  p roperties. In support of th is  concept,
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i t  has been shown th a t a c tiva tio n  o f cho line rg ic  mechanisms in the medulla 
can reverse opioid-induced depression o f resp ira tion  (W ille tte  et W., 1987) and 
fu rth e rm o re , th a t the anticho linesterase physostigm ine se lec tive ly  antagonises 
m orphine-induced re sp ira to ry  depression but not analgesia (W einstock e t 
1980). Because o f th is  evidence, and the absence of any in d ica tion  o f high 
a f f in ity  b inding in e ithe r sa tu ra tion  (Section 3.2.2) o r in h ib itio n  studies 
(Section 3.3) i t  was considered im prudent to  include the poss ib ility  o f p 
isoreceptors when making recep to r assignments in th is thesis.
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4.11 C O NCLU DING  REMARKS A ND FU R TH ER  WORK
Studies on the e ffe c ts  o f opioids on resp ira tion  in the ra t are legion, but 
a ttem p ts  to define the opioid recep to r invo lvem ents in these e ffe c ts  have been 
concentra ted on the use o f se lec tive  or non-se lective  opioid agonists, and a 
comparison of th e ir  potencies to  pertu rb  resp ira tion  (Hassen et ^ . ,  1982; 
P fe if fe r  e t 1983; Faden and Feuerste in , 1983; M orin-Surun e t ^ . ,  1984b; 
Hassen et 1984a and b; Haddad e t 1984; H urle  et ^ . ,  1985; Schaeffer 
and Haddad, 1985; C a s tillo  e t a l., 1986; M artynova and Medvedev, 1986; 
Haddad and Lasala, 1987). The lim ita t io n s  o f such m ethodology have been 
reviewed (Feuerste in , 1985). Some im provem ent was provided by the 
developm ent o f methods which p e rm itte d  the de te rm ina tion  o f an equiva lent 
to  a pA 2  in v ivo  (Sm its and Takem ori, 1970) which have been w ide ly employed 
in studies o f opioid recep to r invo lvem ent in  re sp ira to ry  depression (M cG illia rd  
and Takem ori, 1978; F lo rez and Pazos, 1982; Pazos and F lo rez, 1983; Pazos 
and F lo rez , 1984), despite the re s tr ic t iv e  nature o f the in fo rm a tion  thus 
obtained (Section 4.5.3).
The d if f ic u lt ie s  and problem s inherent in previously used methods 
p a r tia lly  expla in  the d iffe rences in the recep to r assignments in  opioid-induced 
re sp ira to ry  depression which have appeared in the lite ra tu re . W h ils t some 
groups have c la im ed an exclusive p recep to r m ediation  o f th is  e ffe c t (Hassen 
e t ^ . ,  1982; P fe if fe r  e t a l., 1983) and others suggest a prom inent but not 
exclusive ro le  fo r recepto rs  (Faden and Feuerste in , 1983; Hassen e t a l., 
1984b; Hayes et 1985) i t  has also been proposed th a t both p and 6 recep to r 
types are im portan t (M cG illia rd  and Takem ori, 1978; Ward and Holaday, 1982; 
Pazos and F lo rez , 1983; Haddad et a l., 1984; Morin-Surun e t ^ . ,  1984b; H urle  
e t a l., 1985) and conversely th a t opio id -induced re sp ira to ry  depression is 
p r im a rily  6 -receptor m ediated (Haddad and Lasala, 1987).
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I t  is now m ore w ide ly  accepted th a t the use of characterised 
antagonists o ffe rs  the best m ethod to  define recep to r involvem ents (Leslie , 
1987) since the m a them atica l re la tionsh ip  between the recep to r binding o f and 
blockade o f response by antagonists is s im pler and the re fo re  more accessible 
to study than th a t between binding and response fo r agonists (Section 1.7.2.2). 
The new method described in  th is thesis fo r the de te rm ina tion  of pA^ in v ivo 
by the in fusion o f naloxone to  d if fe re n t known, steady-sta te  blood 
concentra tions has provided data which im p lies tha t the a ff in it ie s  o f naloxone 
fo r  m u ltip le  opioid recep to r sites |n  v ivo  closely matches those values 
previously determ ined in v it ro  (4.5.6,1). This is more lik e ly  to  be the case fo r 
antagonists than fo r agonists because o f the  lack o f e ffe c t o f sodium ion in 
blood on antagonist a ff in it ie s  (P e rt and Snyder, 1974; Cheney and L a h ti, 1987) 
and th is  c h a ra c te ris tic  fu r th e r heightens the d es irab ility  o f the use o f 
antagonists, not agonists, to  define recep to r Involvem ents in v ivo .
I t  is believed th a t th is  new m ethod provides, fo r the f ir s t  tim e  in  v ivo, 
pAg data which can be d ire c tly  in te rp re te d  in term s o f recep to r invo lvem ent. 
I t  is concluded from  the use of th is  technique th a t p opioid receptors alone 
m ediate the periphera l e ffe c ts  o f in travenously-adm in iste red  opioids on 
resp ira tion , heart ra te  and blood pressure, but th a t both p receptors and 
another recep to r fo r  which naloxone has low er a ff in ity ,  possibly ô , are 
responsible fo r  the depression o f m inute  volume w hich  is not vaga lly - 
dependent. W hilst k opioid receptors in the CNS c le a rly  can in fluence 
resp ira to ry  ra te  and tid a l volum e, s tim u la tion  o f th is  recep to r type does not 
produce resp ira to ry  depression (F igure 53).
A lthough these conclusions are drawn from  a study o f the resp ira to ry  
e ffe c t o f opioids in the urethane-anaesthetised ra t, w ith  p a rticu la r re ference
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CNS
P and non-P
Increase in FrequencyAPNEA(selectively blocked Reduction in Tidal VolumeReduction in Frequency
No change in Minute VolumeReduction in Minute Volume
PERIPHERY
Figure 53 Location of and Respiratory Effects
Resulting from  Stimulation of M ultiple Opioid Receptors 
in the Anaesthetised R at
The schem atic summarises the resu lts obtained and described in th is  thesis. 
Apnea is produced by p recep to r s tim u la tion  in the periphery on ly. Both p and 
non-p receptors in  the CNS m ediate depression o f frequency, t id a l volume and 
m inu te  volum e. The depressive e ffe c ts  o f Ô recep to r s tim u la tio n  in  the CNS 
are expressed la rge ly  on frequency. C e n tra lly  located k recepto rs  m ediate  
opposite e ffe c ts  on frequency and t id a l volume, leaving m inu te  volum e 
unchanged.
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to  the fen tany l drug series, i t  is probable th a t s im ila r results would have been 
obta ined in  the unanaesthetised anim al, since Pazos and F lorez (1983) reported  
th a t the apparent naloxone pA^ fo r  antagonism o f opioid-induced resp ira to ry  
depression was the same in both s itua tions. F u rthe r, i t  is considered un like ly  
th a t the a ttitu d e  o f the anim al had any bearing on the resp ira to ry  depressant 
potency o f the opioids (M auderly and G erlach, 1987) in con trast to  the 
apparent im portance o f th is variab le  on the m agnitude of the card iovascular 
responses to  opioids (Sapru and K riege r, 1979). In add ition , o f a ll the 
anaesthetics su itab le  fo r use in sm all labo ra to ry  animals, urethane is least 
lik e ly  to  in fluence  the outcom e of the study by v irtu e  o f its  m in im al e ffe c ts  on 
resting  re sp ira to ry  param eters (Sapru and K rie g e r, 1979; Hughes et 1982; 
Maggi and M e li, 1986; Carruba e t ^ . ,  1987).
There is l i t t le  doubt tha t in the ra t p opioid receptors are p rim a rily  
responsible fo r  the m ed ia tion  o f the re sp ira to ry  depressant e ffe c ts  o f opioids 
and th a t k receptors are re la tiv e ly  un im portan t in th is  regard. However, the 
assertion th a t the non-p recep to r com ponent (Section 4.5.6.2) is in fa c t a 6 
recep to r is open to  question. The s treng th  o f th is assignment could be 
increased i f  a re ference  naloxone pA ^ value fo r an e ffe c t known to  be 
m ediated by the 6 recep to r could be obtained; such an e ffe c t as analgesia 
produced by in tra th e ca l DPDPE may be a su itab le  candidate (Rodriguez e t a l., 
1986).
The naloxone in fusion  p ro toco l could be read ily  m od ified  in order to 
investiga te  opio id  recep to r invo lvem ents fo r  o ther e ffe c ts  or in o ther species, 
provid ing  th a t the plasma clearance o f the antagonist could f ir s t  be 
determ ined and a more sensitive  a n a ly tica l m ethod fo r measurement o f blood 
naloxone concen tra tion  would thus be desirable.
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